matchedPattern,context,lineNumber,columnNumber,publicationName
3243A > G,"...n association with other organs involvement, like 3243A > G, 3260A > G, 3303C > T in the tRNALeu (UU...",48,669,Acta_Myol_2011_Jul_30(1)_9-15.txt
4317A > G,"...R) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8...",48,769,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"...ene (MTTK), 9997T > C in the tRNAGly gene (MTTG), 12297T > C in the tRNA Leu(CUN)(MTTL2) and 15923A ...",48,894,Acta_Myol_2011_Jul_30(1)_9-15.txt
15923A > G,"...MTTG), 12297T > C in the tRNA Leu(CUN)(MTTL2) and 15923A > G in the tRNAThr gene (MTTT)",48,937,Acta_Myol_2011_Jul_30(1)_9-15.txt
3303C > T,...usually associated to the mutations 3260 A > G or 3303C > T in the tRNALeu (UUR) gene (MTTL1),50,226,Acta_Myol_2011_Jul_30(1)_9-15.txt
3303C > T,...usually associated to the mutations 3260 A > G or 3303C > T in the tRNALeu (UUR) gene (MTTL1),50,226,Acta_Myol_2011_Jul_30(1)_9-15.txt
9957T > C,"...308T > C, various MT-ND5 gene mutations, MTCOXIII 9957T >",135,59,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344A > G,"MTTK 8344A > G, less frequent 8356T > C mutation",144,7,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > G,MT-ATPase 6 8993T >,155,14,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344 A > G,...ested MERRF patients carry the mitochondrial MTTK 8344 A > G mutation (63). Other symptoms may inclu...,198,237,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause a neurodegene...,203,49,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause a neurodegene...,203,49,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause a neurodegene...,203,49,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) in a Leig",398,28,Acta_Myol_2011_Jul_30(1)_9-15.txt
308 G>A,TNF 	6p21.3	-308 G>A	rs1800629	Activation of osteoclasts and ma...,51,14,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
308 G>A,TNF 	6p21.3	-308 G>A	rs1800629	Activation of osteoclasts and ma...,51,14,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
172G > T,118. Lu J  Wang LE  Xiong P    172G > T variant in the 5' untranslated region of ...,565,32,Acta_Otorhinolaryngol_Ital_2012_Feb_32(1)_1-11.txt
-1237T>C,"...d the risk of Hodgkin lymphoma in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 19...",79,72,Adv_Hematol_2011_Nov_29_2011_736261.txt
-938C>A,"...a in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 1944C>G gene polymorphisms and ...",79,101,Adv_Hematol_2011_Nov_29_2011_736261.txt
13145A>G,"...ngle nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. ...",4,1418,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...red to non-carriers. Similarly, CT/TT genotype at 14943C>T had a significantly higher prevalence of ...",4,1803,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,...ngs suggest that the PTPN22 gene polymorphisms at 20628A>G and 14943C>T may enhance serum specific I...,4,1949,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,PTPN22 gene polymorphism (1858C>T) impairs T-cell signaling and may influenc...,13,27,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,"...d five SNPs of the PTPN22 gene, one in promoter (-1123G>C), one in exon (1858C>T) and three in intro...",22,181,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"... in exon (1858C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previous reported...",22,244,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...combination of the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2",22,664,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,"...f the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2",22,677,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...e, CU patients with the GG homozygous genotype at 20628A>G exhibited a significantly higher prevalen...",29,114,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...=0.047; Fig. B). Similarly, the CT/TT genotype at 14943C>T was associated with a significantly highe...",29,483,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,... play important role in the polymorphism. The SNP 1858C>T is the most prevalent polymorphism in a Eu...,34,455,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...18 The present study found that both 20628A>G and 14943C>T were associated with a higher prevalence ...,36,406,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,... intronic polymorphisms of PTPN22 at 20628A>G and 14943C>T enhances serum specific IgE responses to ...,43,65,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,... of serum specific IgE to TSST-1 according to the 20628A>G polymorphism. (B) Prevalence of serum spe...,50,186,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,13145A>G	Forward	tcccaaatcatcctccagaa,58,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,14943C>T	Forward	gtctaacccctttgggcttc,61,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,14943C>T	Forward	gtctaacccctttgggcttc,61,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,1858C>T	Forward	gagtgcagtggcacaatcat,67,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,14943C>T (rs11582409)	CC	276 (67.5%)	246 (63.4%)	0...,99,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
677 C>T,...tions are known to modulate disease risk in MTHFR 677 C>T individuals (31). It may be important to c...,189,1161,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
113G > T,"LHX2	Exon 1	Chr9: 125,814,336	rs7868184	c.-113G > T	4/97 (4)	5′-UTR",122,44,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
21G > T,"Intron 3	Chr9: 125,823,178	n/a	c.728–21G > T	5/97 (5)	Intronic, not conserved",124,39,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
22 G > A,"We observed one heterozygous change in SOX2: c.*22 G > A (exon 1 + 22 bp) in two patients, includi...",143,49,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
2C>T,Con-3	VU1203	DDX11	 IVS22+2C>T	Mother of VU1202	[19],73,27,Anemia_2010_Jul_18_2010_565268.txt
109G>T,"...PFH due to a HBG2 gene promoter mutation (HBG2:g.-109G>T). This mutation, located at the 3′ end of t...",3,1663,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...tudies and DNA analysis revealed that the HBG2:g.-109G>T mutation is also found in the family member...,3,1980,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...1a). Also, 31 heterozygotes for the silent HBB:g.-101C>T β-thalassemia mutation have been included (...",19,264,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...oter mutation (depicted in black) and the HBG2:g.-158C>T polymorphism (depicted in light gray) or th...,20,200,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...vel HBG2:g.-109G>T mutation and the silent HBB:g.-101C>T β-thalassemia mutation (I-3; see also Fig. ...,22,164,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...the gene’s transcription initiation site (HBG2:g.-109G>T; Fig. 2b). DNA sequencing did not reveal an...,48,521,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...tween positions −672 and +25. Neither the HBG2:g.-158C>T (XmnI) nor the HBG1:g.-225-222(AGCA)del pol...,48,729,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...II-3) were compound heterozygotes for the HBG2:g.-158C>T polymorphism and the novel HBG2:g.-109G>T m...,53,245,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...g.-109G>T promoter mutation and the silent HBB:g.-101C>T β-thalassemia mutation. The HBG2:g.-109G>T ...,53,675,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...g.-109G>T promoter mutation and the silent HBB:g.-101C>T β-thalassemia mutation. The HBG2:g.-109G>T ...,53,675,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...halassemic chromosomes, bearing the silent HBB:g.-101C>T mutation nor in 209 normal (nonthalassemic)...",53,825,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...pectively, in order to assess whether the HBG2:g.-109G>T mutation affects protein binding in vitro. ...",55,569,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...riments [18], these data suggest that the HBG2:g.-109G>T mutation is responsible for the resulting n...",55,1777,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201C>T,"...econd most frequent type, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No d...",61,379,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,The HBG2:g.-109G>T mutation was found both in heterozygosity a...,63,13,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...ll as in compound heterozygosity with the HBG2:g.-158C>T (XmnI) polymorphism and the silent HBB:g.-1...,63,117,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...m itself exerts a silencing effect on the HBG2:g.-109G>T mutation or (b) another yet unidentified ci...,63,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,The HBG2:g.-109G>T mutation resides at the 3′ end of the dista...,65,13,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"... reactivation in the adult stage, (b) the HBG1:g.-117G>A and HBG2:g.-109G>T reside on different gene...",67,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-588 A>G,...DNA polymorphism of the Agamma globin gene (Agamma-588 A>G) is linked with the XmnI polymorphism (Gg...,84,110,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,"... A>G) is linked with the XmnI polymorphism (Ggamma-158 C>T). Hemoglobin 19:419–423, doi:10.3109/0363...",84,395,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,...hereditary persistence of fetal hemoglobin [Agamma-158 C>T] results from two independent gene conver...,85,435,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-201 C->T,"...agnostou A Karababa P  (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations in the promoter reg...",95,115,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,... Sabine confirms the functional role of the Agamma-158 C>T mutation in gamma-globin gene transcripti...,99,297,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,... Sabine confirms the functional role of the Agamma-158 C>T mutation in gamma-globin gene transcripti...,99,297,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
835 T > A,... in one patient. We detected a novel mutation (c. 835 T > A) in exon 6 in our patient,48,714,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
835 T > A,... in one patient. We detected a novel mutation (c. 835 T > A) in exon 6 in our patient,48,714,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
163T>C,"...1, compared to A101 alleles (1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C i...",9,507,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"...tron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7). We found only one nucleotide di...",9,549,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"... between the cis-AB01 allele and the A105 allele, 803G>C, in contrast to the three nucleotides that ...",9,657,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
1142C>T,"...mutations compared to the A101 allele as follows: 1142C>T in intron 4, 163T>C and 179C>T in intron 6...",15,182,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
163T>C,"... the A101 allele as follows: 1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C i...",15,203,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
467C>T,"...42C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. The cis-AB01 allele h...",15,234,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"...tron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. The cis-AB01 allele has the only...",15,245,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
326T>G,"...leotide polymorphisms in the human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequenc...",7,97,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...leotide polymorphisms in the human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequenc...",7,97,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequency of -838A carriers was signi...",7,126,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequency of -838A carriers was signi...",7,126,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered relative to ...",21,515,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,...according to Genbank accession number AB003688). +326T>G (V109G) and -79C>T have been previously des...,21,642,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,... accession number AB003688). +326T>G (V109G) and -79C>T have been previously described (rs2066827 an...,21,662,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...pectively), and -838C>A is a novel polymorphism. +326T>G (V109G) is a missense polymorphism in exon ...",21,776,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,...250 controls. The frequencies for the -79C>T and +326T>G (V109G) polymorphisms did not differ betwee...,23,352,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,Functional effect of the -838C>A polymorphism in the promoter region of the ...,25,27,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...ated with MI, we sought to determine whether the -838C>A genetic variation has functional consequenc...",26,122,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,"...olymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candidates to m...",38,58,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,-79C>T	F: TGATCAGCGGAGACTCGGCG,95,1,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotid...",101,39,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,-838C>A*,103,3,BMC_Biol_2004_Apr_2_2_5.txt
163T > A,... a leucine to-methionine substitution at position 163T > A (PON1 L55M). Both independently influence...,24,202,Arch_Med_Sci_2015_Jun_19_11(3)_513-520.txt
421C>A,"...C19*2 (rs4244285), CYP2C19*17 (rs12248560), ABCG2 421C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH...",7,666,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...A2*1F, (CYP1A2 163C>A, rs762551) and DHODH (DHODH 19C>A, rs3213422) [3,6,7]) were also studied. DHOD...",20,785,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,...ted that while 0 of 14 who had the AC genotype at 421C>A ABCG2 ceased leflunomide as a result of dia...,121,791,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,ABCG2 421C>A (rs2231142)	AC	6/14 (42.9%)	1.297 (0.527 to...,132,7,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
119846C>T,"...ted two novel mutations (NC_010450.3:g. 99514A>G, 119846C>T) by DNA sequencing and polymerase chain ...",7,759,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,...tions with teat number trait in these breeds. The 99514A>G mutation showed an extremely significant ...,7,1071,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...TT”. Our findings suggested that the 99514A>G and 119846C>T mutations of LEF-1 affected porcine teat...,7,1651,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the 3′ end of LEF-1 mRNA a...",18,47,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the 3′ end of LEF-1 mRNA a...",18,47,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...s used to detect the polymorphism of 99514A>G and 119846C>T loci in porcine LEF-1 gene. Aliquots of ...,36,76,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...amino acids. Two novel mutations (NC_010450.3: g. 99514A>G, 119846C>T) were firstly detected by DNA ...",52,223,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...h the Hardy-Weinberg equilibrium (p>0.05). In the 99514A>G mutation, low level PIC was observed in H...",55,379,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...h the Hardy-Weinberg equilibrium (p>0.05). In the 99514A>G mutation, low level PIC was observed in H...",55,379,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"The frequencies of widespread allele “A” in 99514A>G mutation ranged from 0.5536 to 0.9118, an...",58,45,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"The frequencies of widespread allele “A” in 99514A>G mutation ranged from 0.5536 to 0.9118, an...",58,45,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"To further observe the correlation between the 99514A>G and the 119846C>T mutation, the haplotype...",68,48,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,...e was a 1351T>C (NM_001129967.1) transition and a 1666A>C (NM_001129967.1) transversion found in the...,81,187,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,...e was a 1351T>C (NM_001129967.1) transition and a 1666A>C (NM_001129967.1) transversion found in the...,81,187,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,...e was a 1351T>C (NM_001129967.1) transition and a 1666A>C (NM_001129967.1) transversion found in the...,81,187,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,...ransversion found in the 3′ end of LEF1 mRNA. The 1351T>C locus had highly significant associations ...,81,263,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,...ransversion found in the 3′ end of LEF1 mRNA. The 1351T>C locus had highly significant associations ...,81,263,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...(p = 0.017), but no significance in BM, while the 119846C>T mutation displayed significant associati...",81,980,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...ciated with higher teat numbers. In addition, the 99514A>G mutation itself demonstrated a synonymous...",81,1378,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"According to analysis of PIC, the 99514A>G mutation within porcine LEF-1 gene displa...",83,35,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,Table 2 Genetic indexes of the 99514A>G and 119846C>T mutation within porcine LEF...,140,32,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,Table 2 Genetic indexes of the 99514A>G and 119846C>T mutation within porcine LEF...,140,32,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	GZ	0.3787	0.6212	2.6406	0.3537,143,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...Genotypic and allelic frequencies of 99514A>G and 119846C>T mutation within porcine LEF-1 gen,153,59,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	GZ	198	78(0.3939)	111(0.5606)	9(0.0455)	...,172,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	GZ	198	78(0.3939)	111(0.5606)	9(0.0455)	...,172,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
002T>C,"g.15,002T>C	74,168,599	T4A	0.000	-",21,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
041G>A,"g.15,041G>A	74,168,560	V17M	0.000	-",23,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
108C>G,"g.15,108C>G (rs34604640)	74,168,493	P39R	0.000	-",25,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
255G>A,"g.15,255G>A (rs17221833)	74,168,346	R88H	0.000	-",37,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...r g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A (rs17215437 encoding R83H), based on data f...",44,118,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"frequency in controls	g.15,190T>C (F66F",47,28,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...th g.15,190T>C (rs2270676 encoding F66F) and g.15,240G>A (rs17215437 encoding R83H) map to a highly ...",76,274,Behav_Brain_Funct_2011_Sep_7_7_39.txt
47086497C>T,"...en identified in an unrelated clinical case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (h...",91,889,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
308 G>A,"...posure. For example, SNPs in the TNF-α gene (eg, −308 G>A) affected the inflammatory response of eld...",77,298,Biologics_2011_Jan_19_5_7-19.txt
308 G>A,"...posure. For example, SNPs in the TNF-α gene (eg, −308 G>A) affected the inflammatory response of eld...",77,298,Biologics_2011_Jan_19_5_7-19.txt
9435 T > A,MAs	2	M	c.5946delT	9435 T > A	Cerebellum	Ashkenazi Jewish Sibling of ...,33,20,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,MB	2.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the following	[1...,38,25,Biomark_Res_2015_Jun_6_3_13.txt
3A > G,MB	2	NR	c.3264dup	c.IVS19 + 3A > G (c. 8487 + 3A > G)	NR	-	[21],47,29,Biomark_Res_2015_Jun_6_3_13.txt
3A > G,MB	2	NR	c.3264dup	c.IVS19 + 3A > G (c. 8487 + 3A > G)	NR	-	[21],47,29,Biomark_Res_2015_Jun_6_3_13.txt
1195G>A,"...sms. In conclusion, NFKB1 -94 ins/del and COX-2 (-1195G>A) polymorphisms may be, respectively, assoc...",7,1382,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... polymorphism, NFKBIA-826C/T polymorphism, COX-1 (50C>T) polymorphism, and COX-2 (-1195G>A) polymorp...",14,1079,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T) Polymorphis,36,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A) Polymorphis,40,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...ols in the genotypic distribution was the COX-2 (-1195G>A) polymorphism. Among the cases, 71, 269, a...",54,148,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"For COX-2 (-1195G>A) polymorphism, a significantly increased p...",64,13,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"... smoking status was observed only for the COX-2 (-1195G>A) polymorphism (P < 0.01), in which a signi...",71,245,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...the interactions between COX-2-1195G>A and COX-1 (50C>T) polymorphisms, interaction between COX-2 (-...",74,361,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...the interactions between COX-2-1195G>A and COX-1 (50C>T) polymorphisms, interaction between COX-2 (-...",74,361,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...ns/del, NFKBIA-826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms, with prostate cancer risk ...",77,200,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...y COX-1 and COX-2 genes, respectively. The COX-1 (50C>T) polymorphism is located within the coding r...",84,362,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...y COX-1 and COX-2 genes, respectively. The COX-1 (50C>T) polymorphism is located within the coding r...",84,362,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...y COX-1 and COX-2 genes, respectively. The COX-1 (50C>T) polymorphism is located within the coding r...",84,362,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... first to evaluate the association between COX-1 (50C>T) polymorphism and prostate cancer risk, wher...",84,1614,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...ymorphism, NFKBIA-826C/T polymorphism, and COX-1 (50C>T) polymorphism. There are several limitations...",86,291,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A)	 	 	18.34	<0.01,124,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A)	 	 	 	 ,170,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A)	 	 	 	 ,170,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T)	 	 	 	 ,192,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
3494T>C,"...s used as a template to generate point mutations, 3494T>C (L1165P), 4229C>T (T1410M), 4937T>C (M1646...",20,146,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4937T>C,"...nt mutations, 3494T>C (L1165P), 4229C>T (T1410M), 4937T>C (M1646T), 6187_6191delCTCTA (L2063X), and ...",20,182,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
6566A>G,"...4937T>C (M1646T), 6187_6191delCTCTA (L2063X), and 6566A>G (Y2189C) (Figure 1), using the QuickChange...",20,232,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
3494T>C,Leucine-rich repeat (LRR)	3494T>C	L1165P	1	0	Age of onset around 47 years. S...,88,27,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
3494T>C,Leucine-rich repeat (LRR)	3494T>C	L1165P	1	0	Age of onset around 47 years. S...,88,27,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4229C>T,Ras of complex proteins (ROC)	4229C>T	T1410M	19	11	Middle-age to late onset of d...,92,31,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
17T>A,"...oduced into the T7 promoter region (for example, −17T>A denotes that thymine at the −17th position i...",166,266,Biotechnol_Biofuels_2016_Nov_1_9_234.txt
2A>G,32	2	−	−	Intron 9/IVS9+2A>G,68,24,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
2A>G,32	2	−	−	Intron 9/IVS9+2A>G,68,24,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
2581G>A,"...he protein. The third missense alteration, D861N (2581G>A) in exon 14, was detected in a UK patient ...",37,1392,BMC_Cancer_2006_Jun_1_6_145.txt
2581G>A,"PAP211	14	2581G>A	D861N	HPP*, 58 years, UK	mother, CRC, 36 y...",91,11,BMC_Cancer_2006_Jun_1_6_145.txt
-36 G>A,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C...",167,9,BMC_Cancer_2008_May_28_8_152.txt
35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,28,BMC_Cancer_2008_May_28_8_152.txt
271 G>A,...rapy. We investigated the characteristics of the -271 G>A polymorphism of the KDR gene to gain infor...,4,195,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Frequency of the -271 G>A polymorphism genotypes and their relations...,45,19,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...requency of its genotypes (Fig. 1). A search for -271 G>A polymorphisms in the single nucleotide pol...,46,517,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The correlations between the -271 G>A polymorphism genotype and the patients' cl...,54,31,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism was not related to the KDR pr...,91,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism was not related to the KDR pr...,91,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...expression. There was no correlation between the -271 G>A genotype and KDR protein level (Table 3),92,188,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...expression. There was no correlation between the -271 G>A genotype and KDR protein level (Table 3),92,188,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Table 3 Association of -271 G>A polymorphism genotypes with KDR protein ex...,96,25,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...er's exact test). These results suggest that the -271 G>A polymorphism may not be associated with a ...,106,291,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...ctor-binding sites [29]. We hypothesize that the -271 G>A polymorphism is contained in a response el...,108,472,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...ctor-binding sites [29]. We hypothesize that the -271 G>A polymorphism is contained in a response el...,108,472,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...mRNA and KDR protein in association with the KDR -271 G>A polymorphism genotype in tumor tissues of ...,113,106,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...mRNA and KDR protein in association with the KDR -271 G>A polymorphism genotype in tumor tissues of ...,113,106,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,... in NSCLC patients. Our results suggest that the -271 G>A polymorphism of the KDR gene may be a func...,113,349,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,... in NSCLC patients. Our results suggest that the -271 G>A polymorphism of the KDR gene may be a func...,113,349,BMC_Cancer_2009_May_12_9_144.txt
9106C>T,BR342	44+52 CBC	9106C>T	Q2960X	3	+ (8)	+ (3)	2+	0.006	0.182	0.187	...,67,17,BMC_Cancer_2009_Oct_10_9_360.txt
4450C>T,BR450	48	4450C>T	Q1408X	1	+ (7)	+ (7)	-	0.010	0.044	0.054	2...,75,10,BMC_Cancer_2009_Oct_10_9_360.txt
2351T>G,BR437	50	2351T>G	A744A	1	+ (5)	+ (3)	1+	0.000	0.014	0.015	3...,91,11,BMC_Cancer_2009_Oct_10_9_360.txt
1186A>G,BR647	49	1186A>G	Q356R	3	+ (8)	+ (7)	1+	0.005	0.010	0.015	3...,97,11,BMC_Cancer_2009_Oct_10_9_360.txt
1186A>G,BR658	43	1186A>G	Q356R	3	+ (6)	+ (6)	2+	0.001	0.069	0.070	3...,99,11,BMC_Cancer_2009_Oct_10_9_360.txt
1767A>G,1767A>G	N550H,105,4,BMC_Cancer_2009_Oct_10_9_360.txt
-113T>G,"BR587	38+60 CBC	IVS24-113T>G		3	- (0)	- (0)	1+	0.922	0.063	0.984	2 (40,...",121,23,BMC_Cancer_2009_Oct_10_9_360.txt
1613A>G,1613A>G	E462G,128,1,BMC_Cancer_2009_Oct_10_9_360.txt
1613A>G,1613A>G	E462G,128,1,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,6328C>T	R2034C,132,4,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,6328C>T	R2034C,132,4,BMC_Cancer_2009_Oct_10_9_360.txt
2457T>C,2457T>C	H743H,136,4,BMC_Cancer_2009_Oct_10_9_360.txt
855T>G,BR640	30	855T>G	L246V	3	+ (7)	- (0)	1+	0.117	0.261	0.378	2 ...,146,11,BMC_Cancer_2009_Oct_10_9_360.txt
1G > A,B162	NA	NA	NA	0	0	0	0	NA	c.IVS20+1G > A	27,55,34,BMC_Cancer_2010_Nov_30_10_654.txt
818G > A,...quencing product showed that the second mutation (818G > A) represented less than 30% of the observe...,72,262,BMC_Cancer_2011_Jun_13_11_243.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
818 G > A,"...7C > T as originally described, and surprisingly, 818 G > A). The first mutation represents heterozy...",74,194,BMC_Cancer_2011_Jun_13_11_243.txt
54C>T,"...tion between gliomas and the LIG4 rs1805388 (Ex2 +54C>T, Thr9Ile) TT genotype (adjusted OR, 3.27; 95...",10,111,BMC_Cancer_2013_May_10_13_234.txt
-1A>G,"...ous variant genotype (GG) of XRCC4 rs1805377 (IVS7-1A>G, splice-site) was associated with a signific...",10,326,BMC_Cancer_2013_May_10_13_234.txt
-1A>G,"...ous variant genotype (GG) of XRCC4 rs1805377 (IVS7-1A>G, splice-site) was associated with a signific...",10,326,BMC_Cancer_2013_May_10_13_234.txt
-1A>G,"... the first evidence that the XRCC4 rs1805377 (IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>T...",220,140,BMC_Cancer_2013_May_10_13_234.txt
54C>T,"...(IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>T, Thr9Ile) polymorphisms contribute to the ri...",220,185,BMC_Cancer_2013_May_10_13_234.txt
681G>A,...eline genotyping of CYP2C19 allele *2 (rs4244285; 681G>A) was performed. The Cox-proportional hazard...,7,92,BMC_Cardiovasc_Disord_2013_Aug_27_13_61.txt
1699G>A,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was als...",265,38,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
334T>C,"...e APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) either alone ...",279,843,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
464G>T,"...ough some substitutions (the -1012A>G, −25C>A and 464G>T) of the VDR gene increased the risk of clin...",281,1033,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
46C>T,"...rg. For the F12 genomic region, the single 'risk' 46C>T FST value was compared with the 95% confiden...",42,906,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,...mples (0.539 in Aymara and 0.577 in Quechua). The 46C>T frequency pattern in Native Americans was cl...,58,524,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,...mples (0.539 in Aymara and 0.577 in Quechua). The 46C>T frequency pattern in Native Americans was cl...,58,524,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,46C>T	0.104	0.047	0.020,70,1,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,46C>T	0.104	0.047	0.020,70,1,BMC_Evol_Biol_2010_Mar_27_10_84.txt
869T>C,...Ps (one promoter SNP -509C>T and two exon 1 SNPs +869T>C and +915G>C) and three VEGF SNPs (one promo...,20,217,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...d +915G>C) and three VEGF SNPs (one promoter SNP -1498T>C, one 5'-untranslated region SNP -634G>C an...",20,276,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"The selected three TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs180...",29,33,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,"...800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the exon 1] and three promot...",29,94,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...as previously described [24]. Assays on the VEGF -1498T>C (rs833061), -634G>C (rs2010963), and +936C...",29,603,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915 G >C,TGFB1 915 G >C (rs1800471)			0.447,89,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T > C,VEGF -1498T > C (rs833061)			0.748,95,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C > T,VEGF +936C > T (rs3025039)			0.550,107,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C > T,VEGF +936C > T (rs3025039)			0.550,107,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"...example, in high-risk Chinese populations, TGFB1 -509C>T was associated with a reduced risk of gastr...",184,174,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...e of four potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or...",186,502,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634C>G,"...orts the notion that variant genotypes of the VEGF-634C>G polymorphism, but not other tested SNPs, m...",191,137,BMC_Gastroenterol_2009_Oct_16_9_77.txt
6A>G,...le nucleotide polymorphisms (SNPs) including IVS4+6A>G (rs6957975) and L398L (rs2301629); and 2 newl...,25,499,BMC_Gastroenterol_2012_Oct_15_12_141.txt
6A>G,...le nucleotide polymorphisms (SNPs) including IVS4+6A>G (rs6957975) and L398L (rs2301629); and 2 newl...,25,499,BMC_Gastroenterol_2012_Oct_15_12_141.txt
-12C>A,"...and 2 newly identified SNPs, IVS4-52 A>G and IVS17-12C>A were discovered (Table 1)",25,589,BMC_Gastroenterol_2012_Oct_15_12_141.txt
-12C>A,"...and 2 newly identified SNPs, IVS4-52 A>G and IVS17-12C>A were discovered (Table 1)",25,589,BMC_Gastroenterol_2012_Oct_15_12_141.txt
-52 A>G,Intron 4	IVS4-52 A>G	NA	none	benign	1/39 (het: Pt-8) (0.013)	NA...,34,14,BMC_Gastroenterol_2012_Oct_15_12_141.txt
-12 C>A,Intron 17	IVS17-12 C>A	NA	none	benign	1/39 (het: Pt-9) (0.013)	NA...,40,16,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1G>A,"...-28]. Genotypes of those cases were 851del4/IVS11+1G>A [9,27], 1638ins23/S225X [26], and genotype no...",108,313,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1G>A,"...escribed [25], the 851del4 (mutation I) and IVS11+1G>A (mutation II) are the most frequent mutations...",110,88,BMC_Gastroenterol_2012_Oct_15_12_141.txt
5G>A,"... common mutations were 1638ins23, S255X, and IVS6+5G>A [20]. There is no doubt about the pathogenici...",110,338,BMC_Gastroenterol_2012_Oct_15_12_141.txt
467C>T,...B expression. Sequencing of this A allele (having 467C>T and 1061delC associated with the common A2 ...,7,661,BMC_Genet_2003_Nov_17_4_17.txt
106C>T,"...ns regularly encountered in the O1v [O02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro7...",7,798,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"...02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4 and 5, respectivel...",7,836,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"...02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4 and 5, respectivel...",7,836,BMC_Genet_2003_Nov_17_4_17.txt
297A>G,"... O1v-related mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On scr...",7,1072,BMC_Genet_2003_Nov_17_4_17.txt
297A>G,"... O1v-related mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On scr...",7,1072,BMC_Genet_2003_Nov_17_4_17.txt
646T>A,"...ated mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening o...",7,1080,BMC_Genet_2003_Nov_17_4_17.txt
681G>A,"...ations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other sam...",7,1088,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"..., 771C>T and 829G>A). On screening other samples, 46G>A was absent, but two new O alleles were found...",7,1144,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...d an African O1v allele having 188G>A but lacking 189C>T. Sequencing of introns 2, 3, 4 and 5 in com...",7,1263,BMC_Genet_2003_Nov_17_4_17.txt
467C>T,...s allele except for the characteristic mutations (467C>T and 1061delC in exon 7) found in the common...,41,134,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...hereas a hitherto undescribed mutation in exon 2 (46G>A) was found in all five samples. As opposed t...,43,294,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,... African individual lacked the O1v-characteristic 189C>T (silent) mutation,49,457,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...ce the new allele has a novel mutation in exon 2 (46G>A) and an unexpected lack of the O1v-specific ...,112,54,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...ce the new allele has a novel mutation in exon 2 (46G>A) and an unexpected lack of the O1v-specific ...,112,54,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...cted lack of the O1v-specific mutation in exon 4 (189C>T), other introns in the A2-like allele of th...",112,124,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...cted lack of the O1v-specific mutation in exon 4 (189C>T), other introns in the A2-like allele of th...",112,124,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...cted lack of the O1v-specific mutation in exon 4 (189C>T), other introns in the A2-like allele of th...",112,124,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...cted lack of the O1v-specific mutation in exon 4 (189C>T), other introns in the A2-like allele of th...",112,124,BMC_Genet_2003_Nov_17_4_17.txt
399G>A,"...e consensus from O1v-specific, whereas 354G>A and 399G>A were mutations not previously encountered i...",114,232,BMC_Genet_2003_Nov_17_4_17.txt
277A>G,"...allele when compared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intro...",117,173,BMC_Genet_2003_Nov_17_4_17.txt
106C>T,"...veral respects. The O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, res...",122,97,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"... O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, respectively, in combi...",122,116,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...e Scandinavian Aweak alleles [16]. The finding of 188G>A without 189C>T in the new allele was also u...,128,274,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...e Scandinavian Aweak alleles [16]. The finding of 188G>A without 189C>T in the new allele was also u...,128,274,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,...Aweak alleles [16]. The finding of 188G>A without 189C>T in the new allele was also unexpected. When...,128,289,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...one otherwise normal O1 allele (Jordanian) having 188G>A. Although infrequent, additional genetic di...",128,531,BMC_Genet_2003_Nov_17_4_17.txt
354G>A,"...an the O1v-specific 205C>T, as well as the unique 354G>A and 399G>A) appear to be a specific charact...",134,147,BMC_Genet_2003_Nov_17_4_17.txt
354G>A,"...an the O1v-specific 205C>T, as well as the unique 354G>A and 399G>A) appear to be a specific charact...",134,147,BMC_Genet_2003_Nov_17_4_17.txt
1024G > T, COL1A1	c.101+1024G >,69,15,BMC_Genet_2010_Oct_21_11_95.txt
-41G > A,c.1666-41G >,81,8,BMC_Genet_2010_Oct_21_11_95.txt
-41G > A,c.1666-41G >,81,8,BMC_Genet_2010_Oct_21_11_95.txt
964A>G,"...ular, we analyzed the genotype of this SNP on c. -964A>G. Our data show a different distribution of ...",92,215,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
275T>A,...ypers D Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low M...,138,116,BMC_Med_2013_Jan_11_11_9.txt
275T>A,...ypers D Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low M...,138,116,BMC_Med_2013_Jan_11_11_9.txt
275T>A,...ypers D Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low M...,138,116,BMC_Med_2013_Jan_11_11_9.txt
2152C>T,...Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA expos...,138,124,BMC_Med_2013_Jan_11_11_9.txt
27G>C,...ent with severe-profound HL who had genotype IVS1+27G>C / [V27I; E114G] (Table 1) and in his non-aff...,47,905,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,...ent with severe-profound HL who had genotype IVS1+27G>C / [V27I; E114G] (Table 1) and in his non-aff...,47,905,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,"...ffected mother (genotyped IVS1+27G>C/+). The IVS1+27G>C variation was not previously described, but ...",47,1003,BMC_Med_Genet_2005_Mar_24_6_12.txt
224G>A,"...guage to communicate. The dominant mutation R75Q (224G>A) was found in five members, as the sole mut...",59,233,BMC_Med_Genet_2005_Mar_24_6_12.txt
224G>A,"...guage to communicate. The dominant mutation R75Q (224G>A) was found in five members, as the sole mut...",59,233,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,IVS1+27G>C / [V27I; E114G]	1	Altaian,107,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
516G>C,W172C	516G>C,123,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,IVS1+27G>C,151,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
341A>G,[V27I; E114G]	79G>A+341A>G,163,21,BMC_Med_Genet_2005_Mar_24_6_12.txt
571T>C,F191L	571T>C,170,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
207G>C,"...173605_1, respectively. For the SLC22A5 promoter -207G>C (rs2631367), a TaqMan Assay by Design was p...",31,366,BMC_Med_Genet_2006_Jun_23_7_54.txt
1672G>C,"Regarding the L503F (1672G>C) polymorphism, it was described by Pelteko...",67,22,BMC_Med_Genet_2006_Jun_23_7_54.txt
207G>C,"...ohn's disease, together with the OCTN2-promoter (-207G>C) variant. In fact, the authors found that t...",67,179,BMC_Med_Genet_2006_Jun_23_7_54.txt
207G>C,...for alleles and genotypes of the OCTN2-promoter (-207G>C) and of the other SLC22A5 intronic variant ...,67,934,BMC_Med_Genet_2006_Jun_23_7_54.txt
-1G>C,III	P	F	35	9.2	21.6	4032	7.80	485	+/+	c.808-1G>C/r.spl?,52,44,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,F	M	60	1.6	2.0	30	1.12 (619)	78	-/-	c. 995 G>C/pG332A,60,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,A	F	57	1.7	2.2	52	4.27	52	-/+	c. 995 G>C/pG332A,63,35,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,A	F	57	1.7	2.2	52	4.27	52	-/+	c. 995 G>C/pG332A,63,35,BMC_Med_Genet_2008_Jun_20_9_54.txt
-1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,24,BMC_Med_Genet_2008_Jun_20_9_54.txt
-1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,21,BMC_Med_Genet_2008_Jun_20_9_54.txt
-1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,21,BMC_Med_Genet_2008_Jun_20_9_54.txt
-1G>C,C	16.85	50.67	c.808-1G>C/r.spl?,195,21,BMC_Med_Genet_2008_Jun_20_9_54.txt
-1G>C,"...otide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small insertion. In effe...",238,321,BMC_Med_Genet_2008_Jun_20_9_54.txt
22T>C,...10.1186/1471-2350-10-29Research ArticleA novel c.-22T>C mutation in GALK1 promoter is associated wit...,3,131,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...hree nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to th...",12,52,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...hree nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to th...",12,52,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...tide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C ...",12,63,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"The c.-22T>C mutation, which was observed frequently in i...",15,8,BMC_Med_Genet_2009_Mar_24_10_29.txt
-22T>C,"... USA) restriction enzyme was used to confirm the c-22T>C mutation on the PCR products, using the pri...",36,192,BMC_Med_Genet_2009_Mar_24_10_29.txt
-22T>C,"... USA) restriction enzyme was used to confirm the c-22T>C mutation on the PCR products, using the pri...",36,192,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,... CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 hea...,36,437,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,...) primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults wi...,36,451,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...fied in the promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the p...",49,422,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"... promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of ...",49,433,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"... promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of ...",49,433,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...on of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of these polymorp...",49,447,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...C, are benign sequence variations. In terms of c.-22T>C, 50 individuals with T/T, 12 with T/C, and 1...",49,967,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,c.-22T>C	T/T	50	96.1 ± 24.3	<0.001	1.16 ± 0.25	<0.001...,64,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...uencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR amp...,69,131,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...nts digested with BsgI for the confirmation of c.-22T>C (B) are shown (Lane M, DNA size marker; lane...",69,248,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...d increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not si...",80,488,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,Figure 3 c.-22T>C mutation resulted in increased reporter acti...,82,13,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...promoter activity. The reporter construct with c.-22T>C enhanced luciferase activity, both in the He...",91,258,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...proteins that bind to the GALK1 promoter, with c.-22T>C, will be necessary to elucidate the mechanis...",97,371,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,The c.-22T>C of GALK1 gene was frequently observed in sub...,100,8,BMC_Med_Genet_2009_Mar_24_10_29.txt
-2 A>G,"... intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature,...",7,850,BMC_Med_Genet_2011_Jun_27_12_86.txt
-2A>G,...the effect of IVS 5 (c.574+1G>C) and IVS16 (c.2206-2A>G) point mutations on NTRK1 splicing. A. Schem...,36,80,BMC_Med_Genet_2011_Jun_27_12_86.txt
-2A>G,"...e patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown to be...",38,405,BMC_Med_Genet_2011_Jun_27_12_86.txt
-2A>G,"...e patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown to be...",38,405,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...er mother was shown to be a carrier for the c.574+1G>C mutation. To the best of our knowledge, these...",38,480,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...er mother was shown to be a carrier for the c.574+1G>C mutation. To the best of our knowledge, these...",38,480,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, ...",40,41,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, ...",40,41,BMC_Med_Genet_2011_Jun_27_12_86.txt
-2A>G,"...er of the proband, who are carriers for the c.2206-2A>G mutation",42,1897,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,... different mutation of the same nucleotide (c.574+1G>A) was previously detected in a patient with CI...,44,416,BMC_Med_Genet_2011_Jun_27_12_86.txt
-2A>G,...n-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the conte...,44,1462,BMC_Med_Genet_2011_Jun_27_12_86.txt
-1112C > T,"...ve enhancement of human IL13 transcription by IL13-1112C > T, a polymorphism associated with allergi...",231,212,BMC_Med_Genet_2011_Oct_25_12_143.txt
-1112C > T,"...ve enhancement of human IL13 transcription by IL13-1112C > T, a polymorphism associated with allergi...",231,212,BMC_Med_Genet_2011_Oct_25_12_143.txt
1154 G-->A,...also suggest a potential implication of the VEGF -1154 G-->A and -634 G-->C polymorphisms in the dev...,67,1970,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
193 G>A,"1	193 G>A	Val65Met	Exon 2	Arab	[2,3]",47,3,BMC_Neurol_2011_Oct_1_11_119.txt
671 G>C,4	671 G>C	Trp224Ser	Exon 6	-	[1],53,3,BMC_Neurol_2011_Oct_1_11_119.txt
1313 G>A,"7	1313 G>A	Arg438His	Exon 10	Pakistani	[2], This stu...",59,3,BMC_Neurol_2011_Oct_1_11_119.txt
1408C>T,8	1408C>T	Gln470X	Exon 11	-	[1],61,3,BMC_Neurol_2011_Oct_1_11_119.txt
1531 G>A,"9	1531 G>A	Asp511Asn	Exon 11	Pakistani	[2], This stu...",63,3,BMC_Neurol_2011_Oct_1_11_119.txt
1531 G>A,"9	1531 G>A	Asp511Asn	Exon 11	Pakistani	[2], This stu...",63,3,BMC_Neurol_2011_Oct_1_11_119.txt
1576 G>T,10	1576 G>T	Glu526X	Exon 12	-	[1],65,4,BMC_Neurol_2011_Oct_1_11_119.txt
1942 C>T,12	1942 C>T	Gln648X	Exon 15	Pakistani	This study,69,4,BMC_Neurol_2011_Oct_1_11_119.txt
1942 C>T,12	1942 C>T	Gln648X	Exon 15	Pakistani	This study,69,4,BMC_Neurol_2011_Oct_1_11_119.txt
458C>G,c. 458C>G	c. 1204C>T,119,4,BMC_Neurosci_2016_Feb_1_17_6.txt
1204C>T,c. 458C>G	c. 1204C>T,119,14,BMC_Neurosci_2016_Feb_1_17_6.txt
1204C>T,c. 458C>G	c. 1204C>T,119,14,BMC_Neurosci_2016_Feb_1_17_6.txt
1204C>T,c. 458C>G	c. 1204C>T,119,14,BMC_Neurosci_2016_Feb_1_17_6.txt
3A>G,...fication of a belgian founder mutation BRCA1 IVS5+3A>G Disease Markers 1999a 15 69 73 10595255,95,203,Br_J_Cancer_2002_Dec_2_87(12)_1379-1385.txt
765G>C,...f cancer risk. A single nucleotide polymorphism (−765G>C) in the promoter region of the COX-2 gene w...,7,623,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...agen, Valencia, CA, USA). A TaqMan assay for the −765G>C COX-2 polymorphism was developed using a Ta...",16,210,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...agen, Valencia, CA, USA). A TaqMan assay for the −765G>C COX-2 polymorphism was developed using a Ta...",16,210,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,...ciation between colorectal cancer risk and COX-2 −765G>C genotype or n-6 PUFA intake (Table,85,351,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,...ciation between colorectal cancer risk and COX-2 −765G>C genotype or n-6 PUFA intake (Table,85,351,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...7). At present, data on the functionality of the −765G>C polymorphism and the direction/magnitude of...",130,799,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
-464 T>C,c.1-464 T>C	Promotera	44	30 (68%)	6 (14%)	8 (18%)	38	...,103,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
-464 T>C,c.1-464 T>C	Promotera	44	30 (68%)	6 (14%)	8 (18%)	38	...,103,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
-290 T>C,c.1-290 T>C	Promotera	44	29 (66%)	6 (14%)	9 (20%)	42	...,104,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
-53 C>T,c.1-53 C>T	Promotera	44	2 (5%)	0	42 (95%)	38	1 (3%)	0...,106,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
-316 A>G,c.1-316 A>G	5′ UTRd	44	10 (23%)	34 (77%)	0	46	2 (4%)	...,110,4,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
1306C>T,...-nucleotide polymorphism (SNP) analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by tetra-p...,20,132,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...ective SNP genotypes. The median values for MMP-2−1306C>T were 10.9, 9.5 and 11.6 ng mg−1 for genoty...",30,156,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...e did find significant associations between MMP-2−1306C>T and TNM stage and survival, that is, worse...",37,1028,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...e did find significant associations between MMP-2−1306C>T and TNM stage and survival, that is, worse...",37,1028,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"... (Sjöblom et al, 2006). Our results for SNP MMP-9−1562C>T correspond well with data from Asiatic pat...",37,1384,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"... (Sjöblom et al, 2006). Our results for SNP MMP-9−1562C>T correspond well with data from Asiatic pat...",37,1384,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,...onding single nucleotide polymorphisms of MMP-2 (−1306C>T) and MMP-9 (−1562C>T). Multivariate analys...,10,314,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-2-1306C>T,"...(Meijer et al, 2006). Genotype frequencies for MMP-2-1306C>T were CC: n=108: CT: n=79 and TT: n=11, ...",30,438,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,"...were CC: n=108: CT: n=79 and TT: n=11, and for MMP-9-1562C>T CC: n=139; CT: n=50 and TT: n=9",30,499,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according...,38,43,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
8672G>A,"...msterdam, The Netherlands). Both the 1A>G and the 8672G>A ATM mutants were sequenced in full to veri...",36,419,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...msterdam, The Netherlands). Both the 1A>G and the 8672G>A ATM mutants were sequenced in full to veri...",36,419,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,... Gatti RA Concannon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral...,130,184,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
-6T>G,...ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry Hum ...,131,322,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
276G>T,...ropago G Baroni MG  2005 The adiponectin gene SNP+276G>T associates with early-onset coronary artery...,276,144,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type ...",286,167,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
3279T>G,"...*6 (221G>A), UGT1A1*28 ((TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>...",36,460,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
391C>A,"...T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (whole delet...",36,530,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...ucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392...",70,128,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
387T>G,"...A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular,...",70,159,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
392G>A,"...G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular, there was a per...",70,175,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...particular, there was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients...",70,248,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...particular, there was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients...",70,248,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...particular, there was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients...",70,248,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
5G>A,...6	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,64,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5G>A,...6	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,64,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5G>A,...6	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,64,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
-27G>A,IVS2-27G>A		This study,114,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
-16G>A,IVS43-16G>A		25,125,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
39 T>A,IVS48+39 T>A		This study,126,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
39 T>A,IVS48+39 T>A		This study,126,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
-2A>T,... and p.Gln2187X); two splice-site mutations (IVS22-2A>T and IVS38+5G>A); three frameshift variants: ...,130,172,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
-2A>T,"...ovel splice-site alterations were described, IVS21-2A>T (ARDM-90) and IVS38+5G>A (ARDM-181). Both pa...",177,56,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
16255759 T>A,"...ISPD mutations at the heterozygous state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, whic...",116,338,Brain_2013_Jan_3_136(1)_269-281.txt
16255759 T>A,"...s premature stop codon mutation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozyg...",116,565,Brain_2013_Jan_3_136(1)_269-281.txt
16445843 C>T,"... heterozygous missense mutation in exon 2: g.chr7:16445843 C>T, which is c.377G>A, leading to p.Arg1...",116,837,Brain_2013_Jan_3_136(1)_269-281.txt
16255759 T>A,"...ed a heterozygous stop mutation in exon 9: g.chr7:16255759 T>A, leading to c.1183 A>T and causing p....",121,84,Brain_2013_Jan_3_136(1)_269-281.txt
98A>T,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,27,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Novel,49,28,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel...,50,12,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (...,51,11,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (...,51,11,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et ...,51,28,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et ...,51,28,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q...,53,19,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,16,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,29,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,11	21 y	c.[98A>T] (P) + c.264-21_ 264-1delinsC (M)	p.D33V (P)...,57,13,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q...,58,13,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	...,58,25,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min...,60,48,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116...,61,12,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116...,61,12,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,61,23,Brain_2014_May_18_137(5)_1350-1360.txt
347G >A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R2...,61,36,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",74,5,Brain_2014_May_18_137(5)_1350-1360.txt
-1G>A,".... Previous expression studies concluded that c.364-1G>A is a pathogenic mutation (Mills et al., 2005...",153,1017,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",201,5,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",201,5,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,...he maternal allele. Homozygosity for E50K plus c.[364-1G>A] produced a similar clinical picture (par...,223,150,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,"...ion system, PNPO enzyme activity for E50K plus c.[364-1G>A] and R95H was undetectable and 18% of wil...",223,711,Brain_2014_May_18_137(5)_1350-1360.txt
158Val -> Met,...in schizophrenia through an interaction with COMT 158Val -> Met Proceedings of the National Academy ...,378,171,Brain_Imaging_Behav_2014_Jan_8_8(2)_153-182.txt
17	A>G,DNAH9	4	(8)	17	A>G	X	X	X	Splice intron	Transition	 	4.05	No co...,134,13,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
20	G>A,SPTLC3	1	(2)	20	G>A	X	X	X	Splice intron	Transition	 	5.91	No co...,160,14,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
1260C>A,...insufficiency. Genotypes were determined for the –1260C>A (rs10877012) and +2838T>C (rs4646536) CYP2...,3,1959,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,... was used to assess functional expression of the –1260C>A CYP27B1 variants. The association between ...,3,2099,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,... was used to assess functional expression of the –1260C>A CYP27B1 variants. The association between ...,3,2099,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,...ream of the transcription start site of CYP27B1 (–1260C>A) and was strongly associated with either t...,24,104,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
61A >G,...phisms in KRAS wildtype tumors suggested that EGF 61A >G was significantly associated with decreased...,66,336,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
87T>C,...peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canad...,153,171,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
87T>C,...peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canad...,153,171,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
-420C > G,"...sis through AMPK activation [58]. Furthermore, SNP-420C > G of the resistin gene was associated with...",318,919,Cardiovasc_Diabetol_2011_Jan_21_10_8.txt
2588G > C,...augeri A.  Flothmann K.  Hemmrich N.    The ABCA4 2588G > C Stargardt mutation: single origin and in...,68,54,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
277 A>G,...1 3′-long-terminal repeat (LTR) SNPs (142 T>C and 277 A>G) are associated with syncytin-1 overexpres...,96,203,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
1432A>G,"...t study, exome sequencing identified a homozygous 1432A>G DNA variant encoding the missense change N...",15,64,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,"...t study, exome sequencing identified a homozygous 1432A>G DNA variant encoding the missense change N...",15,64,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
3243A>G,...pe-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem...,245,156,Cell_Rep_2015_May_28_11(10)_1614-1624.txt
1073C>T,...as carrier of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Ch...,1153,390,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
2995G>A,"... in 1998 found SNPs in exons 21 (2677G>T) and 24 (2995G>A) in the MDR1 gene. Subsequently, over 50 d...",47,769,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
3435C>T,"...03, exon 12), 2677G>T/A (rs2032582, exon 21), and 3435C>T (rs1045642, exon 26). These SNPs have a wi...",47,1016,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
3435C>T,"...03, exon 12), 2677G>T/A (rs2032582, exon 21), and 3435C>T (rs1045642, exon 26). These SNPs have a wi...",47,1016,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
318C>T,...hn J  Capasso M  Lanciotti M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA...,146,57,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
1082G > A,"...lationship of three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susc...",65,456,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
69 C>T,...ene was sequenced and one intron variation (c.374+69 C>T in intron 4) and two exon 10 variations (c....,13,2726,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
69 C>T,...ene was sequenced and one intron variation (c.374+69 C>T in intron 4) and two exon 10 variations (c....,13,2726,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
69 C>T,...ene was sequenced and one intron variation (c.374+69 C>T in intron 4) and two exon 10 variations (c....,13,2726,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
69 T>C,"...igure 2 FSH receptor variations: (A) intron 4c374+69 T>C, (B) exon 10 Ala307Thr, and (C) exon 10 Ser...",30,52,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
1679 T>G,"...detected. The commonly found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected ...",32,1129,Cureus_8(9)_e798.txt
1905+1 G>A,"...The commonly found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected either",32,1139,Cureus_8(9)_e798.txt
2846 A>T,"... found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected either",32,1151,Cureus_8(9)_e798.txt
1905+1 G>A,"...herapy [8]. Interestingly, DPYD*2A (also known as 1905+1 G>A) was not significantly associated with ...",37,686,Cureus_8(9)_e798.txt
-786T>C,...uded in the analysis. They were genotyped for eNOS-786T>C SNP (rs2070744) with the Taqman® allelic d...,85,287,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
-786T>C,...uded in the analysis. They were genotyped for eNOS-786T>C SNP (rs2070744) with the Taqman® allelic d...,85,287,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
-126G > T,"...investigation (25). For instance, the variant IVS1-126G > T in a large family with the G533C mutatio...",26,2179,Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_91-97.txt
854T>C,"...>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and ...",9,134,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"...A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) p...",9,161,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",22,650,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward prime...",31,15,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward prime...",31,15,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"For IL-8 c.-352A>T (rs4073) polymorphism, the forward primer w...",33,13,Croat_Med_J_2014_Dec_55(6)_638-646.txt
854T>C,"For IL-10 c.-854T>C (rs1800871) polymorphism, the forward prime...",35,14,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"For TNF c.-488G>A (rs1800629) polymorphism, the primers used ...",39,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"For TNF c.-488G>A (rs1800629) polymorphism, the primers used ...",39,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"... IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-488...",320,241,Croat_Med_J_2014_Dec_55(6)_638-646.txt
1555A>G,"...ne, in which the hearing loss associated with the 1555A>G mitochondrial mutation is more severe in p...",66,940,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,...3] and the deafness phenotype associated with the 1555A>G mutation in MTRNR1 was shown to be modifie...,69,425,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,...3] and the deafness phenotype associated with the 1555A>G mutation in MTRNR1 was shown to be modifie...,69,425,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,...3] and the deafness phenotype associated with the 1555A>G mutation in MTRNR1 was shown to be modifie...,69,425,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,... the severity of hearing loss associated with the 1555A>G mitochondrial mutation Am. J. Med. Genet 2...,173,139,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,... the severity of hearing loss associated with the 1555A>G mitochondrial mutation Am. J. Med. Genet 2...,173,139,Curr_Genomics_2010_Jun_11(4)_269-278.txt
13G>A,"1	c.1A>T, c. 13G>A",288,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
262C>T,...etween functional polymorphism of catalase gene (-262C>T) and recurrent depressive disorder. Neuro. ...,214,127,Curr_Neuropharmacol_2014_Mar_12(2)_108-119.txt
1562C> T,...High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C> T) Polymorphism in Patients With ST-Elevati...,158,90,Curr_Ther_Res_Clin_Exp_2015_Feb_23_77_40-45.txt
1562C> T,...High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C> T) Polymorphism in Patients With ST-Elevati...,158,90,Curr_Ther_Res_Clin_Exp_2015_Feb_23_77_40-45.txt
1G>A,...l heterozygous intron 1 splice site variant (c.99+1G>A) in both the index individual and the father....,5,1890,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
221G > C,"...891, previously classified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P/Q), respectively, ...",38,456,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
4 C > T,"...ified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P/Q), respectively, were also identified ...",38,477,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
2T>G,... conjunction with a GK splice site mutation (IVS8+2T>G) and was associated with marked hyperglycemia...,153,1365,Diabetes_2011_Dec_13_60(12)_3175-3185.txt
2T>G,... conjunction with a GK splice site mutation (IVS8+2T>G) and was associated with marked hyperglycemia...,153,1365,Diabetes_2011_Dec_13_60(12)_3175-3185.txt
276G->T,Association of the 276G->T polymorphism of the adiponectin gene with ...,184,20,Diabetes_Care_2013_Aug_11_36(8)_2408-2414.txt
276G->T,Association of the 276G->T polymorphism of the adiponectin gene with ...,184,20,Diabetes_Care_2013_Aug_11_36(8)_2408-2414.txt
948 G > T,".... However, they found an association between the -948 G > T single-nucleotide polymorphism (SNP) and...",87,448,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948 G > T,".... However, they found an association between the -948 G > T single-nucleotide polymorphism (SNP) and...",87,448,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948G > T,"... three genetic polymorphisms studied (rs9770242, -948G > T, rs4730153)",87,692,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948G > T,"... from Germany. They genotyped 3 SNPs (rs9770242, -948G > T, rs4730153). The authors did not find ass...",93,144,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
658G > A,"...[33]	n: 3005	N/D	22.8 ± 2.7	431 (14.3)	rs860185, −658G > A, +1930insA, rs12086634, rs2236905, rs2298...",305,66,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
11A>G,IVS2 -11A>G	Exon skipping	Protein truncation	CGL2	[33],121,7,Diagn_Pathol_2013_May_9_8_78.txt
11A>G,IVS2 -11A>G	Exon skipping	Protein truncation	CGL2	[33],121,7,Diagn_Pathol_2013_May_9_8_78.txt
519A>G,"3.2. MMP1-1607 1G>2G, -519A>G, MMP",297,24,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,"3.2. MMP1-1607 1G>2G, -519A>G, MMP",297,24,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
-181A>G,-181A>G gene polymorphisms in bladder cance,298,1,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,"MMP1 -519A>G, -1607 1G>2G, MMP7 -181A>G gene polymorphis...",303,7,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
-181A>G,"AssociationofMMP1-519A>G, -16091G>2G, MMP7-181A>G polymorphisms withtumorgrade/stagecategori...",330,43,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
-519A>G,(G) of MMP1-519A>G was higher in cases as com,350,12,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
-181 A>G,"cases. In MMP7-181 A>G, the variant G allele wa",360,15,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
1555A>G,Heteroplasmy for the 1555A>G mutation in the mitochondria,502,22,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
204 A>C,...Srivastava A.  Choudhuri G.  Mittal B.   CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promot...,232,54,Dis_Markers_2015_Apr_6_2015_185969.txt
1513A>C,"...um than those carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the su...",8,845,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...th polymorphism (PCR-RFLP) was used for analyzing 1513A>C and PCR for -762T>C SNPs. PCR primers were...,26,182,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...th polymorphism (PCR-RFLP) was used for analyzing 1513A>C and PCR for -762T>C SNPs. PCR primers were...,26,182,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"..., and 50 ng genome DNA. The PCR amplification for 1513A>C included initial denaturation at 95°C for ...",26,808,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...NPs between case and control groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had...,38,415,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ol groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had higher frequency than con...,38,441,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ol groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had higher frequency than con...,38,441,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ol groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had higher frequency than con...,38,441,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...n control group (all P < 0.05). Both AC and CC of 1513A>C were risk factors of TB, and C was risk al...",38,536,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...C (Figure 2(b)) and CC (Figure 2(c)) carriers of -762T>C had greater MTB in sputum than those TT car...,44,376,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...r function or expression, especially 1513A>C and -762T>C SNPs [13]. A previous study published by Ga...",51,187,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...study was that TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses t...,53,84,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"In conclusion, our study demonstrated that 1513A>C and -762T>C SNPs in P2X7 gene may be assoc...",55,44,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...be associated with the susceptibility to TB, and -762T>C SNP may contribute to the development of MT...",55,136,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...o the development of MTB. The mutant genotype of -762T>C (TC and CC) may lower human capability of p...,55,213,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...o the development of MTB. The mutant genotype of -762T>C (TC and CC) may lower human capability of p...,55,213,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Table 2 Genotype frequency distributions of 1513A>C and -762T>C in P2X7 gene,88,45,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,1513A>C	 	 	 	 	 ,93,1,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,1513A>C	 	 	 	 	 ,93,1,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,-762T>C	 	 	 	 	 ,106,1,Dis_Markers_2015_Dec_20_2015_671272.txt
857C>T,"...   Tumor necrosis factor alpha -308G>A, -863C>A, -857C>T gene polymorphisms and tuberculosis suscept...",159,105,Dis_Markers_2015_Dec_20_2015_671272.txt
677 C>T,... F.  Hasbek Z.    Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofol...,239,71,Dis_Markers_2015_Jan_31_2015_681313.txt
1 G>A,"...ified a novel homozygous mutation in BEST1, c.636+1 G>A. Family members were found to carry one copy...",11,255,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
6986A>G,... was amplified and sequenced to analyze CYP3A5*3 (6986A>G) polymorphism (5′–GGCATAGGAGATACCCACGTA–3′...,27,590,Drug_Des_Devel_Ther_2014_Nov_7_8_2241-2249.txt
6986A>G,... was amplified and sequenced to analyze CYP3A5*3 (6986A>G) polymorphism (5′–GGCATAGGAGATACCCACGTA–3′...,27,590,Drug_Des_Devel_Ther_2014_Nov_7_8_2241-2249.txt
425T>C,... C substitution in site 1678 of the DNA sequence (425T>C in the cDNA) and results in one amino acid ...,68,94,Drug_Des_Devel_Ther_2016_Feb_15_10_687-696.txt
425T>C,... C substitution in site 1678 of the DNA sequence (425T>C in the cDNA) and results in one amino acid ...,68,94,Drug_Des_Devel_Ther_2016_Feb_15_10_687-696.txt
-401T>C,... level at HRT treatment. Among these SNPs the IVS1-401T>C was most strongly related to HDL increase ...,58,855,EJIFCC_2008_Apr_3_19(1)_48-53.txt
-401T>C,... level at HRT treatment. Among these SNPs the IVS1-401T>C was most strongly related to HDL increase ...,58,855,EJIFCC_2008_Apr_3_19(1)_48-53.txt
-401T>C,... level at HRT treatment. Among these SNPs the IVS1-401T>C was most strongly related to HDL increase ...,58,855,EJIFCC_2008_Apr_3_19(1)_48-53.txt
238 G>A,...C  Schmut O  Wedrich A    TNF-alpha –308 G>A and –238 G>A polymorphisms are not major risk factors i...,89,102,Electron_Physician_2016_Feb_25_8(2)_1978-1983.txt
3243A>G,...eled phase 2 study on patients carrying the mtDNA 3243A>G mutation. The latter mutation is one of th...,207,572,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
299G>A,sizes for ALAD IVS2+299G>A were 160 b,347,21,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,"Nor is it clear why ALAD IVS2+299G>A, a",588,31,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
2255T>C,"...region, 1173C>T (rs9934438), 1542G>C (rs8050894), 2255T>C (rs2359612), 3730G>A (rs7294) in introns, ...",60,153,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,[20]. Yuan et al. showed that -1639G>A can be that varian,81,32,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,...iduals with the GG genotype of polymorphic locus -1639G>A require a higher dose of warfarin can be e...,91,70,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"... of Wadelius et al., three polymorphic variants (−1639G>A (rs9923231), 1173C>T (rs9934438), and 2255...",94,63,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,...ion is shown to be 0.391 for polymorphic variant -1639G>A. The coefficient of determination (R2) cal...,94,344,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"On the whole, the combination of VKORC1 -1639G>A, CYP2C9 (*2 and *3), and clinical factors ...",211,42,EPMA_J_2012_Sep_27_3(1)_10.txt
-1639G>A,"...en L Zhong QJ Wang XF Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weigh...",320,84,EPMA_J_2012_Sep_27_3(1)_10.txt
3243A>G,"mutations (e.g. 3243A>G, m.4300A>G) in specific clinical scenarios...",446,17,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,...Majamaa K   Causes of death in pedigrees with the 3243A>G mutation i,639,108,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
88068052C > A,...lymorphisms (SNPs) within intron 2 at position g. 88068052C > A [Figure 3a] and intron 5 at position...,40,879,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88068052C > A,...g parent also identified SNPs within intron 2 (g. 88068052C > A) and intron 5 (g. 88033661T > C). Ac...,53,162,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88068052C > A,...g parent also identified SNPs within intron 2 (g. 88068052C > A) and intron 5 (g. 88033661T > C). Ac...,53,162,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
521T>C,...er explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. When t...,4,911,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...icant differences between OATP1B1 mutation in the 521T>C and wild-type homozygote for rosuvastatin p...,152,342,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,Although OATP1B1 521T>C has significant effect on the pharmacokinet...,154,18,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,Although OATP1B1 521T>C has significant effect on the pharmacokinet...,154,18,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...r the same result could be presented that OATP1B1 521T>C had significant effect on the transport of ...,158,161,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521 T>C,...*1a-HEK293T (P < 0.05). Gene mutation of OATP1B1 (521 T>C) may decrease its transport capacity. Howe...,160,806,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
421C>A,... Yu BN  He YJ  Fan L  Li Q  Liu ZQ   Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokineti...,208,59,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
1G>T,"...(LOF) single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A...",3,1993,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.041,105,18,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
621+1G>T, 621+1G>T	c.489+1G>T	 ,166,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 621+1G>T	c.489+1G>T	 ,166,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1898+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1898+1G>A	c.1766+1G>A	 ,178,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2789+5G>A, 2789+5G>A	c.2657+5G>A	 ,180,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3120+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3120+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
406-1G>A, 406-1G>A	c.274-1G>A	 ,190,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
711+5G>A, 711+5G>A	c.579+5G>A	 ,203,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 711+5G>A	c.579+5G>A	 ,203,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
-1G>T, 712-1G>T	c.580-1G>T	 ,204,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1248+1G>A, 1248+1G>A	c.1116+1G>A	 ,219,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1341+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1525-1G>A, 1525-1G>A	c.1393-1G>A	 ,225,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
-8G>A, 1717-8G>A	c.1585-8G>A	 ,233,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
-1G>A, 1812-1G>A	c.1680-1G>A	 ,240,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2622+1G>A, 2622+1G>A	c.2490+1G>A	 ,255,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3121-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3121-1G>A, 3121-1G>A	c.2989-1G>A	 ,268,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3744G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3744G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 4005+1G>A	c.3873+1G>A	 ,288,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2789+5G>A,"... and full-length transcript such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1265,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3272-26 A>G,"...ength transcript such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1276,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,37,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
489+1G>T,...s in trans)a	F508del/621+1G>T	c.[1521_1523delCTT][489+1G>T],352,84,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
-27G>A,96 Seppälä E.H.  Autio V.  Duggal P.   KLF6  IVS1-27G>A variant and the risk of prostate cancer in ...,595,50,Eur_Urol_2014_Oct_66(4)_752-768.txt
-27G>A,96 Seppälä E.H.  Autio V.  Duggal P.   KLF6  IVS1-27G>A variant and the risk of prostate cancer in ...,595,50,Eur_Urol_2014_Oct_66(4)_752-768.txt
485 T>A,... and control group to be 0.316. Point mutation C. 485 T>A was detected in one case in the experiment...,3,2548,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...ted in one case in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 ar...,3,2615,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...ted in one case in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 ar...,3,2615,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 are possibly resp...,3,2630,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 are possibly resp...,3,2630,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...e revealed a single nucleotide substitution, a C. 504 C>T homozygous mutation in 14/41 premature inf...",39,102,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...and r-GGT between the preterm infants with the C. 504 C>T mutation and the preterm infants without t...,44,436,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...T mutation and the preterm infants without the C. 504 C>T mutation (P<0.05 for both). The results re...,44,492,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...). The results revealed that the patients with C. 504 C>T in the experimental group had raised serum...,44,575,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...was a correlation between the MDR3 gene exon 6 C. 504 C>T synonymous mutation and PNAC in premature ...,55,89,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group was detected with a C. 485 T>A missense mutation and raised r-GGT. Our re...,55,381,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,The results reveal that C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 we...,57,28,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,The results reveal that C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 were detected in ...,57,43,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...le for the development of PNAC in infants. The C. 504 C>T mutation in exon 6 of the MDR3 gene may be...,57,204,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...le for the development of PNAC in infants. The C. 504 C>T mutation in exon 6 of the MDR3 gene may be...,57,204,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,C. 504 C>T	CC	22 (53.7%)	43 (76.8%)	7.058	0.029,80,4,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...n of the distribution of allele frequencies in C. 504 C>T in the two groups,83,70,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...n of the distribution of allele frequencies in C. 504 C>T in the two groups,83,70,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...atory results between infants with and without C. 504 C>T mutation,90,79,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,With C. 504 C>T mutation	19	127±20.1	128.8±20.7	70.2±10.8	...,93,9,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
-25A>C,19(I)	c.5194-25A>C	1,87,13,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
-25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,10,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>A,IVS17 − 1G>A	n.i.	Bil	No	RT	Sarcoma	Rhab (8),119,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	Yes	RT	Epithelial	Bl (62),121,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	No	RT	Sarcoma	His (31),123,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
404A >T,"...eotide 404 (SNP rs33977775) in the coding region (404A >T). Importantly, this polymorphism causes an...",157,126,Front_Endocrinol_(Lausanne)_2013_Mar_18_4_23.txt
404A >T,"...eotide 404 (SNP rs33977775) in the coding region (404A >T). Importantly, this polymorphism causes an...",157,126,Front_Endocrinol_(Lausanne)_2013_Mar_18_4_23.txt
455T>C,"...lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diab...",322,78,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
262T>C,The 262T>C promoter polymorphism of the catalase gene ...,403,5,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
1G > A,...ylase E2 (dbt) gene on chromosome 22	ti274	IVS6 + 1G > A	Abnormal output from CNS. The abnormality m...,151,94,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
1G > A,...ylase E2 (dbt) gene on chromosome 22	ti274	IVS6 + 1G > A	Abnormal output from CNS. The abnormality m...,151,94,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
4580704 C > G,Polymorphism of CLOCK gene rs 4580704 C > G is associated with susceptibility of...,246,31,Front_Neurol_2015_Oct_23_6_224.txt
4580704 C > G,Polymorphism of CLOCK gene rs 4580704 C > G is associated with susceptibility of...,246,31,Front_Neurol_2015_Oct_23_6_224.txt
61 A > G,.... Xiong G. L.   (2015 ). Association between EGF +61 A > G polymorphism and gastric cancer risk: a m...,1023,76,Front_Pharmacol_2016_Sep_26_7_327.txt
29C > T,...B1*	Transforming growth factor-β 1	Association of 29C > T polymorphism in the transforming growth fa...,175,54,Front_Physiol_2012_Aug_8_3_303.txt
29C>T,...H. Tanaka M. Miyachi M.   (2012 ). Association of 29C>T polymorphism in the transforming growth fact...,401,100,Front_Physiol_2012_Aug_8_3_303.txt
-1G > A,NM_000256.3 (MYBPC3):c.3815-1G > A rs397516044	Pathogenic/Likely pathogenic	W...,67,29,Front_Physiol_2016_Oct_28_7_499.txt
4019 G > A,"g. 4019 G > A R98Q	N/A	Rani et al., 2012b; Ramachandr...",75,5,Front_Physiol_2016_Oct_28_7_499.txt
4019 G > A,"g. 4019 G > A R98Q	N/A	Rani et al., 2012b; Ramachandr...",75,5,Front_Physiol_2016_Oct_28_7_499.txt
9532503 G > A,gl23	Sterile	CHr1:9532503 G > A	G28 > R,74,19,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532503 G > A,gl23	Sterile	CHr1:9532503 G > A	G28 > R,74,19,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532503 G > A,gl23	Sterile	CHr1:9532503 G > A	G28 > R,74,19,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533621 G > A,s1pl41	Sterile	CHr1:9533621 G > A	C155 > Y,84,21,Front_Plant_Sci_2015_Mar_12_6_147.txt
61A > G,...g H-G  Choi JE  Lee WK  Kam S  Cha SI  Kim CH    +61A > G polymorphism in the EGF gene does not incr...,130,57,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
5665G>T,...Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunctio...,3,251,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...stigate the association of ET-1 5665G>T and eNOS −786T>C polymorphisms with soluble adhesion molecul...,5,500,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...stigate the association of ET-1 5665G>T and eNOS −786T>C polymorphisms with soluble adhesion molecul...,5,500,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...of microvessels.5,7 The eNOS polymorphic variant −786T>C is associated with a decreased NO productio...",16,507,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...he aim of this study was to investigate the eNOS −786T>C (rs2070744) and ET-1 5665G>T (rs5370) gene ...,18,52,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...he aim of this study was to investigate the eNOS −786T>C (rs2070744) and ET-1 5665G>T (rs5370) gene ...,18,52,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T polymorphism was analyzed in 101 SCA patie...,40,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...of homozygous for the variant allele (TT) of ET-1 5665G>T gene polymorphism in SCA patients (Table 1...,40,361,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...of homozygous for the variant allele (TT) of ET-1 5665G>T gene polymorphism in SCA patients (Table 1...,40,361,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...polymorphism in SCA patients (Table 1). The eNOS −786T>C gene polymorphism analysis showed 56.7% (34...,40,424,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...rium. In the control group, the frequency of ET-1 5665G>T gene polymorphism was 60.2% (65/108) for w...",40,730,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...atients’ carriers of the minor allele of the ET-1 5665G>T (P < 0.001) (Fig. 1),46,334,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...atients’ carriers of the minor allele of the ET-1 5665G>T (P < 0.001) (Fig. 1),46,334,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...can stimulate vascular smooth muscle.18 The eNOS −786T>C minor allele can be associated with an enha...,57,510,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,We suggest that eNOS −786T>C and ET-1 5665G>T gene polymorphisms may participate in the ...,68,39,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...n molecules levels (sVCAM-1 and sICAM-1) and ET-1 5665G>T and eNOS −786T>C gene polymorphisms,102,89,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... (sVCAM-1 and sICAM-1) and ET-1 5665G>T and eNOS −786T>C gene polymorphisms,102,107,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Table 3 ET-1 5665G>T and eNOS −786T>C gene polymorphisms associ...,120,14,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...The multivariate model of the association of ET-1 5665G>T gene polymorphism, sVCAM-1, and lactate de...",148,59,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	0.351	0.127	2.772	0.011,152,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
1767G>T,LR00-144	PPR	g.-1767G>T	G/T	G/G	G/T	n/a	0/518 (0%),147,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,LR00-144	PPR	g.-1767G>T	G/T	G/G	G/T	n/a	0/518 (0%),147,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,LR02-304	CE12A	g.-1726C>A	C/A	C/A	C/C	n/a	0/528 (0%),155,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...el variants identified in the patients, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.1471...",178,472,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...identified in the patients, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.2076...",178,484,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...ions’. Three of the seven candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identifie...",178,729,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"... of the seven candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identified in patient...",178,741,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,... identified in patient LR00-144: two of these (g.-2945A>G and -1767G>T) were maternal and one (g.215...,178,819,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,...that is conserved between mouse and human; and g. 20765C>A that resides in the 3′-UTR); the remainin...,178,1442,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,...that is conserved between mouse and human; and g. 20765C>A that resides in the 3′-UTR); the remainin...,178,1442,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,Functional polymorphism	g.-1453C>G	PPR	Created	EGR3	Regulator of synaptic pla...,199,28,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,Functional polymorphism	g.-1453C>G	PPR	Created	EGR3	Regulator of synaptic pla...,199,28,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...ue, mouse and Fugu. Notably, in two instances (g.-1726C>A and g.8213T>C), the major human nucleotide...",212,269,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...ue, mouse and Fugu. Notably, in two instances (g.-1726C>A and g.8213T>C), the major human nucleotide...",212,269,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...ue, mouse and Fugu. Notably, in two instances (g.-1726C>A and g.8213T>C), the major human nucleotide...",212,269,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...s is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromosomes), g.-1726C>A (716 chromos...",221,660,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...s is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromosomes), g.-1726C>A (716 chromos...",221,660,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,... Pax6 and NeuroD/β2 (Breslin et al. 2002). The g.-1767G>T substitution is also predicted to create a...,303,1454,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,... Pax6 and NeuroD/β2 (Breslin et al. 2002). The g.-1767G>T substitution is also predicted to create a...,303,1454,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,...atient LR00-144 supports the proposal that the g.-1767G>T candidate mutation could contribute to the...,303,2152,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,...atient LR00-144 supports the proposal that the g.-1767G>T candidate mutation could contribute to the...,303,2152,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"Finally, the two candidate mutations g.-1726C>A and g.14718C>T identified in patients LR02...",309,41,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1068T>C,"...8; OR= 2.06; 95% CI: 1.14–3.75) at SNP rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous var...",8,724,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1068T>C,rs1718119	1068T>C	Exon 11	Thr-348-Ala	T (+)a	0.492	0.216	0.5...,120,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1068T>C,rs1718119	1068T>C	Exon 11	Thr-348-Ala	T (+)a	0.492	0.216	0.5...,120,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1513T>G,rs3751143	1513T>G	Exon 13	Glu-496-Ala	T (+)a	0.864	0.761	0.9...,126,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1772C>T,rs1621388b	1772C>T	Exon 13	Pro-582-Pro	C (+)b	0.625	0.875	0.6...,130,12,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
876 G > A,"... novel polymorphism in exon 5 at position 876 (c.+876 G > A, GenBank accession No. NM_214379) of the...",40,575,Genet_Mol_Biol_2011_Mar_1_Jan-Mar_34(1)_56-61.txt
179C > T,hLIG1	179C > T	A60V	Unknown	No	Neutral (83%)	0.56 ± 0.06...,146,7,Genetics_2015_Nov_9_201(3)_1263-1274.txt
179C > T,hLIG1	179C > T	A60V	Unknown	No	Neutral (83%)	0.56 ± 0.06...,146,7,Genetics_2015_Nov_9_201(3)_1263-1274.txt
457G > A,457G > A	E153K	Heterozygous	No	Neutral (83%)	0.60 ...,150,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
488G > A,488G > A	S163N	Unknown	No	Neutral (83%)	0.60 ± 0.1...,151,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1045G > A,1045G > A	V349M	Unknown	No	Neutral (60%)	0.47 ± 0....,153,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1969T > G,1969T > G	L657V	Heterozygous	Yes	Neutral (83%)	0.7...,158,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1969T > G,1969T > G	L657V	Heterozygous	Yes	Neutral (83%)	0.7...,158,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
2290G > A,2290G > A	A764T	Unknown	Yes	Deleterious (87%)	0.73...,159,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
2446G > A,2446G > A	V816M	Unknown	No	Neutral (74%)	0.70 ± 0....,161,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
970C > T,970C > T	R324C	Heterozygous	Yes	Neutral (60%)	1.00...,166,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
970C > T,970C > T	R324C	Heterozygous	Yes	Neutral (60%)	1.00...,166,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1441T > C,1441T > C	S481P	Unknown	No	Deleterious (61%)	Non-f...,169,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
428G > A,hPPP1CA	428G > A	R143H	Heterozygous	Yes	Deleterious (87%)	...,174,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
428G > A,hPPP1CA	428G > A	R143H	Heterozygous	Yes	Deleterious (87%)	...,174,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
348G > T,hPPP1CC	348G > T	E116D	Unknown	Yes	Neutral (75%)	0.57 ± 0....,176,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
601C > T,601C > T	L201F	Heterozygous	Yes	Deleterious (51%)	...,178,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
866T > G,866T > G	L289R	Heterozygous	Yes	Deleterious (87%)	...,180,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1639G>A,"...ticoagulant	A common promoter variant in VKORC1, -1639G>A (rs17878363), has significant implications...",19,60,Genome_Med_2012_May_25_4(5)_45.txt
829C>T,... miR-24 binding site in the 3' UTR of human DHFR (829C>T) interfered with miR-24 function and result...,27,105,Genome_Med_2012_May_25_4(5)_45.txt
1639G>A,... allele frequency 0.467) in its promoter region (-1639G>A) results in the formation of a novel E-box...,86,550,Genome_Med_2012_May_25_4(5)_45.txt
1639G>A,...n [137]. The clinical implications of the VKORC1 -1639G>A regulatory variant and a coding variant of...,135,1057,Genome_Med_2012_May_25_4(5)_45.txt
161 A>C,"...295,228 C>A; 1,295,248–1,295,243 CC>TT; and 1,295,161 A>C [46]. However, when these mutations (−57 A...",49,293,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,"...ntroduced three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human em...",51,530,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,"... three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human embryonic s...",51,539,Genome_Med_2016_Jun_20_8_69.txt
146 C>T,...ease in hTERT mRNA while neither the −57 A>C nor −146 C>T mutation had any effect on hTERT transcrip...,51,786,Genome_Med_2016_Jun_20_8_69.txt
4883G>A,"...gene, at least one G allele (GG; AG) at the CD44 +4883G>A gene locus (rs187116) associated with clin...",53,638,Gut_Liver_2011_Dec_21_5(4)_397-405.txt
1661+12A>G,"... and the other was an unknown functional variant (1661+12A>G and 1551-9T>A, respectively). The polym...",60,356,Hered_Cancer_Clin_Pract_2005_May_15_3(2)_65-70.txt
2642A>T,"...d. Moreover, two linked nucleotide substitutions (2642A>T, 2743T>C, Acc. U37574) in BRCA1 intron 1 w...",3,1670,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,...delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRCA1 expressio...,3,2513,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,...delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRCA1 expressio...,3,2513,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,"...ce alterations within the BRCA1 intron 1 2642A>T, 2743T>C (Acc. U37574) were also detected in 16 pat...",35,215,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
1298 A>C,"...l SNPs in the MTHFR gene, 677 C>T (rs1801133) and 1298 A>C (rs1801131), both associated with reduced...",11,467,Hered_Cancer_Clin_Pract_2012_Dec_10_10(Suppl_4)_A7.txt
5G>C,JS-05	1	H	c.2439+5G>C	p.I775_A813del	ND,481,19,Hum_Genome_Var_2014_Nov_6_1_14020.txt
-2A>G,c.342-2A>,600,6,Hum_Genome_Var_2014_Nov_6_1_14020.txt
-2A>G,c.342-2A>,611,6,Hum_Genome_Var_2014_Nov_6_1_14020.txt
919G>A,...f the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,171,130,Hum_Genome_Var_2015_Nov_12_2_15044.txt
1G>T,"...icker amplitude. Patient no. 22, who had an IVS11+1G>T mutation, exhibited nearly negative ERG in ma...",23,1444,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c...",26,753,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified in the current study. As pre...",26,833,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified in the current study. As pre...",26,833,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>A, 	 	 	Intron6	IVS6+1G>A	Splice error	NA	PD	Yes	 	 	 	 	 	 	 	 	 	 	 	...,54,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,8	2	 	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	1	M	Total/total	+/+	+/...,59,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
2T>G,10	3	 	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	38	M	Total/total	−/−	+...,61,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,23	5	Familial	Intron11	IVS11+1G>T	Splice error	NA	PST	Yes	7	M	Total/total	−/−	+...,74,30,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,24	5	 	Intron11	IVS11+1G>T	Splice error	NA	PST	Yes	36	M	Normal/normal	−/...,75,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
718C>T,"...no. 16 and family no. 4 exhibit same genotype, c. 718C>T, while visual acuity shows variety. In addi...",80,322,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1858C > T,... Amundsen SS Kvien TK Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juven...,213,59,Hum_Genomics_2006_Jun_1_2(6)_391-402.txt
521 T > C,"...re prospectively enrolled on the basis of SLCO1B1 521 T > C genotype. Additionally, subjects were ge...",3,1275,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,"...typed for SLCO1B1  11187 G > A, - 10499 A > C and 388 A > G polymorphisms, and the CYP2C8*3 polymorp...",3,1377,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...otyped and enrolled in the study based on SLCO1B1 521 T > C genotype. The goal was to enrol equal nu...,25,560,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...otyped and enrolled in the study based on SLCO1B1 521 T > C genotype. The goal was to enrol equal nu...,25,560,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,SLCO1B1 - 11187 G > A	PCR-forward: TGCTGCAACCATATCAACAA,30,11,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
10499 A > C,SLCO1B1 -10499 A > C	PCR-forward: Biotin-GTAAAAGCCATTCCCAAA...,33,10,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
10499 A > C,SLCO1B1 -10499 A > C	PCR-forward: Biotin-GTAAAAGCCATTCCCAAA...,33,10,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"... (range 45.7 to 93.3 kg). In terms of the SLCO1B1 521 T > C screening genotype, 13 subjects were T/T...",116,215,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"...ions [34]. Polymorphisms in SLCO1B1, particularly 521 T > C, have been shown significantly to alter ...",129,660,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...t al. which showed no association between SLCO1B1 521 T > C genotype and rosiglitazone or pioglitazo...,129,1309,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...t al. which showed no association between SLCO1B1 521 T > C genotype and rosiglitazone or pioglitazo...,129,1309,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
894G >T,...l nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunction and have...,3,939,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...l nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunction and have...,3,939,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...l nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunction and have...,3,939,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,...t (CABG) patients and 155 non-CAD controls. eNOS -786T >C and 894G >T polymorphisms were genotyped b...,3,1353,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"... diseasecoronary artery bypass graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphisms...",5,66,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"... diseasecoronary artery bypass graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphisms...",5,66,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,"...ss graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphismsmokin",5,94,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,eNOS -786T >C genotypin,32,7,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,Distribution of eNOS -786T >C and 894G >T polymorphism,80,23,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,Distribution of eNOS -786T >C and 894G >T polymorphism,80,35,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,"...were in Hardy-Weinberg equilibrium. For the eNOS -786T >C polymorphism, the frequencies of the genot...",81,249,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 2 Frequencies of eNOS -786T > C and 894G > T genotypes and alleles in CABG patients an...,83,43,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,894G > T Alleles	n = 308	n = 310,118,1,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...pe 2 diabetes) among genotypes or alleles for the 894G >T polymorphism (data not shown). The same an...,129,1440,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"..., we investigated the association of -786T >C and 894G >T polymorphisms of the eNOS gene with CAD. O...",192,418,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...e eNOS gene are not associated with CAD. The eNOS 894G >T polymorphism is associated with CAD in cur...,200,297,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"...helial nitric oxide synthase gene polymorphisms (-786T > C. 4a4b, 894G > T) in Korean patients with ...",215,98,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"...helial nitric oxide synthase gene polymorphisms (-786T > C. 4a4b, 894G > T) in Korean patients with ...",215,98,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
3435C > T,ABCB1	rs1045642	C	3435C > T	0.89	0.8	0.88	NA	0.84	0.43	0.58	0.45	0.8...,302,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
3435C > T,ABCB1	rs1045642	C	3435C > T	0.89	0.8	0.88	NA	0.84	0.43	0.58	0.45	0.8...,302,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12394837A > G,ABCB1	rs2032583	G	12394837A > G	0.14	0.18	0.25	0.25	0.23	0.16	0.03	0...,305,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12455162A > G,ABCB1	rs3789243	G	12455162A > G	0.63	0.61	0.41	0.58	0.44	0.43	0.72	N...,306,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12399262A > G,ABCB1	rs10248420	G	12399262A > G	0.59	0.56	0.59	0.64	0.56	0.17	0.48	0...,308,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12399262A > G,ABCB1	rs10248420	G	12399262A > G	0.59	0.56	0.59	0.64	0.56	0.17	0.48	0...,308,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
983T > C,"CYP2B6	rs28399499	C	983T > C;I328T, *18	0.17	0.09	0.04	0.07	0.02	0.0	0...",314,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
983T > C,"CYP2B6	rs28399499	C	983T > C;I328T, *18	0.17	0.09	0.04	0.07	0.02	0.0	0...",314,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
983T > C,"CYP2B6	rs28399499	C	983T > C;I328T, *18	0.17	0.09	0.04	0.07	0.02	0.0	0...",314,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15213256G > A,CYP2C18	rs7896133	A	15213256G > A	0.2	0.2	0.12	0.11	0.16	0.07	0.08	NA	...,316,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15243758C > T,CYP2C18	rs2860840	T	15243758C > T	0.0	0.09	0	0.01	0.06	0.35	0.23	0.28	...,317,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15243758C > T,CYP2C18	rs2860840	T	15243758C > T	0.0	0.09	0	0.01	0.06	0.35	0.23	0.28	...,317,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
681G > A,"CYP2C19	rs4244285	A	681G > A, *2	0.22	0.2	0.16	NA	NA	0.15	0.26	0.16	0....",321,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1846G > A,"CYP2D6	rs3892097	A	1846G > A, *4	0.0	0.01	NA	NA	NA	0.5	NA	NA	NA",322,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
711G > A,"CYP3A5	rs10264272	A	711G > A;K208K, *6	0.2	0.17	0.15	0.25	0.14	0.0	0.0...",330,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
129 A > G,CYP3A7	rs10211	G	129 A > G	0.35	0.52	0.75	0.72	0.44	0.06	0.34	0.19	...,331,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
129 A > G,CYP3A7	rs10211	G	129 A > G	0.35	0.52	0.75	0.72	0.44	0.06	0.34	0.19	...,331,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,"...vidence of the clinical significance of the ABCB1 1236C > T allele, however, although it appears min...",348,408,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,"...vidence of the clinical significance of the ABCB1 1236C > T allele, however, although it appears min...",348,408,Hum_Genomics_2011_May_1_5(4)_265-282.txt
28A>G,...pathogenicity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated ...,8,777,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,... of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UTR) ...,8,790,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
64G>T,"...drome, namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-...",15,148,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
53G>T,"...ely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-...",15,158,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
53G>T,"...ely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-...",15,158,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [...",15,178,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; ...",15,198,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011; W...",15,222,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly re...",15,1124,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
11C>T,"...s, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly reduce the activ...",15,1138,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untr...,17,66,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ds (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numberi...,21,61,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ds (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numberi...,21,61,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...2 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used throu...,21,74,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...way (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manuscript have been...,21,303,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...way (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manuscript have been...,21,303,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated canc...,23,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...dentified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No ...",48,271,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e c.-93G>A is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variant...",48,437,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variants of uncertai...",48,450,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,To determine whether the c.-28A>G and c.-7C>T variants were in cis with another pathogenic ...,51,42,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...e S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the first-deg...",57,1577,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...e S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the first-deg...",57,1577,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ithin or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investig...,60,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ithin or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investig...,60,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ithin or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investig...,60,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...0001, paired t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with par...",60,1352,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...tical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant abo...",67,312,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ding to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows indica...",67,1297,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ding to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows indica...",67,1297,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ome occupancy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due t...,72,940,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, inclu...",74,1760,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, inclu...",74,1760,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...set of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the two families we...,76,73,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"...H1 expression, as described previously for the c.-42C>T variant, which was associated with drastical...",76,593,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cau...,78,30,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cause of cancer ...,78,43,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...thin or flanking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identifi...",78,516,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Proban...",78,678,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF of 0.0003, sho...",78,934,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... c.-7C>T variants cosegregated. Therefore, the c.-28A>G and c.-7C>T variants are the most likely cau...",78,1951,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ants cosegregated. Therefore, the c.-28A>G and c.-7C>T variants are the most likely cause of predisp...",78,1964,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in MLH...",80,395,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in MLH...",80,395,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a hereditary...,82,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...hermore, a variant of the adjacent nucleotide (c.-27C>A) also segregates with Lynch syndrome in seve...",82,702,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in...",84,24,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both prob...",84,34,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both prob...",84,34,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...scription factors. Due to the proximity of the c.-28A>G and c.-7C>T variants to transcription initia...,84,1865,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 varia...",99,37,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
238 G>A,...ng G  Gao Y  Liu L  Gao T   TNF-a Gene Promoter – 238 G>A and -308 G>A Polymorphisms Alter Risk of P...,138,62,Indian_J_Dermatol_2015_Jul-Aug_60(4)_345-350.txt
399 G>A,XRCC1 codon 399 G>A Arg/Gln (rs25487),132,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
72 G>C,TP53 (p53) codon 72 G>C Arg/Pro (rs1042522),143,18,Infect_Agent_Cancer_2013_May_4_8_15.txt
77T->C,"... Romestaing P Gerard JP Pisani P Hall J The XRCC1–77T->C variant: haplotypes, breast cancer risk, re...",213,83,Infect_Agent_Cancer_2013_May_4_8_15.txt
10364A>G,...nd two coding SNPs (AAFC02034082.1:c.10326C>T and 10364A>G). The latter coding SNP (AAFC02034082.1:c...,43,799,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"... region (AAFC02034082.1:g.9367 G>C (P=0.0288) and 9419A>C (P=0.0397)) with BMS, and a suggestive ass...",46,145,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
61450 C>A,"...onfirmed the association of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p ...",53,957,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
83897 T>A,"...sociation of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p = 0.02). Howeve...",53,972,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
765T>C,c.− 765T>C (rs2243828)	Non-coding,270,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.-653G>A (rs2333227)	Non-coding,273,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
822C>A,c.− 822C>A (rs2243827)	Non-coding,298,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.− 653G>A (rs2333227)	Non-coding,306,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.− 653G>A (rs2333227)	Non-coding,306,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
234 T>G,"...t 13 families exhibited a BRCA1 exon 3 nucleotide 234 T>G mutation (pCys39Gly), which is not previou...",123,96,Int_J_Circumpolar_Health_2012_Aug_16_71_10_3402_ijch_v71i0_19155.txt
12A>G,"...ly). In addition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, ...",42,282,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
-2A>C,"...Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dual oxidase 2 gene responsible for ...",81,137,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
-2A>C,"...Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dual oxidase 2 gene responsible for ...",81,137,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
-2A>C,"...Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dual oxidase 2 gene responsible for ...",81,137,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2482 A > G,"... the A/A and the G/A + G/G genotypes of the AMHR2 2482 A > G polymorphism (rs2002555), nor the C/C a...",3,1948,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
2482 A > G,"...85-t004_Table 4Table 4 The genotypes of the AMHR2 2482 A > G polymorphism (rs2002555) vs. age, BMI, ...",91,64,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
763C>G,...s to investigate the potential association of the 763C>G polymorphism in the secretory phospholipase...,16,100,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...ciation between the risk of endometriosis and the 763C>G polymorphism of PLA2G2A. Genotype distribut...,25,101,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,The present study suggests that the 763C>G polymorphism of PLA2G2A play,30,37,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...PLA2IIa gene of the amplicon, the position of the 763C>G polymorphism, the place of the restriction ...",76,79,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,763C>G genotypes in genomic DNA of the study subje...,79,1,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,763C>G genotypes in genomic DNA of the study subje...,79,1,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...ith Wooton et al, which reported no effect of the 763C>G polymorphism on HDL-C and TG levels in the ...",158,327,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...ith Wooton et al, which reported no effect of the 763C>G polymorphism on HDL-C and TG levels in the ...",158,327,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,... beneficial effects of mutation in this gene. The 763C>G polymorphism of PLA2G2A is also in linkage ...,160,471,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,... beneficial effects of mutation in this gene. The 763C>G polymorphism of PLA2G2A is also in linkage ...,160,471,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
82 A > G,"...iagnosis of MTC. On the other hand, variant (IVS8+82 A > G; InsC 85–86) was associated with the pres...",79,356,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A > G,"...iagnosis of MTC. On the other hand, variant (IVS8+82 A > G; InsC 85–86) was associated with the pres...",79,356,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A > G,"...abnormal splicing, postulating that variant (IVS8+82 A > G; 85–86 InsC) could interrupt and/or creat...",79,568,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
126 G>T,"...inally, in silico analysis revealed that the IVS1–126 G>T genetic variant creates a new binding site...",84,1673,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A>G,IVS8+82 A>G; 85–86 insC (rs3026750)	Tamanah a (2009)	77...,115,6,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
-634 G>C,...Q.   Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-c...,297,112,Int_J_Mol_Sci_2012_Nov_13_13(11)_14845-14864.txt
584C > T,"...G > A (rs2070895), endothelial lipase gene (LIPG) 584C > T (rs2000813), methylenetetrahydrofolate re...",19,301,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,"...813), methylenetetrahydrofolate reductase (MTHFR) 677C > T (rs1801133), the E3 ubiquitin ligase myos...",19,367,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	480 (49.1)	233 (31.0),134,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T (rs2000813)	CC	454 (46.4)	308 (41.0),141,6,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	117.1 ± 16.9	74.2 ± 9.3	42...,211,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,SBP	LIPC −250G > A genotype	2.211	0.587	0.081	3.764	0.000,266,11,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	1.887	0.760	0.054	2.482	0.013,267,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,DBP	LIPG 584C > T genotype	1.396	0.403	0.077	3.460	0.001,271,10,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A genotype	4.317	0.933	0.154	4.629	0.000,287,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A genotype	4.317	0.933	0.154	4.629	0.000,287,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	2.783	0.764	0.126	3.644	0.000,295,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A genotype	2.862	0.650	0.148	4.405	0.000,301,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	2.414	0.882	0.093	2.736	0.006,302,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
66A>G,...van der Linde I.J.  Daniels O.  Blom H.J.   MTRR  66A>G polymorphism in relation to congenital heart...,224,113,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
235Met >Thr,"...ethionine to threonine substitution at codon 235 (235Met >Thr) in the AGT gene, a mutation associate...",115,340,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
235Met >Thr,"... births [54]. However, the mechanism by which the 235Met >Thr mutation affects maternal-placental an...",115,693,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
-149T>C,"...KT  Kwack K    Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphism...",198,91,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
-499A>G,"...the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and...",198,121,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
-499A>G,"...the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and...",198,121,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
80G>A,...  Dennis J  Ma Y  Xie G  Bykerk V  Pope J    RFC1 80G>A is a genetic determinant of methotrexate eff...,263,61,Iran_J_Ped_Hematol_Oncol_2016_Mar_15_6(1)_52-63.txt
2992C >T,...h weight of offspring showed association with H19 2992C >T SNP genotype of mothers (8). The small si...,71,378,Iran_J_Pediatr_2015_Apr_18_25(2)_e461.txt
420 C>G,"...ale et al showed no association between resistin -420 C>G polymorphism with PCOS, they found an asso...",306,450,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
45 T>G,"...th PCOS, they found an association between ADIPOQ 45 T>G polymorphism and PCOS (18, 25, 26).",306,523,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
45 G>T,The 45 G>T polymorphism has been reported to be associ...,308,5,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
467G>A,... designating the variation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R1...,19,410,Ital_J_Pediatr_2013_Feb_14_39_12.txt
531G>A,"...riation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R156H, as well as sev...",19,429,Ital_J_Pediatr_2013_Feb_14_39_12.txt
12769 G>A,"...12,22,23 Of the few remaining changes, 2 (1%), m. 12769 G>A with a frequency of 2% and m.14612 G>A w...",51,580,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
2T>C,... (p.Glu216_Lys251del). This TGFB3 mutation (c.754+2T>C) segregated with the clinical phenotype and w...,58,1070,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
681G>A,Cytochrome P450 2C19 681G>A polymorphism and high on‐clopidogrel platel...,115,22,J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.txt
300T >G,"...82insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respe...",3,1954,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...l distribution and frequencies of BRCA1 5382insC, 300T >G, 185delAG, and 3819del5 mutations. * - onl...",33,123,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...mutation was 5382insC (35/1845, 1.9%) followed by 300T >G (18/1486, 1.2%). Comparing 5382insC mutati...",37,164,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"... second founder mutation for Polish population is 300T >G, detected in 0.082% of the analysed sample...",46,54,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...NA change was detected in 0.05% control subjects. 300T >G mutation is regarded as the founder change...,46,210,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...NA change was detected in 0.05% control subjects. 300T >G mutation is regarded as the founder change...,46,210,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). Carriage of o...,55,216,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). Carriage of o...,55,216,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
1G > A,...G/A transition in intron 6 at position +1 c.357 + 1G >,73,1156,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
2518 A>G,...nificant difference in the distribution of MCP-1 −2518 A>G polymorphic variants in patients with SLE...,7,198,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"...t and protein [20, 21]. Involvement of the MCP-1 –2518 A>G promoter polymorphism in SLE development ...",18,322,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...We analysed the distribution of functional MCP-1 –2518 A>G polymorphic variants in SLE patients (n =...,18,513,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.1. Distribution of MCP-1 –2518 A>G  Genotypes and Alleles in SLE Patients an...,31,29,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...ficant difference in the prevalence of the MCP-1 –2518 A>G polymorphic variant in patients with SLE ...,32,216,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"To date, the MCP-1 –2518 A>G polymorphism has been associated with cor...",40,21,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Reports on the contribution of the MCP-1 –2518 A>G polymorphism to SLE incidence and clinica...,42,43,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"...factors, which may act in synergy with the MCP-1 –2518 A>G polymorphism to change the risk of SLE in...",46,348,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
35T > C,"...olving T to C transition at nucleotide number 35 (35T > C), which resulted in substitution of isoleu...",50,1008,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
593A>G,593A>G	3	Asn198Ser	30	M	+12.2	+8.3	N,89,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,593A>G	3	Asn198Ser	6,101,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	21	M	+6.4	+8.2	N	N	n/a	N	F	Prob...,110,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,266A>G	2	Gln89Arg	6,140,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,266A>G	2	Gln89Arg	6,140,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
530C>A,530C>,167,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
24G>T,...of exon 25 but not in the splice junction (c.3364‐24G>T). The common SNP rs2306033 (MAF 25% in 1000 ...,383,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
66A>G,...ueant-Rodriguez RM  Chen M    Association of MTRR 66A>G polymorphism with superoxide dismutase and d...,120,73,J_Cell_Mol_Med_2011_Nov_24_15(11)_2486-2497.txt
1G>A,...ype was associated with the splice mutation c.879+1G>A. Primary adrenocortical insufficiency and typ...,15,744,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
1C>G,"... one heterozygous for the splicing mutation c.879+1C>G (patients 29, 30, 31, and 48) presented a mil...",133,1181,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
-1G>A,"129	82	OC	Serous	IIIC	G2	TP53 c.920-1G>A, g.7576927C>T (splice site)	—",80,36,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
681G>A,"..., Ltd, Osaka, Japan). Detection of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alle...",37,245,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
636G>A,"...tion of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alleles was performed by polyme...",37,272,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
934C>T,"...51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
745G>C,"4	48/M	Insulin-dependent DM	DM, pigmentation	745G>C/745G>C in HJV	HJV-HH",52,46,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1100T>G,"...nsulin-dependent DM	DM, pigmentation,hypogonadism	1100T>G/2008-2009delAC in TRF2, No mutation in ATP...",54,59,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1206C>A,"...endent DM, history of alcoholism	DM, pigmentation	1206C>A/wt in TFR2	FPN-like iron overload",57,69,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
45T>G,"...dy was to examine the associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",9,77,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponectin (Ad) gene with adipon...",9,144,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponectin (Ad) gene with adipon...",9,144,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...ations between rs2241766 (+45T>G) and rs1501299 (+276G>T) in the ADIPOQ gene and cardiovascular dise...,27,598,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,"... study to examine the associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",29,260,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...he literature: rs2241766 (+45T>G) and rs1501299 (+276G>T) are the most cited regarding the cardiovas...,45,120,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"...garding the cardiovascular risk, the rs17300539 (−11391G>A) was highly associated with adiponectin l...",45,199,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
2841A>T,"...llowing SNPs were selected in this study: SLC2A1 -2841A>T (rs710218), VEGFA+936C>T (rs3025039) [NM_0...",31,222,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,"...encies of the AA, AT, and TT genotypes of SLC2A1 -2841A>T were 51.7%, 37.7%, and 10.6%, respectively...",91,118,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,SLC2A1 -2841A>T	AA (n = 41)	9.40 ± 2.63	0.155	AA	9.40 ± 2....,118,9,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...tients with squamous cell carcinomas. The SLC2A1 -2841A>T polymorphism was significantly associated ...,134,157,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...tients with squamous cell carcinomas. The SLC2A1 -2841A>T polymorphism was significantly associated ...,134,157,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,Table 5 Association between the SLC2A1 -2841A>T gene polymorphism and the mean SUVmax in p...,136,41,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,The functional effect of the SLC2A1 -2841A>T polymorphism has not been completely chara...,159,38,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...ents with early stage NSCLC. Although the SLC2A1 -2841A>T polymorphism in combination with the APEX1...,171,198,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936 C>T,...phism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea Anticancer...,193,136,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
1G>A,"...groups of controls (Table 2). Of these, the c.444+1G>A splice site mutation has been previously repo...",61,763,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1G>A,"...groups of controls (Table 2). Of these, the c.444+1G>A splice site mutation has been previously repo...",61,763,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>A,c.319+2T>A	-	Novel	1/171	ND	Swedish	0	0	-	-,66,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>G,"...nts with complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C12...",96,242,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
2T>G,"...nts with complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C12...",96,242,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
1791+2T>G,"...ith complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C...",96,247,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
313A>G,"...sms c. 472G>A (p. Val108/158Met) in gene COMT, c. 313A>G (p. Ile105Val) in gene GSTP1 and c. 47T>C (...",41,470,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
906T>C,"...tified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>...",3,1727,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,"...tified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>...",3,1727,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a k...",3,1754,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a known microsatellit...",3,1772,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"...s: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and ...",41,141,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"..., −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat p...",41,170,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
930C>G,"...repeat polymorphism (Fig. 1). One novel variant, −930C>G (deposited into GenBank as ss61570833), was...",41,262,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat polymorphism in exon ...",43,76,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106 T>C,−1106 T>C	rs936460	626199			T/T	T/C	C/C,51,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106 T>C,−1106 T>C	rs936460	626199			T/T	T/C	C/C,51,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906 T>C,−906 T>C	rs3758653	626399			T/T	T/C	C/C,54,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,... and genotypic distributions of the promoter SNP −809G>A differed significantly between cases and co...,80,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...ltaneously. A combination of four polymorphisms (−809G>A, −616G>C, −219C>T and 12-bp repeat) appeare...",82,580,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...iation with schizophrenia in this study. The SNP −521T>C, which was previously reported to show asso...",99,155,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1G>T,"...lice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-...",32,483,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
-2A>G,"...e found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,506,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"... was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%). Frequency of the other 36 mutations w...",38,130,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
266C>T,"c. 266C>T	p. P76S	2	 	1	 	0.50	Suzuki et al.5, 6",81,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
367C>T,"c. 367C>T	p. P123S	4	 	1	 	0.50	Tsukamoto et al.2, 4",84,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,c. 600+1G>T	 	Intron 5	 	1	 	0.50	This study,87,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,c. 600+1G>T	 	Intron 5	 	1	 	0.50	This study,87,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,c. 919-2A>G	 	Intron 7	1	11	1	7.00	Coucke et al.21,91,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1001+1G>A,c. 1001+1G>A	 	Intron 8	 	2	 	1.00	Coyle et al.22,92,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1001+1G>A,c. 1001+1G>A	 	Intron 8	 	2	 	1.00	Coyle et al.22,92,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1105A>G,"c. 1105A>G	p. K369E	9	 	1	 	0.50	Usami et al.2, 3",94,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1115C>T,"c. 1115C>T	p. A372V	9	 	1	 	0.50	Usami et al.2, 3",95,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1174A>T,"c. 1174A>T	p. N392Y	10	 	3	 	1.50	Park et al.14, 16",96,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1300G>A,c. 1300G>A	p. A434T	11	 	 	1	0.50	This study,100,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1315G>A,"c. 1315G>A	p. G439R	11	 	1	 	0.50	Suzuki et al.5, 6",101,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1315G>A,"c. 1315G>A	p. G439R	11	 	1	 	0.50	Suzuki et al.5, 6",101,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1343C>T,"c. 1343C>T	p. S448L	11	 	1	 	0.50	Wang et al.7, 8",102,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1343C>T,"c. 1343C>T	p. S448L	11	 	1	 	0.50	Wang et al.7, 8",102,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1343C>T,"c. 1343C>T	p. S448L	11	 	1	 	0.50	Wang et al.7, 8",102,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1595G>T,"c. 1595G>T	p. S532I	14	 	2	 	1.00	Usami et al.3, 17",105,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,"c. 1707+5G>A	 	Intron 15	1	6	 	4.00	Park et al.8, 9",108,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,"c. 1707+5G>A	 	Intron 15	1	6	 	4.00	Park et al.8, 9",108,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1743G>C,"c. 1743G>C	p. R581S	16	 	2	 	1.00	Iwasaki et al.5, 18...",109,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2162C>T,"c. 2162C>T	p. T721M	19	 	1	1	1.00	Usami et al.2, 3",115,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168C>T,c. 2168C>T	p. H723Y	19	1	 	 	1.00	This study,117,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2180T>A,c. 2180T>A	p. L727X	19	 	1	 	0.50	This study,118,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1002-9A>G,"a c. 1002-9A>G, uncertain pathogenicity",119,6,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1001+1G>A,1379	10	p. [1001+1G>A][H723R]	0	+	+	−	−	NA	66.25	46.25	57.5,131,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,1625	16	p. [919-2A>G][H723R]	0	+	+	NA	+	NA	100	95	88.1,133,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4434	8	p. [T410M][1707+5G>A]	1	+	+	−	+	−	92.5	100	91.3,174,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4518	26	p. [H723R][919-2A>G]	0	+	+	+	+	−	105	97.5	98.1,180,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4545	12	p. [1707+5G>A][H723R]	4	+	+	+	+	+	86.25	28.75	53.1,182,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4645	23	p. [919-2A>G] [=]	14	+	−	+	−	−	96.25	105	93.8,188,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,4671	2	p. [H723R][600+1G>T]	0	+	−	−	+	−	NA	NA	NA,213,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,4671	2	p. [H723R][600+1G>T]	0	+	−	−	+	−	NA	NA	NA,213,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
-1G>T,11	int2	c.94-1G>T	 	Splice donor variant,95,13,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
-2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,16,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
-2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,16,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
310 T>C,I.59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,...59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,53,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.82	49	M	380	0	39	No	No	 	No	Yes	No	 	c.[310 T>C];[=,220,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.82	49	M	380	0	39	No	No	 	No	Yes	No	 	c.[310 T>C];[=,220,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
492 C>G,I.118	54	F	240	5	140	No	Yes	RA	Yes	Yes	Yes	 	c.[492 C>G];[542 C>A,228,49,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
431 C>G,"...26	47	F	250	64	90	No	No	 	No	No	No	 	c.[306 C>G];[431 C>G,579 C>A",230,54,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.152	58	F	82	25	47	No	Yes	 	Yes	Yes	No	 	c.[310 T>C];[=,234,46,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.152	58	F	82	25	47	No	Yes	 	Yes	Yes	No	 	c.[310 T>C];[=,234,46,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
9185T>C,...ariable phenotype including Leigh syndrome with a 9185T>C mutation in the MTATP6 gene Neuropediatric...,199,82,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
516G>T,"... (SNPs) CYP3A5*6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained ...",9,644,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
785A>G,"...6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained by Sequenom iPL...",9,659,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
785A>G,"...6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained by Sequenom iPL...",9,659,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
785A>G,"...6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained by Sequenom iPL...",9,659,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
-2A>G,"...l acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (paternal) and on...",18,343,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
-1G>A,"...p codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and...",36,351,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
-1G>A,"...mino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A...",36,363,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"...Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), ...",36,378,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"...Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), ...",36,378,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...VS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/dono...",36,409,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/donor sites; c.1...",36,421,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
-1G>A,"...vel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in ...",57,98,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
9101C>T,"...d to examine the relationship between the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms and...",7,84,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...ents with CRC and 533 control individuals. The g.-9101C>T, g.-8748C>T, and g.72C>T SNPs in CTTN and ...",7,380,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,The CTTN g.-9101C>T polymorphism may influence lymph node posi...,13,13,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...d at investigating the association of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms wit...",24,1131,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...gating the association of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms with the risk o...",24,1143,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...gating the association of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms with the risk o...",24,1143,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,... were partially amplified using a primer set for -9101C>T and -8748C>T (CTTN-PF1; TCCCAGGTGAGTACCCAT...,33,137,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,...ension at 72℃. The PCR products for -9101C>T and -8748C>T were digested with 2 U of Eco 52 I for 12 ...,33,547,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,...ension at 72℃. The PCR products for -9101C>T and -8748C>T were digested with 2 U of Eco 52 I for 12 ...,33,547,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The genotype frequencies of the CTTN g.-9101C>T polymorphism were 97.0% (TT), 3.0% (TC), a...",43,41,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...p. The genotype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",43,604,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...p. The genotype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",43,604,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"The major haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplot...",49,45,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplotype did not diff...",49,61,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"The haplotype frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between CRC gr...",52,50,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...er studies with large populations and the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms are...",69,606,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
48-30T>C,"...nymous mutation (A155A) and one intronic variant (48-30T>C), which were not present in 220 control a...",93,636,J_Med_Case_Rep_2013_Mar_18_7_78.txt
-2 A>G,"...74-5delGTinsCAC), four splice site mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one ...",46,730,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
-2A>G,253	4		IVS4-2A>G		Splice site	1	1		0	1	1 (n = 1),54,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
-2A>G,255	4		IVS4-2A>G		Splice site	1	1	PFF	0	1	1 (n = 2),57,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,261	7		IVS7+1 G>T		Splice site	1	1	L	1	1	1 (n = 3),65,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,263*	7		IVS7+1 G>T		Splice site	1	1		1	1	1 (n = 1),67,14,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 T>G,267	9		IVS9+2 T>G		Splice site	1	1		0	1	0,71,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1G>T,"...d to cause exon skipping: three in intron 7 (IVS7+1G>T), four in intron 4 (IVS4-2 A>G), one in intro...",110,951,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
-2 A>G,"c.1733insC, IVS10-2 A>G",157,24,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
-2 A>G,"...ite mutation in the BHD gene within intron 4 (IVS4-2 A>G) (table 1). However, we did not identify se...",213,518,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
-24C>T,... were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due to low...,103,1266,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
-24C>T,... were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due to low...,103,1266,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
539A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probably damaging	Possibly dama...,119,49,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
153609246 C>T,Patient 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benig...,122,22,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
454C>T,Patient 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benign	Benign	180	0.00	C55	Not ...,122,48,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23901935 G>T,Patient 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probab...,129,25,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,Patient 12	F	52	38	MYH7	23901935  G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably dama...,132,51,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,Patient 12	F	52	38	MYH7	23901935  G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably dama...,132,51,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
88451727 A>G,Patient 16	F	73	?	LDB3	88451727 A>G	NM_007078.2	764A>G	p.Lys255Arg	Benign...,136,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
63356265 A>G,Patient 20	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not...,160,25,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
775A>G,...tient 20	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0....,160,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
566C>T,...atient 25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 8...,165,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47354463 T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Beni...,167,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3392T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Benign	Possibly damaging	89	0...,167,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3392T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Benign	Possibly damaging	89	0...,167,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3392T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Benign	Possibly damaging	89	0...,167,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
877C>T,...ient 28	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Probably damaging	Probably dama...,170,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3157G>A,...tient 29	M	24	17	?	SCN5A	38622493 G>A	NM_198056.2	3157G>A	Glu1053Lys	Probably damaging	Possibly dama...,194,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1178C>T,MYH7	23898517 C>T	NM_000257.2	1178C>T	Ala393Val	Possibly damaging	Possibly damag...,195,36,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
151478451C>T,Patient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly ...,198,27,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
253C>T,...atient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly damaging	Benign	74	0.12	C...,198,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2827C>T,...nt 35	M	16	18	Yes	MYBPC3	47356671 C>T	NM_000256.3	2827C>T	Arg943X	–	–	–	–	–	Not found	Pathogenic	Dut...,201,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23898464 G>A,Patient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibl...,204,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,...tient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibly damaging	Probably damag...,204,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,...tient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possibly damaging	Probably dama...,210,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,...tient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possibly damaging	Probably dama...,210,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
19213986 T>C,Patient 47	F	71	?	Yes	CSRP3	19213986 T>C	NM_003476.3	10T>C	Trp4Arg	Possibly da...,213,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probably damaging	Probably dama...,215,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1987C>T,...atient 52	F	38	26	No	MYH7	23896043C>T	NM_000257.2	1987C>T	Arg663Cys	Probably damaging	Possibly damag...,219,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
220285587A>C,Patient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably...,220,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,...tient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably damaging	Probably damagi...,220,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,...tient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably damaging	Probably damagi...,220,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,...tient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably damaging	Probably damagi...,220,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23902821G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Pos...,222,11,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Possibly damaging	23	0.13	C...,222,35,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Possibly damaging	23	0.13	C...,222,35,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
182A>G,"...Hypoplastic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heteroz...",97,65,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2407G>T, V2.09	F	16	AD	Hypoplastic	COL17A1	NM_000494.3	c.[2407G>T]; [=]	p.[G803*];[=]	Maternal	73	S4,100,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
124C>T, V2.18	M	13	?	Hypoplastic	LAMB3	NM_000228.2	c.[124C>T]; [=]	p.[R42*];[=]	?	74	S5,101,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1282C>T,....26	M	13	AD	Hypomineralised	FAM83H	NM_198488.3	c.[1282C>T];[=]	p.[Q428*];[=]	Paternal	Novel	S7,103,54,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1646G>A, V2.48	F	20	AD	Hypoplastic	COL17A1	NM_000494.3	c.[1646G>A];[=]	p.[W549*];[=]	Maternal	Novel	S10,106,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1646G>A, V2.48	F	20	AD	Hypoplastic	COL17A1	NM_000494.3	c.[1646G>A];[=]	p.[W549*];[=]	Maternal	Novel	S10,106,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
532-1G>C, V2.53	F	19	?	Hypoplastic	AMBN	NM_016519.5	c.[532-1G>C];[532-1G>C]	p.[0?];[(0?)]	Homozygous	Nove...,107,47,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1873C>T,"...	?	Hypoplastic, hypomature	COL17A1	NM_000494.3	c.[1873C>T];[=]	p.[R625*];[=]	?	Novel	S13",109,62,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
383G>A,"... 31, 34, 35, 38, 44, 45, 48	WNT10A	NM_025216.2	c.[383G>A];[=]	p.[R128Q];[=]	Maternal	77	S15",114,107,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
343A>C,"... 37, 38, 41, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[343A>C](;)[682T>A]	p.[K115Q](;)[F228I]	?	Novel and...",115,103,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"..., 44, 45, 47, 48	WNT10A	NM_025216.2	c.[343A>C](;)[682T>A]	p.[K115Q](;)[F228I]	?	Novel and 78	S16",115,114,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[321C>A];[321C>A]	p.[C107*];[C107*]	Homozygous	78	S17",116,152,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[321C>A];[321C>A]	p.[C107*];[C107*]	Homozygous	78	S17",116,152,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...38, 41, 42, 45, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S18",117,124,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
637G>A,"... 22, 23, 24, 28, 31, 41, 45	WNT10A	NM_025216.2	c.[637G>A];[=]	p.[G213S];[=]	?	79	S21",120,79,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound heterozygous	78...",121,144,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound heterozygous	78...",121,144,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound heterozygous	78...",121,144,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"... 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A ](;)[321C>A]	p.[F228I](;)[C107*]	?	78	S23",122,99,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...38, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S29",128,108,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A, V2.54	F	49	?	ED	WNT10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound he...,130,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
954-2A>T,"...hypomineralised, hypoplastic	MMP20	NM_004771.3	c.[954-2A>T];[126+6T>G]	p.[0?];[0?]	Compound heterozy...",152,68,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-2A>G,"...ypomineralised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	M...",155,69,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-2A>G,"...ypomineralised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	M...",155,69,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-3C>A,"...lised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal a...",155,78,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
590-3C>A,"...lised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal a...",155,78,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1294G>A,...stic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal and de novo	82 ...,155,92,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1156C>T,...	?	Mucopolysaccharidosis IVA	GALNS	NM_000512.4	c.[1156C>T];[?]	p.[R386C];[?]	de novo	84	S45,158,61,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
5G>C,...an FTLD founder pedigree segregating the GRN IVS1+5G>C splice donor site mutation (Cruts et al. 2006...,43,2022,J_Mol_Neurosci_2011_Nov_26_45(3)_516-521.txt
3291T>C,...i M.   Neuromuscular syndrome associated with the 3291T>C mutation of mitochondrial DNA: a second ca...,79,115,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,... with mitochondrial encephalomyopathy harboring a 3291T>C mutation in mitochondrial DNA Neurol Sci 3...,81,142,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenetics an...",131,110,J_Nucleic_Acids_2012_Sep_3_2012_985260.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenetics an...",131,110,J_Nucleic_Acids_2012_Sep_3_2012_985260.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
861C>A,"...s1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 58...",7,425,J_Stroke_2013_May_31_15(2)_115-121.txt
5808T>G,"..., 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438),...",7,473,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",7,494,J_Stroke_2013_May_31_15(2)_115-121.txt
8814T>C,"...9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using ...",7,564,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...high prevalence of wild-type CYP2C9 polymorphism (1075A>C, P<0.001), and six heterozygote SNPs in VR...",10,276,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...VRORC1 (P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>...",10,374,J_Stroke_2013_May_31_15(2)_115-121.txt
7566C>T,"...y interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based on these data, a w...",10,409,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,"...oups. We selected 26 SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C)...",36,310,J_Stroke_2013_May_31_15(2)_115-121.txt
3673A>G,"... (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 64...",36,418,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"..., 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C...",36,466,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>T,"...808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9...",36,487,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), ...",36,518,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"... 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glutamyl car...",36,536,J_Stroke_2013_May_31_15(2)_115-121.txt
8015C>T,"... and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA...",36,674,J_Stroke_2013_May_31_15(2)_115-121.txt
8015C>T,"... and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA...",36,674,J_Stroke_2013_May_31_15(2)_115-121.txt
8240A>G,"...llite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,692,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...cant difference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs1...",50,158,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...ference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]...",50,166,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... (P<0.001), and prevalence of heterozygote CYP2C9 1075A>C (rs1057910) with high WRI (P<0.001) (Figur...",52,152,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...riability and prevalence of selected SNPs (VKORC1 9041G>A and CYP2C9 1075A>C). However, the linkage ...",57,348,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...riability and prevalence of selected SNPs (VKORC1 9041G>A and CYP2C9 1075A>C). However, the linkage ...",57,348,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...lence of selected SNPs (VKORC1 9041G>A and CYP2C9 1075A>C). However, the linkage in VKORC1 SNPs has ...",57,367,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,... find significant influence of CYP2C9 (1076T>C or 430C>T) on warfarin dose although this position wa...,59,494,J_Stroke_2013_May_31_15(2)_115-121.txt
1639 G>A,...on of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes Clin Chem 2007 53 1...,128,136,J_Stroke_2013_May_31_15(2)_115-121.txt
2T>C,c.286+2T>,158,7,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,... serum arising as a consequence of the CFH c.3134‐5T>C variant was undertaken by Western blotting. S...,229,102,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>C,"...h resulted in complete CD46 deficiency. The c.286+2T>C variant was of maternal origin, while the c.2...",246,175,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
1555A > G,"...G, 176-191del16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. ...",7,454,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...lC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples that showe...",7,476,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,"..., 176-191del16, 235delC, and 299-300delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and 2168A > G), an...",27,621,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...A > G and 2168A > G), and mitochondrial 12S rRNA (1555A > G and 1494C > T). The test results were de...",27,697,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...A > G and 2168A > G), and mitochondrial 12S rRNA (1555A > G and 1494C > T). The test results were de...",27,697,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1494C > T (12S rRNA)	1503G > A	1,44,22,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1494C > T (12S rRNA)	1503G > A	1,44,22,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,1494C > T	0	1	0	0,74,1,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,1494C > T	0	1	0	0,74,1,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,IVS7-2A > G/IVS7-2A > G	2	7	0	0,76,17,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,2168A > G/IVS7-2A > G	1	1	0	0,78,15,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,235delC/IVS7-2A > G	0	1	0	0,82,13,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,235delC/IVS7-2A > G	0	1	0	0,82,13,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,IVS7-2A > G	0	1	0	0,85,5,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,538C > T/-	0	1	0	0,88,1,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"The frequencies of SLC26A4 mutation, including 2168A > G (H723R) and IVS7-2A > G, were 2.01% (4/1...",94,48,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,"... Han Chinese patients, respectively. Of note, IVS7-2A > G mutant alleles accounted for 83.33% (25/30...",94,193,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,...ported gene mutation. The mutation frequencies of 538C > T for GJB3 were 0.0% (0/199) in Uyghur pati...,96,275,J_Transl_Med_2011_Sep_14_9_154.txt
1G > A,"...rn deaf population, L236P, T416P, E384G, and IVS8+1G > A are common mutant loci of SLC26A4 [21], whe...",106,309,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...A are common mutant loci of SLC26A4 [21], whereas 2168A > G is the primary mutant locus in Japanese ...",106,364,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,"... (22/151) in Han Chinese NSD patients, whilst IVS7-2A > G mutant alleles account for 83.33% (25/30) ...",106,1230,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,...tion. This is consistent with the report that IVS7-2A > G is the primary mutation of SLC26A4 in Han ...,106,1348,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...ted with aminoglycoside-induced deafness [31,32]. 1555A > G and 1494C > T are the most important and...",108,113,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...rted by Li et al. [11]. The mutation frequency of 1494C > T is even lower than that of 1555A > G. 14...,108,565,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...rted by Li et al. [11]. The mutation frequency of 1494C > T is even lower than that of 1555A > G. 14...,108,565,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,... X Han B Yuan H Platt OS Han D Wu BL SLC26A4 c.919-2A > G varies among Chinese ethnic groups as a ca...,140,120,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,... X Han B Yuan H Platt OS Han D Wu BL SLC26A4 c.919-2A > G varies among Chinese ethnic groups as a ca...,140,120,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,...DY Zhang X Xue DD Jin ZC Frequency of SLC26A4 IVS7-2A > G mutation in patients with severe to profou...,155,108,J_Transl_Med_2011_Sep_14_9_154.txt
-2A > G,...DY Zhang X Xue DD Jin ZC Frequency of SLC26A4 IVS7-2A > G mutation in patients with severe to profou...,155,108,J_Transl_Med_2011_Sep_14_9_154.txt
1236C > T,"...2℃ extension for 10 minutes. The genotype of MDR1 1236C > T (assay ID: C__7586662_10), ABCG2 421C > ...",33,639,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
1236C > T,"...r estimation of a haplotype in three genotypes of 1236C > T, 2677G > T/A, 3435C > T in MDR-1 gene, T...",49,259,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
2677G > T,"Table 3 Primer and Probe Sequences for MDR1 2677G > T, 2677G > A, 3435C >",75,45,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
118A>G,...tsch J   The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and p...,79,105,Korean_J_Pain_2016_Jan_4_29(1)_34-39.txt
1875T>A,...mpare the effects of NF-Y on the reference and g.-1875T>A variant OCTN1 promoters. p<0.05 was consid...,33,307,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...t in the haplotypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter ...,40,1202,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...t in the haplotypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter ...,40,1202,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...ypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter activities, whe...",40,1217,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...omoter activities, whereas two (g.-1145A>G and g.-248C>G) had decreased promoter activities; the act...",40,1295,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...omoter activities, whereas two (g.-1145A>G and g.-248C>G) had decreased promoter activities; the act...",40,1295,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"...ibited decreased promoter activities contained g.-1145A>G and g.-248C>G. However, H1 and H3 also had...",40,1637,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...8C>G. However, H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed...",40,1704,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,Effect of the variant g.-1875T>A on the binding affinity of NF-Y to the OCT...,42,26,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,Effect of the variant g.-1875T>A on the binding affinity of NF-Y to the OCT...,42,26,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
510C>T,"... identified two novel variants, g.-2063A>C and g.-510C>T. The region from -104 bp to -1 bp upstream ...",51,1001,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"... These three haplotypes contained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these varian...",53,195,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...d g.-248C>G. Of these variants, g.-1145A>G and g.-248C>G showed significantly decreased promoter act...",53,267,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...ibly because of the presence of g.-1745A>G and g.-1875T>A, respectively, which showed increased prom...",53,525,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...sequence TCGCCAATAAC. In contrast, the variant g.-1875T>A has the sequence TCGCCAAAAAC, which is a p...",57,329,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...sequence TCGCCAATAAC. In contrast, the variant g.-1875T>A has the sequence TCGCCAAAAAC, which is a p...",57,329,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
207G>C,... the OCTN1 variant L503F and the OCTN2 variant g.-207G>C was significantly associated with susceptib...,59,116,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...TN1 regulate promoter activity was determined: g.-1875T>A, a variant present in H3, was associated w...",61,316,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1793G>A,"...ed extensively. Along with C677T, the 1298A>C and 1793G>A polymorphism were associated with the plas...",252,433,Lipids_Health_Dis_2006_Jan_23_5_1.txt
80G->A,...ister M Rosenblatt DS Nicolas JP  A Polymorphism (80G->A) in the Reduced Folate Carrier Gene and Its...,464,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",475,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",475,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
786T>C,"... R Gensini GF  Endothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism infl...",487,130,Lipids_Health_Dis_2006_Jan_23_5_1.txt
3238C>G,...mized cluster samples. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,7,173,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...was to determine the interactions of the ApoC-III 3238C>G (rs5128) polymorphism and alcohol consumpt...,18,1508,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...at 4°C until analysis. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,31,180,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...ed t test. The allele frequencies of the ApoC-III 3238C>G were determined by gene counting. A chi-sq...,40,392,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...ed t test. The allele frequencies of the ApoC-III 3238C>G were determined by gene counting. A chi-sq...,40,392,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...genotypic and allelic frequencies of the ApoC-III 3238C>G are shown in Table 2. The frequencies of C...,88,55,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.324	6.542	0.011	1.068-1.642,137,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.709	9.600	0.002	1.218-2.400,147,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.678	15.923	0.000	1.301-2.163,155,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.324	6.542	0.011	1.068-1.642,160,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	2.200	12.048	0.044	1.410-3.434,165,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.574	6.223	0.013	1.102-2.248,175,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.874	16.157	0.000	1.380-2.545,179,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.874	16.157	0.000	1.380-2.545,179,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	2.319	10.577	0.001	1.397-3.849,183,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...allelic and genotypic frequencies of the ApoC-III 3238C>G between the nondrinkers and drinkers. The ...,196,123,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,The relationship between the ApoC-III 3238C>G polymorphism and plasma or serum lipid lev...,198,39,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,The interactions of the ApoC-III 3238C>G polymorphism and alcohol consumption on se...,200,34,Lipids_Health_Dis_2010_Aug_17_9_86.txt
455T>C,...lly PW Huff MW Hegele RA Association between the -455T>C promoter polymorphism of the APOC3 gene and...,258,142,Lipids_Health_Dis_2010_Aug_17_9_86.txt
482 C>T,"...ransfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with co...",273,224,Lipids_Health_Dis_2010_Aug_17_9_86.txt
482 C>T,"...ransfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with co...",273,224,Lipids_Health_Dis_2010_Aug_17_9_86.txt
482 C>T,"...ransfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with co...",273,224,Lipids_Health_Dis_2010_Aug_17_9_86.txt
214C>A,"...ibed within this gene. One missense polymorphism, 214C>A at codon 72 with Met replacing Leu, is outs...",27,320,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...n and polymorphism or SNP or Leu72Met  or 214C>A and type 2 diabetes,33,217,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...und an association of MTLRP genetic polymorphism (214C>A) with Type 2 diabetes in Caucasian populati...,101,78,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,Several previous studies suggested that MTLRP 214C>A polymorphism was associated with the risk f...,103,47,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,Several previous studies suggested that MTLRP 214C>A polymorphism was associated with the risk f...,103,47,Lipids_Health_Dis_2014_Aug_5_13_124.txt
202 G>A,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCA...",78,5,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCAACGGCAAGC...",78,14,Malar_J_2015_Aug_7_14_308.txt
376 A>G,A+ (376 A>G)	CTGCGTTTTCTCCGCCAATC AGGGCAACGGCAAGCCTTAC...,79,5,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A− (202 G>A, 376 A>G)	898	423, 184, 169, 106, 32	423, 184, 127,...",89,14,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A+ (376 A>G)	585	402, 187	289, 187, 117	[22, 35]",90,5,Malar_J_2015_Aug_7_14_308.txt
1196 C>T,... ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infections: a review...,120,74,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
1196 C>T,... ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infections: a review...,120,74,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
896A>G,48 Yao Y  Ren X  He L    TLR4 +896A>G (Asp299Gly) polymorphism is not associated ...,223,32,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
1298A>C,...tion to plasma homocysteine and MTHFR  677C>T and 1298A>C genotypes and haplotypes – evidence for an...,186,135,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
786T>C,"...s/nitrates. Here, we first demonstrate that NOS3 −786T>C variant affects nitrite/nitrate levels in I...",25,1523,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...Ps) NOS2A Ser608Leu (C2087T, rs2297518) and NOS3 −786T>C (rs2070744) was performed by real-time PCR ...",53,228,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...zed in patients and controls with different NOS3 −786T>C genotypes, some statistically significant d...",129,89,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nts NOS2 −2.5 kb (CCTTT)n and Ser608Leu and NOS3 −786T>C in IEI patients,142,344,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ents and healthy subjects, having different NOS3 −786T>C genotypes, through their quartiles. The bot...",169,345,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,−786T>C NOS3	 	 	 	 ,189,2,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
684G>A,"...e in these glioma patients. More importantly, the 684G>A polymorphism is significantly associated wi...",8,244,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,Our study indicates that the NOTCH3 gene 684G>A polymorphism may be used as a prognosis mar...,10,42,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,...ed on their NOTCH3 genotypes. The distribution of 381C>T and 474C>A polymorphisms did not have a sig...,36,114,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,... NOTCH3 genotypes. The distribution of 381C>T and 474C>A polymorphisms did not have a significantly ...,36,125,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ed by western blot assay. Figure 1 shows only the 684G>A polymorphism significantly affected the tum...,45,126,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,"...l than 684GA and 684AA carriers. In contrast, the 381C>T and 474C>A did not affect the NOTCH3 expres...",45,309,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,...els were similar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,488,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...milar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,499,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...milar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,499,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...rphism in patients receiving different treatment. 684G>A polymorphism was the only one which can aff...,52,139,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...0.001) in overall patients. (B) The effect of the 684G>A polymorphism on the survival rate in glioma...,52,394,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684 G>A,"... the seemingly non-functional polymorphisms, like 684 G>A, could affect transcription, splicing, mRN...",63,348,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... Thirdly, the molecular mechanism under which the 684G>A polymorphism affect the gloimas risk and th...",67,436,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
-6C>G,"...ygote mutation. In addition, we found the HJV c.98-6C>G polymorphic variant in both the sister and p...",43,509,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
-6C>G,"...ygote mutation. In addition, we found the HJV c.98-6C>G polymorphic variant in both the sister and p...",43,509,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
-6C>G,"...e proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorphic variant was found i...",317,397,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
186C>T,"...notypes, compared to controls [11]. The SOD3 IVS1+186C>T polymorphism is associated with a significa...",22,539,Mol_Biol_Int_2013_Dec_16_2013_189237.txt
186C>T,"...notypes, compared to controls [11]. The SOD3 IVS1+186C>T polymorphism is associated with a significa...",22,539,Mol_Biol_Int_2013_Dec_16_2013_189237.txt
1444A>G,"... −42 + 1444 position in the HMOX2 gene (the −42 + 1444A>G-HMOX2 polymorphism, rs2270363) and its mod...",3,1722,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,...R 0.41). The G/C genotype and the C allele of the 19 G>C-HMOX1 polymorphism and the G/G genotype and...,3,2260,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"..., 0.19, 0.34, 0.59, respectively). Therefore, the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphi...",3,2724,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... −42 + 1444 position in the HMOX2 gene (the −42 + 1444A>G-HMOX2 polymorphism, rs2270363) and AMD. We...",18,448,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... −42 + 1444 position in the HMOX2 gene (the −42 + 1444A>G-HMOX2 polymorphism, rs2270363) and AMD. We...",18,448,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,...tion by some clinical and life-style factors. The 19 G>C-HMOX1 polymorphism is located in the coding...,18,606,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...lele frequency ≥3% in an European population. The 19G>C-HMOX1 polymorphism is a non-synonymous mutat...,18,857,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...lele frequency ≥3% in an European population. The 19G>C-HMOX1 polymorphism is a non-synonymous mutat...,18,857,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...lele frequency ≥3% in an European population. The 19G>C-HMOX1 polymorphism is a non-synonymous mutat...,18,857,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...allele distributions of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms in AMD patients and co...,50,68,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... AMD occurrence and the G/A genotype of the −42 + 1444A>G-HMOX2 polymorphism was found, whereas the ...",50,571,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... AMD occurrence and the G/A genotype of the −42 + 1444A>G-HMOX2 polymorphism was found, whereas the ...",50,571,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism increased progression o...,52,357,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...OX1 polymorphism and the A/G genotype of the 42 + 1444A>G-HMOX2 polymorphism were associated with a ...,57,223,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,The association between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphi...,60,37,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...ion between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphism was subjected to strati...,60,63,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...9G>C polymorphism of the HMOX1 gene and the −42 + 1444A>G polymorphism of the HMOX2 gene may be asso...,73,93,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...t that the 19G>C-HMOX1 polymorphism and the −42 + 1444A>G-HMOX2 polymorphism may be linked with the ...,76,85,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
28625C>T,"... at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in linkage disequilibrium with each ...",3,1326,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7294C>T,... regions could alter gene expression. The SNP g. +7294C>T was a missense mutation Arg2432Cys. It is ...,264,158,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1163T>C,"... primary breast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detec...",15,345,Mol_Cancer_2010_Jul_1_9_173.txt
1163T>C,"... primary breast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detec...",15,345,Mol_Cancer_2010_Jul_1_9_173.txt
1G>T,"c.3756+1G>T			Homozygous	Profound	Liburd et al., 2001",101,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et al....,128,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et al....,128,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et al....,129,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belguith et a...,130,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belguith et a...,130,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>C,"c.8968−1G>C			Homozygous	Profound	Kalay et al., 2007",137,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1639G>A,"...genotyping of CYP450 2C9 (*2 and *3) and VKORC1 (−1639G>A), with a result produced in approximately ...",234,157,Mol_Diagn_Ther_2013_Jun_16_17(3)_165-184.txt
1C>T,"...) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM...",5,1084,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"...NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DN...",5,1182,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"...NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DN...",5,1182,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-2A>G,"KLHDC1	Ph+005	14,49265391,49265392,1,A/G	c.568-2A>G	93 (14)	48 (1)	52% (7%)	Acceptor lost",73,47,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"HOOK1	Ph-006	1,60103421,60103422,1,G/A	c.1662-1G>A	186 (153)	87 (0)	47% (0%)	Acceptor lost",75,46,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,49,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"HOOK1	Ph-006	c.1662-1G>A	1	0.94/–	0.877/–	5861	344	3.767	58% wt RNA, ...",88,20,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"HOOK1	Ph-006	c.1662-1G>A	1	0.94/–	0.877/–	5861	344	3.767	58% wt RNA, ...",88,20,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,...14 of ABCC3 (OMIM#604323) gene (NM_003786.3:c.1783-1G>A); it was present with a frequency of 51%. Th...,100,177,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-2A>G,"...n the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at positi...",102,91,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-2A>G,"...n the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at positi...",102,91,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1C>T,"...he SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Despite t...",106,184,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2T>C,"...sversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (chr5:11...",119,653,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-1G>A,"...ing aberrant mRNA. However, the NM_015888.4:c.1662-1G>A mutation has not been reported in literature...",129,352,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,APC (NM_000038.4:c.1312+5G>A) splicing mutation detected by whole-exome se...,146,25,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
-2A>G,...9 somatic mutations. (A) KLHDC1 (NM_172193.1:c.568-2A>G) splicing mutation near the 3’ acceptor spli...,153,66,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,...Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor site at ...,153,457,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,...Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor site at ...,153,457,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,... O   The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts ...,186,108,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,IVS10	c.845+1G>A	p.?	i	Novel	36,42,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>T,IVS10	c.845+1G>T	p.?	f	Novel	77,43,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
-1G>A,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (2002)	31,48,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
-1G>C,IVS14	c.1412-1G>C	p.?	i	Novel	26,52,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
-1G>A,IVS15	c.1564-1G>A	p.?	f	Novel	32,55,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS18	c.2025+1G>A	p.N607_K675del3	f	Denier et al. (2004)	21,63,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS18	c.2025+1G>A	p.N607_K675del3	f	Denier et al. (2004)	21,63,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
-1G>T,IVS6	c.269-1G>T	p.?	f	Novel	3,74,11,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
-2A>C,IVS9	c.558-2A>C	p.?	i	Novel	3,80,11,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,The mutation c.2025+1G>A within CCM1 (CCM1:p.N607_K675del) was found i...,103,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,...quencing revealed the splice site mutation c.2025+1G>A within CCM1 likely resulting in skipping of e...,105,562,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,CCM1:c.2025+1G>A is predicted to cause a 69 amino acid deletio...,109,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
2246G>T,...revealed a nucleotide alteration between G and T (2246G>T) in exon 15 in the two affected individual...,24,256,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
489C>T,Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer’s disease ....,351,33,Mol_Pain_2016_May_12_12_1744806916646786.txt
677C>T,...oung IS  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels ...,246,106,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,...oung IS  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels ...,246,106,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
1298A>C,...DJ  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydro...,255,103,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
415 T > C,"4	1 of 2	1 of 1	4q12:55,603,415 T > C	I924T	Neutral (0.86)",143,30,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
774 A > C,"3	1 of 1	2 of 5	1p34.3:35,453,774 A > C	L970R	Deleterious (1)",159,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
774 A > C,"3	1 of 1	2 of 5	1p34.3:35,453,774 A > C	L970R	Deleterious (1)",159,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
839 A > G,"3	1 of 1	1 of 5	18q11.2:19,093,839 A > G	N1598S	Deleterious (1)",217,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
595 G > A,"6	1 of 1	1 of 2	11q13.4:70,644,595 G > A	A578V	Deleterious (1)",241,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
588 G > A,"6	0 of 1	1 of 2	16q24.3:90,030,588 G > A	R399Q	n/a Deleterious (1)",257,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
588 G > A,"6	0 of 1	1 of 2	16q24.3:90,030,588 G > A	R399Q	n/a Deleterious (1)",257,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
217 C > T,"4	1 of 1	3 of 3	6q22.31:119,670,217 C > T	G5D	Neutral (0.87)",314,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
217 C > T,"4	1 of 1	3 of 3	6q22.31:119,670,217 C > T	G5D	Neutral (0.87)",314,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
319 G > A,"2	1 of 2	2 of 3	14q32.2:100,992,319 G > A	R405H	Deleterious (1)",347,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
787T > C,...nspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density . B...,194,165,Mol_Ther_Methods_Clin_Dev_2016_Feb_3_3_15059.txt
13G>T,1	IVS1+13G>T	1 ARRP (003-178)	0,51,8,Mol_Vis_2007_Apr_5_13_588-593.txt
2T>C,Intron 7	c.718+2T>C	Aberrant splicing	Juvenile RP		 [16],48,16,Mol_Vis_2008_Apr_21_14_675-682.txt
4A>G,"Intron 12	c.1224+4A>G, (IVS12+4A>G)	Aberrant splicing	RP	Found in h...",55,18,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...set RP	Found in compound heterozygosity with c.99+1G>A	 [11],57,86,Mol_Vis_2008_Apr_21_14_675-682.txt
-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [18]",65,17,Mol_Vis_2008_Apr_21_14_675-682.txt
-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [18]",65,30,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...ch have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the don...",102,741,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...ch have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the don...",102,741,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>C,c.78+1G>C	splice site	frameshift→ truncated protein	int...,88,6,Mol_Vis_2008_Dec_12_14_2321-2332.txt
2A>G,...zygous mutations: a splicing site mutation c.985 −2A>G in family F1 and a nonsense mutation c.2197C>...,111,113,Mol_Vis_2008_Dec_29_14_2451-2457.txt
1G>A,"...lettre et al. reported a recurrent mutation c.985–1G>A, which has a similar consequence [9,11]. This...",122,849,Mol_Vis_2008_Dec_29_14_2451-2457.txt
1G>A,"...lettre et al. reported a recurrent mutation c.985–1G>A, which has a similar consequence [9,11]. This...",122,849,Mol_Vis_2008_Dec_29_14_2451-2457.txt
38T>G,"...in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) were selected,...",40,311,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) were selected, as they had been found to ha...",40,340,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...). In APOE, the promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 polymorphism...",40,978,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"...he promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 polymorphisms in exon 4 (...",40,991,Mol_Vis_2009_Jan_16_15_89-98.txt
126 T>C,Promoter	−126 T>C	-	0 (0)	1 (0.25)	0/0/176	0/1/199,59,11,Mol_Vis_2009_Jan_16_15_89-98.txt
83 G>A,Promoter	−83 G>A	-	16 (4.5)	30 (7.5)	2/12/162	3/24/173,60,11,Mol_Vis_2009_Jan_16_15_89-98.txt
57 G>T,Exon 1	c. 57 G>T	Q19H	0 (0)	1 (0.25)	0/0/176	0/1//199,62,11,Mol_Vis_2009_Jan_16_15_89-98.txt
482 A>G,Exon 1	c. 482 A>G	Q161R	0 (0)	1 (0.25)	0/0/176	0/1/199,67,11,Mol_Vis_2009_Jan_16_15_89-98.txt
611 C>T,Exon 2	c. 611 C>T	T204M	0 (0)	2 (0.5)	0/0/176	0/2/198,70,11,Mol_Vis_2009_Jan_16_15_89-98.txt
624 C>G,Exon 2	c. 624 C>G	D208E	1 (0.28)	3 (0.75)	0/1/175	0/3/197,71,11,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35 A>G,Intron 2	IVS 2+35 A>G	-	69 (19.6)	84 (21)	9/51/116	7/70/123,72,14,Mol_Vis_2009_Jan_16_15_89-98.txt
864 C>T,Exon 3	c. 864 C>T	I288I	1 (0.28)	1 (0.25)	0/1/175	0/1/199,74,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1041 T>C,Exon 3	c. 1041 T>C	Y347Y	0 (0)	1 (0.25)	0/0/176	0/1/199,76,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1464 C>T,Exon 3	c. 1464 C>T	A488A	0 (0)	2 (0.5)	0/0/176	0/2/198,79,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1515+73 G>C,3′UTR	1515+73 G>C	-	3 (0.85)	1 (0.25)	0/3/173	0/1/199,80,7,Mol_Vis_2009_Jan_16_15_89-98.txt
1515+73 G>C,3′UTR	1515+73 G>C	-	3 (0.85)	1 (0.25)	0/3/173	0/1/199,80,7,Mol_Vis_2009_Jan_16_15_89-98.txt
1515+73 G>C,3′UTR	1515+73 G>C	-	3 (0.85)	1 (0.25)	0/3/173	0/1/199,80,7,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...es of OPTN (Met98Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) fol...",84,70,Mol_Vis_2009_Jan_16_15_89-98.txt
53 T>C,OPTN	IVS8 −53 T>C	-	27 (7.67)	24 (6)	1/25/150	1/22/177,94,12,Mol_Vis_2009_Jan_16_15_89-98.txt
53 T>C,OPTN	IVS8 −53 T>C	-	27 (7.67)	24 (6)	1/25/150	1/22/177,94,12,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,OPTN	IVS15+10G>A	-	8 (2.27)	7 (1.75)	0/8/168	0/7/193,95,12,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,OPTN	IVS15+10G>A	-	8 (2.27)	7 (1.75)	0/8/168	0/7/193,95,12,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,OPTN	IVS15+10G>A	-	8 (2.27)	7 (1.75)	0/8/168	0/7/193,95,12,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...es of all the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, fo...",100,58,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, followed th...",100,67,Mol_Vis_2009_Jan_16_15_89-98.txt
491 A>T,−491 A>T	T	8 (2.3)	13 (3.25)	TT	0 (0)	0 (0),108,2,Mol_Vis_2009_Jan_16_15_89-98.txt
427 T>C,−427 T>C	C	25 (7.1)	36 (9.0)	CC	1 (0.6)	1 0.5 (0),111,2,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,−219 T>G	G	93 (26.4)	117 (29.25)	GG	10 (5.7)	15 (7....,114,2,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...vealed one LD block, spanning from the promoter (−83G>A) to exon 1 (c.227G>A). Within this block, po...",126,75,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...n 1 (c.227G>A). Within this block, polymorphisms −83G>A and c.227G>A were the only two variants that...",126,138,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,...lotype A-A was not associated with glaucoma. IVS2+35A>G was the only other MYOC polymorphism that ha...,126,504,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...), which are defined by the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated...",130,242,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"...y the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated with POAG. When the ε...",130,264,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"...y the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated with POAG. When the ε...",130,264,Mol_Vis_2009_Jan_16_15_89-98.txt
35 A>G,"...rom all four genes was identified, including IVS2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T...",133,287,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...ed, including IVS2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36...",133,318,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...S2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in...",133,334,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...S2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in...",133,334,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...et98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in APOE. The combinati...",133,354,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,...teraction effect on modulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on another...,133,984,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...r branch, revealing an interaction between them. −491A>T (APOE) was located on a different remote br...",133,1083,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,IVS8–53T>C and IVS5+30C>T	52.5	0.377	7/10,138,6,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,6,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,18,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,18,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,18,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,26,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,22,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,22,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,22,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,43,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,43,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,36,Mol_Vis_2009_Jan_16_15_89-98.txt
16G>T,"...d four novel variants, Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser, each in one control subject,...",148,198,Mol_Vis_2009_Jan_16_15_89-98.txt
16G>T,"...d four novel variants, Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser, each in one control subject,...",148,198,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...on polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statistically associated with POAG...",148,1927,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,Intron 8	IVS8–53T>C	-	21 (3.6)	27 (7.7)	0.006	12 (2.1)	24 (6.0)	...,162,15,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,Promoter	−491A>T	-	28 (4.8)	8 (2.3)	0.054	15 (2.7)	13 (3.25)...,165,11,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,Promoter	−219 T>G	-	222 (37.8)	93 (26.4)	0.00037	187 (33.3)	...,167,11,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...riant, Arg545Gln, and the intronic variant, IVS15+10G>A, also showed comparable allelic distribution...",171,1130,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...hinese POAG patients, only one SNP in WDR36, IVS5+30C>T, showed significant association with POAG, a...",173,207,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...hinese POAG patients, only one SNP in WDR36, IVS5+30C>T, showed significant association with POAG, a...",173,207,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...t al. [35] found the APOE promoter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) t...",175,1016,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...ctions for normal tension glaucoma (between MYOC −83G>A and the APOE ε2/ε3/ε4, MYOC IVS2+35A>G and A...",175,1471,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,...s for POAG (between MYOC Thr353Ile and OPTN IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T...,175,1658,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong synergistic interaction the...",175,2287,Mol_Vis_2009_Jan_16_15_89-98.txt
98T>A,SNORD17 (NR_003045)	98T>A	Non-coding microRNA	rs753213	N	Y(hetero) Sco...,81,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1343G>A,1343G>A	p.Arg448Arg	rs80046336	Y (hetero) Score=22...,134,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1702G>C,...not detect gross structural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) an...,13,577,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...nd 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were present in the corneas ...,13,636,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...nd 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were present in the corneas ...,13,636,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c...",16,24,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p....",16,36,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p....",16,36,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...02G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in ...",16,76,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,...sponsible for LCD in the 3 families. Mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) a...,16,189,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,".... In Family 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of...",61,139,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,... results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Fa...,63,70,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...2G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polymorphisms. Owin...",69,136,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...2G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polymorphisms. Owin...",69,136,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...s present study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), are identifie...",81,365,Mol_Vis_2010_Feb_15_16_224-230.txt
1 G>A,IVS3–1 G>A		AD	COOH-terminus	Snail-like	Chinese	[13],72,6,Mol_Vis_2010_Mar_25_16_534-539.txt
15G>A,CRX	19–48342562	c.253–15G>A,35,23,Mol_Vis_2013_Mar_21_19_654-664.txt
15G>A,CRX	19–48342562	c.253–15G>A,35,23,Mol_Vis_2013_Mar_21_19_654-664.txt
11G>A,CRX	None (c.252+11G>A)	50	99	48	67	0*	-	0*	-	0*	-,82,17,Mol_Vis_2013_Mar_21_19_654-664.txt
2T>G,"...1/F	55	55		RE:20/400	c.802–8_810del17insGC+ c.413+2T>G,del﹡",48,55,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...tion accounted for 11.9% (22/184), and the c.1091–2A>G accounted for 9.8% (17/184). Collectively, th...",82,190,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T >G,"...ne novel heterozygous splice-site mutation, c.413+2T >G, was detected in the 3′- acceptor in intron ...",84,1050,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, from the...",88,344,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, from the...",88,344,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...at these four novel mutations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated with the...",103,188,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1G>T,ADAMTS17	NM_139057.2	c.873+1G>T	-	Disease causin,55,28,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>A,"...mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene ...",72,112,Mol_Vis_2014_Jun_12_20_790-796.txt
1 G>A,"...ly. Interestingly, a splice-site mutation, c.1473+1 G>A, in the ADAMTS17 gene has been reported to b...",72,391,Mol_Vis_2014_Jun_12_20_790-796.txt
857C>T,...entified in TRPM1 was corrected to be c.[857C>T];[857C>T] p.(S286L),7,117,Mol_Vis_2014_Jun_2_20_780.txt
1 G>A,"ARRP10	RP	6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA...",74,32,Mol_Vis_2016_Jun_16_22_646-657.txt
1 G>A,"ARRP10	RP	6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA...",74,32,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,"Biallelic EYS variants, c.[5093T>C; 6416G>A];[9248G>A], were found to be carried by pa...",78,37,Mol_Vis_2016_Jun_16_22_646-657.txt
7228+1G>A,... who carried biallelic heterozygous c.[4957dupA];[7228+1G>A]. The first variant was a reported frame...,80,520,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"...*2 or cause NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent ...",80,686,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"...*2 or cause NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent ...",80,686,Mol_Vis_2016_Jun_16_22_646-657.txt
490C>T,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:3	R...,93,7,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2...,96,7,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2...,96,7,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2...,96,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:4	RP	52/M	3...,97,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:8...,98,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,2#	c.[6557G>A],99,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[6416G>A];[8150delA]	p.[C2139Y];[NA]	W286–1	IRDs	43...,101,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[6416G>A];[8150delA]	p.[C2139Y];[NA]	W286–1	IRDs	43...,101,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[6416G>A];[8392delG]	p.[C2139Y];[NA]	W86–1	IRDs	25/...,105,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:4	...,108,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:4	...,108,7,Mol_Vis_2016_Jun_16_22_646-657.txt
9368A>C,3$	c.[9368A>C];[6416G>A]	p.[N3123T];[C2139Y]	W5–1	IRDs	3...,109,7,Mol_Vis_2016_Jun_16_22_646-657.txt
7609G>A,3$	c.[7609G>A];[7949C>T]	p.[A2537T];[S2650F]	W171–1	IRDs...,111,7,Mol_Vis_2016_Jun_16_22_646-657.txt
3489T>A,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	6...,112,7,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
1 G>A,"... carries a novel heterozygous EYS mutation c.7228+1 G>A, a splice-site variant that may eliminate th...",116,1305,Mol_Vis_2016_Jun_16_22_646-657.txt
522T>C,".... Further, two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patient...",92,678,Mol_Vis_2016_May_16_22_491-502.txt
522T>C,".... Further, two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patient...",92,678,Mol_Vis_2016_May_16_22_491-502.txt
974C>G,"... novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with disease...",92,692,Mol_Vis_2016_May_16_22_491-502.txt
974C>G,"... novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with disease...",92,692,Mol_Vis_2016_May_16_22_491-502.txt
34G>A,...r ABCB1 3435C>T. The results suggested that ABCG2 34G>A would be useful for predicting grade 2 or wo...,10,912,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...se variants, two major functional variants, ABCG2 34G>A (rs2231137), resulting in a Val12Met substit...",22,214,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...aluated the association between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and ...",32,255,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate or severe toxic...",32,279,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate or severe toxic...",32,279,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate or severe toxic...",32,279,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C > T,"...any). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the TaqMan assay (Appl...",58,159,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C > T,"...any). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the TaqMan assay (Appl...",58,159,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,the primer Sequence (5’–3’) of ABCG2 34G>A (V12M,60,38,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,34,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,51,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...n 44 (53%), and T/T alleles in 16 (19%) for ABCB1 3435C>T. The frequencies of the ABCG2 or ABCB1 var...",76,340,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...n 44 (53%), and T/T alleles in 16 (19%) for ABCB1 3435C>T. The frequencies of the ABCG2 or ABCB1 var...",76,340,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...s and SNPs at ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>T (Table 3–5). Statistically significant ass...",87,177,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...urrence of skin toxicity and ABCG2 polymorphisms, 34G>A; 13 (42%) of the 32 patients with at least o...",87,313,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...f the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed skin rash, ag...",87,380,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...f the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed skin rash, ag...",87,380,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...  Association between genetic polymorphisms ABCG2 34G>A and toxicit,89,58,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...l impact on gefitinib-induced toxicities of ABCG2 34G>A. Our results suggested that ABCG2 34G>A woul...,135,423,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,... of ABCG2 34G>A. Our results suggested that ABCG2 34G>A would be useful for predicting grade 2 or wo...,135,463,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...8) We also examined the association between ABCG2 34G>A and disease control, which means responses t...",137,602,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ed that the allele frequency of the variant ABCG2 421C>A was higher and not associated with diarrhea...,141,640,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Geno...",165,111,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
2T>C,...eterozygous essential splice-site mutation c.1194+2T>C was detected in both sisters and was inherite...,21,155,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,"...ified another exon 9 splice-site mutation, c.1194+3A>C, in Fam0484, which includes two cousins affec...",23,230,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,"...inigene splicing constructs containing the c.1194+2T>C mutation identified in Fam3727, showing monoa...",91,181,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,...peptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result ...,91,526,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,...omains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-frame d...,91,542,Nat_Commun_2014_Aug_7_5_4398.txt
-3C>T,c.1687-3C>T	rs76650154	 	 	No effect	5	 ,176,7,Nat_Commun_2014_Aug_7_5_4398.txt
-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,7,Nat_Commun_2014_Aug_7_5_4398.txt
-8T>C,c.2445-8T>C	 	 	 	No effect	 	1,181,7,Nat_Commun_2014_Aug_7_5_4398.txt
896G>A,...hanges35. Albino rats carry a single SNP mutation 896G>A in exon 2 of the Tyr gene resulting in an A...,25,457,Nat_Commun_2014_Jun_26_5_4240.txt
1G>A,"...ere heterozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect spl...",20,204,Nat_Commun_2015_Jun_16_6_7092.txt
1G>A,"...ere heterozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect spl...",20,204,Nat_Commun_2015_Jun_16_6_7092.txt
3A>G,"...gous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing (Table...",20,216,Nat_Commun_2015_Jun_16_6_7092.txt
13	C>T,"3, K2	Pat	13	C>T	0	0	0.0008	2.57	Novel	—",197,11,Nat_Commun_2015_Nov_2_6_8718.txt
13	C>T,"3, K2	Pat	13	C>T	0	0	0.0008	2.57	Novel	—",197,11,Nat_Commun_2015_Nov_2_6_8718.txt
51	G>A,"4–5, K3	Pat	51	G>A	0.0014	0	0	1.37	MOPD1	rs188343279",200,13,Nat_Commun_2015_Nov_2_6_8718.txt
7A>G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/657 AU...,121,8,Nat_Commun_2016_Apr_15_7_11253.txt
290A>G, p.K97R	290A>G	4	1/159 UK FALS	0/897 UK controls0/967 AU c...,122,9,Nat_Commun_2016_Apr_15_7_11253.txt
1525T>C, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361 CA cont...,124,10,Nat_Commun_2016_Apr_15_7_11253.txt
2315T>C, p.I772T	2315T>C	17	1/159 UK FALS	0/897 UK controls0/967 AU...,126,10,Nat_Commun_2016_Apr_15_7_11253.txt
-308G>A,"... InterLymph consortium, the variant allele for TNF-308G>A (rs1800629) and a TNF/LTA haplotype locate...",21,352,Nat_Genet_2010_Aug_18_42(8)_661-664.txt
3A>G,BBS	12620/V.15	N. European	c.2322+3A>G		0/440	0/356	BBS1: M390R hom,137,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
-3C>G,NPHP+	F514	N. European	W150R	c.3264-3C>G	0/440	0/440	0/356	0/356,155,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
23508363A>G,"...t base substitution mutations: a homozygous chr10:23508363A>G mutation, a homozygous chr10:23508305A...",27,733,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508363A>G,"...t base substitution mutations: a homozygous chr10:23508363A>G mutation, a homozygous chr10:23508305A...",27,733,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...us chr10:23508363A>G mutation, a homozygous chr10:23508305A>G mutation and compound heterozygous chr...",27,774,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508365A>G,...08305A>G mutation and compound heterozygous chr10:23508365A>G/chr10:23508446A>C mutations (Figure 2)...,27,827,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...aplotype analyses of additional families with the 437A>G mutation we also included 3 patients genoty...,67,443,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...tween probands from each of the families with the 437A>G mutation. We only used SNPs that were prese...,69,188,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...tween probands from each of the families with the 437A>G mutation. We only used SNPs that were prese...,69,188,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...tween probands from each of the families with the 437A>G mutation. We only used SNPs that were prese...,69,188,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508363A>G,"...es as labels (referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446...",98,904,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508365A>G,"...(referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromo...",98,917,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508365A>G,"...(referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromo...",98,917,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
2T>C,... The second trace is a normal control. The c.1376+2T>C mutation occurs 2 base pairs into intron 13 a...,18,168,NDT_Plus_2008_Jun_27_1(3)_171-175.txt
2893C>T,25	2893C>T	Gln965Xc,98,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2893C>T,25	2893C>T	Gln965Xc,98,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1195C>T,5a	10	Homozygous 1195C>T	Arg399Cys,99,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,7	18	2221G>A	Gly741Arg,102,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
911C>T,10	7	911C>T	Thr304Met,108,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2996A>G,14	26	2996A>G	Tyr999Cysc,116,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,129,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,129,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,21	18	2221G>A	Gly741Arg,130,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,135,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2947G>A,25	2947G>A	Val983Ilec,137,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1315G>A,26	10	1315G>A	Gly439Ser,140,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,144,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3053G>A,26	3053G>A	Arg1018Gln,146,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,31	5	626G>A	Arg209Gln,149,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,154,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,36	5	626G>A	Arg209Gln,158,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
42C>T,The HTR3A polymorphism c. ‐42C>T is ass‐ociated with amygdala responsiveness ...,939,28,Neurogastroenterol_Motil_2016_Jun_11_28(6)_900-913.txt
3G>C,"...r splice site in intron 2 of the GYG1 gene (c.143+3G>C, p.Asp3Glufs*4), either in homozygous (in the...",542,525,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
1G>A,"...mutations in the GBA gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (...",342,609,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
-14A > G,...transcribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes m...,146,518,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
-14A > G,...transcribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes m...,146,518,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
514 C > T,...used to test the hypothesis that the positions of 514 C > T and 231 G > A transitions were each dist...,55,388,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
514 C > T,...used to test the hypothesis that the positions of 514 C > T and 231 G > A transitions were each dist...,55,388,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,...he hypothesis that the positions of 514 C > T and 231 G > A transitions were each distributed accord...,55,402,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,...he hypothesis that the positions of 514 C > T and 231 G > A transitions were each distributed accord...,55,402,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
514 C > T,...nov one sample tests on the relative positions of 514 C > T and 231 G > A transitions from 1449 454-...,136,66,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,... tests on the relative positions of 514 C > T and 231 G > A transitions from 1449 454-derived Mammut...,136,80,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,... tests on the relative positions of 514 C > T and 231 G > A transitions from 1449 454-derived Mammut...,136,80,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
514 C > T,...R amplification of 454-generated ssDNA molecules (514 C > T and 231 G > A). The plot comprises a box...,137,156,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
24 G > A,... the single exception to the predicted pattern (1/24 G > A transitions) is due to a polymerase misin...,141,485,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
24 G > A,... the single exception to the predicted pattern (1/24 G > A transitions) is due to a polymerase misin...,141,485,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
7445A>G,"...s-associated tRNA mutations were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, t...",8,908,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"..., 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle 4295A>G mutations (2,9–14). T...",8,965,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,The respiratory deficiency caused by the tRNAHis 12201T>C mutation results in decreased efficiency ...,100,50,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,The respiratory deficiency caused by the tRNAHis 12201T>C mutation results in decreased efficiency ...,100,50,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
8344A>G,... those in cells carrying MERRF-associated tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G ...,100,304,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...ll lines carrying the deafness-associated tRNAHis 12201T>C mutation. The m.12201T>C mutation alters ...,102,187,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7505T>C,...ciated with the novel mitochondrial tRNASer(UCN)  7505T>C mutation in a Han Chinese family Mol. Gene...,127,184,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
677C>T,...tion with maternal risk in combination with MTHFR 677C>T or MTHFR 1298A>C polymorphisms [19]. Subseq...,14,480,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...d others failing to find any association of RFC-1 80A>G alone or combined [25,26,27]. Moreover, the ...",14,883,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...mates with 95% CI (fixed effects model) for RFC-1 80A>G recessive genetic model is shown in Figure 2...,99,111,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...CI) forest plot for the association between RFC-1 80A>G polymorphism and maternal risk for a DS birt...,138,127,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ta-analysis suggest a possible role for the RFC-1 80A>G polymorphism in modulating maternal risk for...,141,76,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ta-analysis suggest a possible role for the RFC-1 80A>G polymorphism in modulating maternal risk for...,141,76,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
1047H>H,"...utations. (A) GII meningioma sample with an A>AG, 1047H>H/R mutation in codon 3140. (B) GIII meningi...",44,124,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1025T>T,"...don 3140. (B) GIII meningioma sample with a C>CT, 1025T>T silent mutation in codon 3075. PIK3CA, pho...",44,198,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1418+2A>G,...phosphorylation of ERK1 and 2 (Figure 2).[30] The 1418+2A>G splice site mutation seen in this tumor ...,52,1292,Oncotarget_2014_Feb_21_5(10)_3012-3022.txt
694C > T,ERBB4: R232Ter (694C > T)*,104,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1918C > T, 85	FGFR3: R640W (1918C > T)	FGFR3: G697S (2089G > A)*,110,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1G>A,"...he other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situation in non-leth...",209,148,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1G > A,"...09G > A in families Nos. 1 and 19; COL1A1, c.1299+1G > A in families Nos. 44 and 50; and COL1A1, c.7...",92,1759,Orphanet_J_Rare_Dis_2011_Dec_29_6_88.txt
2T > G,c.11548 + 2T > G	IVS59	Ex59 splice defect	+	1	Present study,128,11,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-2A > G,RP1310*	c.12067-2A > G/c.12067-2A > G		USHNC,306,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-2A > G,RP1625*	c.12067-2A > G/p.R274X	1976	USH2	25	Since infancy	NormalA...,336,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
52T > C,c.1328 + 52T > C	IVS7	-	3,378,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-43T > A,c.6486-43T > A	IVS33	UV2	1,388,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-43T > A,c.6486-43T > A	IVS33	UV2	1,388,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-43T > A,c.6486-43T > A	IVS33	UV2	1,388,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
18A > G,c.8681 + 18A > G	IVS43	UV2	1,392,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
53T > G,c.8681 + 53T > G	IVS43	UV2	1,394,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-52G > T,c.9056-52G > T	IVS45	UV	1,398,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
128A > G,c.9958 + 128A > G	IVS50	-	4,404,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-35T > A,c.15298-35T > A	IVS70	UV2	1,414,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-35T > A,c.15298-35T > A	IVS70	UV2	1,414,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-1153G > A,c.15298-1153G > A(g.798209G > A) d	IVS71	UV2	1,416,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-2A > G,"...on-Ashkenazi Jews. The splice-site variant c.12062-2A > G was detected in three patients, in homozyg...",473,511,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
-2A>T,...nd a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figure 1)....,75,204,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
-2A>T,...nd a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figure 1)....,75,204,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
-2A>T,...BX6 in two MA patients. Splice site mutation c.622-2A>T (g.30100162 T>A) in two MA patients compared...,77,91,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
-2A>T,"...e splice site mutation site (g.30100162 T>A, c.622-2A>T in violet brackets and a line) and its conse...",81,206,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,7,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,7,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
1G>C,... third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was...,44,446,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
-2A>G,"...elCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,974,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...ow	37% of LLR	Mb, pons	c.312_320del10insAT, c.751+5G>A",49,144,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...ow	37% of LLR	Mb, pons	c.312_320del10insAT, c.751+5G>A",49,144,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,"..., increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,138,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,...	UD	CT brain: GP and cerebellar atrophy	Homo c.516-2A>G,55,200,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,...	UD	CT brain: GP and cerebellar atrophy	Homo c.516-2A>G,55,200,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,"...taxia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,97,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,"...taxia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,97,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"...ey matter involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,210,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"...cerebellar hemispheres	c.312_320del10insAT, c.240+1G>T",78,205,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"... COX	Normal	UD	CT brain: BG	c.845_846delCT, c.240+1G>T",79,106,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...TC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,176,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
-2A>G,"...lCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,191,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
571G>A,...ductase. We report two sisters homozygous for the 571G>A (E191K) DHCR24 mutation. Comparison of the ...,3,2096,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...ductase. We report two sisters homozygous for the 571G>A (E191K) DHCR24 mutation. Comparison of the ...,3,2096,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...tion	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] ...,45,55,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...tion	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] ...,45,55,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...tion	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] ...,45,55,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1412A>C,...03C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K...,45,181,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1G>A,"10		57,0			c.2022+1G>A heterozygous	IVS13+1G>A ds	Splice site mutation",48,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"20		1,7			c.4303+2T>G heterozygous	IVS25+2T>G ds	Splice site mutati...",67,18,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
498-1G>A,(NM_014845.5)	1	c.[498-1G>A];[122T>C],165,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
498-1G>A,(NM_014845.5)	1	c.[498-1G>A];[122T>C],165,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
793C>T,(NM_014845.5)	2	c.[793C>T];[122T>C]	p.[Arg265*];[Ile41Thr],168,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
793C>T,(NM_014845.5)	2	c.[793C>T];[122T>C]	p.[Arg265*];[Ile41Thr],168,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
122T>C,(NM_014845.5)	2	c.[793C>T];[122T>C]	p.[Arg265*];[Ile41Thr],168,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
110G>C,(NM_005340.5)	2	c.[110G>C];[110G>C]	p.[Arg37Pro];[Arg37Pro],189,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
134T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1447T>G,(NM_024577.3)	1	c.[2860C>T];[1447T>G]	p.[Arg954*];[Phe483Val],264,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1447T>G,(NM_024577.3)	1	c.[2860C>T];[1447T>G]	p.[Arg954*];[Phe483Val],264,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,24,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,34,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,"...5046.5):p.[(Gln552His(;)Ser553Phe)], c.[1656G>T(;)1658C>T",418,88,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
3243A>G,...y all organs and cause significant morbidity. The 3243A>G mutation in the mitochondrial DNA is one o...,6,116,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...nally inherited diabetes and deafness (MIDD). The 3243A>G mutation in the MT-TL1 gene of the mitocho...,11,297,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...disease and was confirmed by demonstration of the 3243A>G transition in blood and urine. The heterop...,13,686,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...disease and was confirmed by demonstration of the 3243A>G transition in blood and urine. The heterop...,13,686,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,The 3243A>G mtDNA mutation constitutes the most common...,19,5,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
229C>T,...7-7ResearchTopoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endomet...,3,195,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
208T>C,"In summary, a point mutation in the Cdh23 gene (208T>C) of C57BL/6J mice results in hearing loss a...",98,49,Pharmacogenomics_J_2012_Feb_20_12(1)_30-44.txt
31 G>A,"...2D6 detected by RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883...",27,73,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...cted by RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 10...",27,81,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"..._138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 ...",27,159,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...elT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_1974 insG, 2291 G>A, 2539_2542 del ...",27,204,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"...863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_1974 insG, 2291 G>A, 2539_2542 del AACT, 2549 delA, 2573_2574...",27,230,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2950 G>C,"...90 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 ...",27,344,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"..., 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125...",27,354,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...7 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup ...",27,364,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...7 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup ...",27,364,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup GTGCCCACT,...",27,374,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup GTGCCCACT,...",27,374,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...d in the genotyping assays: 2988 G>A (CYP2D6*41), 2850 C>T (CYP2D6*2), 2615_2617 delAAG (CYP2D6*9), ...",34,85,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...CYP2D6*9), 1863_1864 ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T...",34,174,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...CYP2D6*9), 1863_1864 ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T...",34,174,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...CYP2D6*9), 1863_1864 ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T...",34,174,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A ...",34,195,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 ...",34,217,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3189 G>A,"...17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 G>A (CYP2D6*29)",34,262,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) h...",58,400,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) h...",58,400,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) had a 31 G>A SNP, 2 (4%) had a 1716 G>A SNP, 2 (4%) had ...",58,455,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) had a 31 G>A SNP, 2 (4%) had a 1716 G>A SNP, 2 (4%) had ...",58,455,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,...15_2617delAAG variant. Representative data of the 1846G>A and 100C>T SNP assays of the RETINA system...,58,689,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...ommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_2617 delAA...",60,281,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...TCGCCCC)2, 2615_2617 delAAG,2850C>T, 2988G>A, and 3183 G>A).We tested those 9TaqMan® Drug Metabolism...",60,355,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,...een the two platforms. Representative data of the 1846G>A and 100 C>T SNPs from the TaqMan® Drug Met...,60,522,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...8 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG, , 2850 C>T, and 2988 G>A) were found within the 1000...",73,389,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...8 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG, , 2850 C>T, and 2988 G>A) were found within the 1000...",73,389,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...anger sequencing by us. Similarly, in sample #41, 31 G>A heterozygous SNP was identified by the 1000...",75,198,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...es (58%)had a 2850C>T SNP, 16 samples (32%) had a 1846G>A SNP, 15 samples (30%) had a100C>T SNP, 14 ...",80,151,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...s (28%) had a 2988 G>A SNP, 5 samples (10%) had a 31 G>A SNP, 4 samples (8%) had a 1707delT variant,...",80,257,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291G>A,"...(8%) had a 1707delT variant, 3 samples (6%) had a 2291G>A SNP, 2 samples (4%) had a 1023 C>T SNP, 2 ...",80,329,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"..., exon 9 conversion with CYP2D7 (*36 or *4N), and 2291 G>A (*59)",80,734,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"..., exon 9 conversion with CYP2D7 (*36 or *4N), and 2291 G>A (*59)",80,734,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988G>A,"...ver,it doesnot include the defining CYP2D6*41 SNP 2988G>A and thus may misclassify some CYP2D6*2 all...",99,691,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"...ip – our platform can detect ten additional loci (124 G>A [CYP2D6*12], 4142_4133 dupGTGCCCACT [CYP2D...",99,1599,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"..., 2587_2590 delGACT [CYP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*...",99,1733,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...YP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*46],3259_3260 insGT [C...",99,1755,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,Examination of heterozygous 1846 G>A alleles by Sanger Sequencing in liver sam...,117,29,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"*8	1758 G>T, 2850 C>T",142,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*8	1758 G>T, 2850 C>T",142,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*8	1758 G>T, 2850 C>T",142,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"*11	883 G>C, 2850 C>T",145,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"*11	883 G>C, 2850 C>T",145,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"*12	124 G>A, 2850 C>T",146,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*12	124 G>A, 2850 C>T",146,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"*29	1659 G>A, 3183 G>A, 2850 C>T",153,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"*35	31 G>A, 2850 C>T",154,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,42,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,*43	77 G>A,160,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2950 G>C,*44	2950 G>C,161,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*46	77 G>A, 1716 G>A, 2850 C>T",163,23,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*56	2850 C>T, 3201 C>T",164,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
609 C>T,...for cellular damage and TD. Studies examining the 609 C>T polymorphism found the T allele is associa...,70,362,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
609 C>T,...for cellular damage and TD. Studies examining the 609 C>T polymorphism found the T allele is associa...,70,362,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
516G>T,"...hose associated with high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,959,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
516G>T,"...hose associated with high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,959,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,No mutation	18492T>C	21563C>T	Other,174,13,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
885153	T-> C,chrXIII: 885153	T-> C,63,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
545020	C-> A,chrV: 545020	C-> A,72,8,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
545020	C-> A,chrV: 545020	C-> A,72,8,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
499172	C-> T,chrXIII: 499172	C-> T,81,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
181G>A,"...Figure 3B). We designated this Tw variant as c.58+181G>A, which was the only sequence variation we d...",67,917,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...b1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1357,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...b1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1357,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...b1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1357,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,c.58+181G>A disrupts a predicted site for Myb protein b...,70,6,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"To confirm the pathogenic effect of c.58+181G>A, we generated two knockin mouse lines: KIA ...",82,42,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
560A>C,"...nts in the promoter and coding regions of APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −...",172,76,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
2278C>T,...Selective quantitative amplification of the WT or 2278C>T ATRIP alleles. Primers located in ATRIP ex...,162,771,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisingly, wa...",189,47,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...ged ATRIP cDNA expressing plasmids (wild type and 2278C>T ATRIP) together with ATR cDNA, followed by...",237,160,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
67334934 G>T,...he 18 hexamers. A fragment containing the SNP (g. 67334934 G>T) in exon 5 was amplified with forward...,283,385,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,... heterzygotes was scored by analyzing the SNP (g. 67334934 G>T) by pyrosequencing. A pyro-seq primer...,283,627,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,... heterzygotes was scored by analyzing the SNP (g. 67334934 G>T) by pyrosequencing. A pyro-seq primer...,283,627,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
21U>A,"... the first nucleotide of 21UR-synth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes),...",238,516,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	A>G,Chr14:60974449	----	0.002	0	A>G	----	3.48,94,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	C>T,Chr14:60977864	rs202029915	0.002	0	C>T	Thr212Met	2.36,109,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	C>T,Chr14:60977864	rs202029915	0.002	0	C>T	Thr212Met	2.36,109,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>T,Chr14:60977954	rs139302405	0.002	0	G>T	Ser242Ile	5.19,112,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>T,Chr14:60977954	rs139302405	0.002	0	G>T	Ser242Ile	5.19,112,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
600 C>A,"...ee J , Kim CH , Lee S  (2014 ) The polymorphism (−600 C>A) of CpG methylation site at the promoter r...",1233,62,PLoS_Genet_2014_Nov_6_10(11)_e1004735.txt
17778	G>T,Q121H	17778	G>T	n/a	18	Mild	7.0	26±3	110±15	II,36,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>T,R116Stop	17761	C>T	<1–3	<1–1	Severe	7.0	n/a	n/a	n/a,37,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17764	C>T,L117F	17764	C>T	n/a	<1	Severe	27.7	0	0	III,42,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17764	C>T,L117F	17764	C>T	n/a	<1	Severe	27.7	0	0	III,42,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>C,G114A	17756	G>C	4–5	5–13	Mild/Moderate	71.3	n/a	n/a	n/a,46,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>C,G114A	17756	G>C	4–5	5–13	Mild/Moderate	71.3	n/a	n/a	n/a,46,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>A,Q97K	17704	C>A	n/a	<1	Severe	83.8	60±0.2	2.9±1	n/a,48,6,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17782	T>C,S123P	17782	T>C	n/a	<1	Severe	86.6	n/a	n/a	n/a,49,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>A,G114E	17756	G>A	8	4–7	Mild/Moderate	93.1	n/a	n/a	n/a,50,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
866G>A,"... polymorphism in the promoter of this gene (UCP2 −866G>A) (rs659366) has been associated in some, bu...",11,546,PLoS_Med_2005_Dec_1_2(12)_e406.txt
472T>C,"...Fig. 1). The other investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with ...",65,1291,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...The other investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with urinary s...",65,1300,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
472T>C,"...f the reconstructed COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summari...",99,69,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
871G>A,...ase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodia...,267,151,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
871G>A,...ase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodia...,267,151,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
871G>A,"...haroen C , Nuchprayoon I  (2005 ) G6PD Viangchan (871G>A) is the most common G6PD-deficient variant ...",269,59,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
3014G>A,"...SNP 2667G>C, Casas et al.,[19] which included SNP 3014G>A, also examined associations with cardiovas...",17,432,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...SNP 2667G>C, Casas et al.,[19] which included SNP 3014G>A, also examined associations with cardiovas...",17,432,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...SNP 2667G>C, Casas et al.,[19] which included SNP 3014G>A, also examined associations with cardiovas...",17,432,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362G>C,"...ional SNPs with low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the Internatio...",36,808,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5606G>T,"...ith low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the International HapMap P...",36,820,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...ystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs...",38,367,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"...s1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606...",38,427,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...s1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606G>T (rs3093071). Repl...",38,448,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...s1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606G>T (rs3093071). Repl...",38,448,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5606G>T,"...0), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606G>T (rs3093071). Replicate quality control sam...",38,473,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362A>T,"...HPFS. Among NHS, the minor allele frequencies for 4362A>T (0.6% cases, 1.1% controls) and 5606G>T (1...",38,885,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362A>T,"...HPFS. Among NHS, the minor allele frequencies for 4362A>T (0.6% cases, 1.1% controls) and 5606G>T (1...",38,885,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...ol women and men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0...,49,799,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"... men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0.95), wherea...",49,811,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"... men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0.95), wherea...",49,811,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...14G>A were in high pairwise LD (r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in...",49,863,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,2667G>C	rs1800947,82,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,3014G>A	rs1130864,88,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,5237A>G	rs2808630,106,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...(Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lower CRP leve...",130,537,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...(Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lower CRP leve...",130,537,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,...ted with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approximately 20% hig...,130,668,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,...ted with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approximately 20% hig...,130,668,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...with approximately 20% higher CRP levels, whereas 5237A>G was not associated with CRP levels in eith...",130,742,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...with approximately 20% higher CRP levels, whereas 5237A>G was not associated with CRP levels in eith...",130,742,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...with approximately 20% higher CRP levels, whereas 5237A>G was not associated with CRP levels in eith...",130,742,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,1919A>T	236/466	0.90 (0.70–1.14)	0.37	1.22	0.009	2...,135,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,3014G>A	237/467	0.88 (0.69–1.12)	0.28	1.15	0.08	24...,137,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,3872C>T	241/475	1.08 (0.85–1.37)	0.54	0.76	0.001	2...,138,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...r allele of 5237A>G, and H3, with minor allele of 3872C>T, had estimated frequencies ranging from 25...",148,306,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...r allele of 5237A>G, and H3, with minor allele of 3872C>T, had estimated frequencies ranging from 25...",148,306,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"3872C>T		[16], [20], [22], [23]				[22]",196,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"... with CRP levels in the Physicians' Health Study, 3872C>T individually was associated with lower CRP...",203,797,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...I 0.99–1.67).[23] Furthermore, the odds ratio for 2667G>C was suggestive of a 50% increase as well, ...",203,963,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...wider. Taken together, these results suggest that 2667G>C and 3872C>T, though associated with lower ...",203,1100,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
258+2T>C,"... a very low, but correct residual splicing of the 258+2T>C SBDS transcript[11]–[13]. To date, there ...",17,864,PLoS_One_2009_Sep_17_4(9)_e7084.txt
71G>A,...SNHL are presented in Fig 1. A heterozygous W24X (71G>A) mutation was identified in the GJB2 gene of...,28,774,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... allele are detected. Row 3. Negative control. B) 1555A>G in MTRNR1. Row 1. Wild-type genotype for n...,31,421,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-2A>G,... V27I*)/SLC26A4; 919-2A>G/919-2A>G	1	SLC26A4; IVS1-2A>G**/L236P	1	GJB2; 35delG	2	GJB2; V27I*/V37I	1,38,57,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-2A>G,...MTRNR1 genes of three others. Two carried the IVS2-2A>G splice variant in the SLC26A5 gene. A third ...,62,204,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-2A>G,...MTRNR1 genes of three others. Two carried the IVS2-2A>G splice variant in the SLC26A5 gene. A third ...,62,204,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...lear SLC26A4 gene and one was homoplasmic for the 1555A>G substitution in the mitochondrial MTRNR1 g...,62,682,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...lear SLC26A4 gene and one was homoplasmic for the 1555A>G substitution in the mitochondrial MTRNR1 g...,62,682,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-2A>G,"... the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in SLC26A4, its clinical significance is unk...",69,2605,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-2A>G,...tük K Zordania R Joost K  2009 Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Estoni...,113,75,PLoS_One_2010_Jul_26_5(7)_e11804.txt
-47A>G,Intron 1	c.52-47A>G	0.01	1.27	1/51,70,14,PLoS_One_2010_Mar_5_5(3)_e9476.txt
639 A>G,F123	Italian	639 A>G	N102S	1	1	7,36,14,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,F123	Italian	639 A>G	N102S	1	1	7,36,14,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,U	American	639 A>G	N102S	1	1	8,40,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,L	American	639 A>G	N102S	1	1	9,46,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,N	German	639 A>G	N102S	1	1	this reporth,52,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,N	German	639 A>G	N102S	1	1	this reporth,52,10,PLoS_One_2010_May_21_5(5)_e10760.txt
668 G>A,LL	French-British-CAf	668 G>A	D112N	1	1	this report,53,23,PLoS_One_2010_May_21_5(5)_e10760.txt
668 G>A,LL	French-British-CAf	668 G>A	D112N	1	1	this report,53,23,PLoS_One_2010_May_21_5(5)_e10760.txt
687 A>G,H	American	687 A>G	D118G	1	1	9,55,12,PLoS_One_2010_May_21_5(5)_e10760.txt
687 A>G,H	American	687 A>G	D118G	1	1	9,55,12,PLoS_One_2010_May_21_5(5)_e10760.txt
695 C>G,2	Egyptian	695 C>G	L121V	1	1	10,58,12,PLoS_One_2010_May_21_5(5)_e10760.txt
999 T>G,F1	Finnish	999 T>G	V122G	1	1	this report,62,12,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,F115	Scottish	858 C>T	T175I	1	2	7,65,15,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,F115	Scottish	858 C>T	T175I	1	2	7,65,15,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,J	Hungarian-American	858 C>T	T175I	1	2	9,66,22,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>A,X	Chinese-Taiwan	863 G>A	G177R	1	2	9,68,18,PLoS_One_2010_May_21_5(5)_e10760.txt
890 G>A,G	German-American	890 G>A	G186R	2	2	9,71,19,PLoS_One_2010_May_21_5(5)_e10760.txt
18A>G,"...)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)...",110,91,PLoS_One_2010_Nov_23_5(11)_e14096.txt
45T>C,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T...",111,24,PLoS_One_2010_Nov_23_5(11)_e14096.txt
25C>T,"...(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p...",111,198,PLoS_One_2010_Nov_23_5(11)_e14096.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,44,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,44,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,44,PLoS_One_2011_Apr_26_6(4)_e19081.txt
2164A>T,...mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,57,PLoS_One_2011_Apr_26_6(4)_e19081.txt
295T>C,...3 coding region (R130Q) and IL-16 gene promoter (−295T>C) and allergic asthma.              Iran J A...,229,260,PLoS_One_2011_Feb_28_6(2)_e16522.txt
77G>A,"...6G) and a variant in the 5′ untranslated region (−77G>A) have been found in the Soat1 gene, and indi...",82,1194,PLoS_One_2011_Oct_14_6(10)_e25344.txt
77G>A,"...6G) and a variant in the 5′ untranslated region (−77G>A) have been found in the Soat1 gene, and indi...",82,1194,PLoS_One_2011_Oct_14_6(10)_e25344.txt
5G>C,5	Atypical	c.5210+5G>C		Splice site	Exon 23 skipping	Deterioration o...,64,19,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...alysis of the novel splice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and ...",170,78,PLoS_One_2011_Sep_13_6(9)_e24511.txt
3243A>G,...n. The whole mtDNA should be screened because the 3243A>G variant is not as frequent in children as ...,5,1900,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...D [1], [3]. Besides the frequently reported mtDNA 3243A>G mutation, whose functional significance ha...",8,678,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...D [1], [3]. Besides the frequently reported mtDNA 3243A>G mutation, whose functional significance ha...",8,678,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9803A>G,CO3	9803A>G	syn				Novel Variant,50,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
293T>C,6	HVII	293T>C					-,55,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
293T>C,6	HVII	293T>C					-,55,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530 T>C,CYB	15530 T>C	syn				-,57,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530 T>C,CYB	15530 T>C	syn				-,57,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5093T>C,ND2	5093T>C	syn				-,60,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,ATP8	8562C>G	P66R	N	T/0.44	Possibly Damaging	Novel Vari...,62,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4086C>T,ND1	4086C>T	syn				33,64,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,ND6	14582A>G	V31A	N	T/1	Benign	-,69,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,ND6	14582A>G	V31A	N	T/1	Benign	-,69,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,14	CO3	9935T>C	syn				-,71,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9548G>A,CO3	9548G>A	syn				36,72,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,HVI	16526G>A					-,75,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
7762G>A,CO2	7762G>A	syn				-,77,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
7762G>A,CO2	7762G>A	syn				-,77,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14002A>G,ND5	14002A>G	T556A	N	T/0.42	Benign	-,79,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"The 3243A>G variant in tRNA leucine, which is the muta...",92,5,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"The 3243A>G variant in tRNA leucine, which is the muta...",92,5,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4086C>T,"...encies occurred in complex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4:...",92,685,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5300C>T,"...plex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 1...",92,707,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10373G>A,"...ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:...",92,721,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11253T>C,"...086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:1...",92,736,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11928A>G,"... 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 1...",92,756,PLoS_One_2012_Apr_19_7(4)_e34956.txt
12346C>T,"... 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T...",92,785,PLoS_One_2012_Apr_19_7(4)_e34956.txt
13135G>A,"... 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A...",92,795,PLoS_One_2012_Apr_19_7(4)_e34956.txt
13135G>A,"... 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A...",92,795,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,"...; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762...",92,829,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,"...; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762...",92,829,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,"...6C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9...",92,839,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9803A>G,"... 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respira...",92,888,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9947G>A,"...plex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chain enzymes...",92,906,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9947G>A,"...plex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chain enzymes...",92,906,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9947G>A,"...plex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chain enzymes...",92,906,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>G) both 6%, and by the NC7 region (3%) (8289...",92,1261,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>G) both 6%, and by the NC7 region (3%) (8289...",92,1261,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...s 2, 6, 9, 10 and 15). Patient 5 carried mutation 3243A>G and was not further investigated because t...",97,382,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...hyroiditis, which has been previously reported in 3243A>G carriers in the presence of diabetes or ot...",113,879,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...he concept that the heteroplasmy load in blood of 3243A>G declines with age [1], [28]",115,936,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,Figure S1 Detection of 3243A>G mitochondrial mutation by sequence analysi...,153,24,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...nd from her mother (m5) showing the heteroplasmic 3243A>G mutation. Levels of heteroplasmy were high...,153,191,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...nd from her mother (m5) showing the heteroplasmic 3243A>G mutation. Levels of heteroplasmy were high...,153,191,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,... diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2...,196,174,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,... diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2...,196,174,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3380G>A,... I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA. Neuromuscul Disord 18 553...,231,149,PLoS_One_2012_Apr_19_7(4)_e34956.txt
336A>G,... Ching JC  So TM  Lai ST    2010 CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute resp...,263,69,PLoS_One_2012_Feb_27_7(2)_e32273.txt
336A>G,... Ching JC  So TM  Lai ST    2010 CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute resp...,263,69,PLoS_One_2012_Feb_27_7(2)_e32273.txt
336A>G,... Ching JC  So TM  Lai ST    2010 CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute resp...,263,69,PLoS_One_2012_Feb_27_7(2)_e32273.txt
-31G>A,The potential effect on mRNA splicing of the c.188-31G>A mutation was analyzed using the splice site...,71,51,PLoS_One_2012_Jan_3_7(1)_e29205.txt
-31G>A,The potential effect on mRNA splicing of the c.188-31G>A mutation was analyzed using the splice site...,71,51,PLoS_One_2012_Jan_3_7(1)_e29205.txt
325C>T,212	337	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,25,26,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,...no	44.2	MT	intron3	IVS3+2–5 (TAGG)del	DSS	intron3	1468C>T	R490X,28,59,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,262	586	yes	n.a.	n.a.	intron5	IVS5 −4A>G	?	-	-	-,31,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,262	586	yes	n.a.	n.a.	intron5	IVS5 −4A>G	?	-	-	-,31,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,162*	131	yes	n.a.	n.a.	intron 5	IVS5 −4A>G	?	-	-	-,32,39,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,Gene region	Intron3 (+2–5del)	Intron5 (−4A>G)	3′UTR (+195del11 bp),40,41,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,...entified in the examined PCD patients were: IVS5 −4A>G and 3′UTR+(195–205)del. No SNPs were reported...,67,88,PLoS_One_2012_Mar_20_7(3)_e33667.txt
-4A>G,"...ed on the above observations, we assumed that IVS5-4A>G did not represent a causative PCD mutation. ...",67,1158,PLoS_One_2012_Mar_20_7(3)_e33667.txt
14G>C,...have never been described before. A heterozygous −14G>C transversion in the 5′UTR was found in a sin...,125,241,PLoS_One_2012_Mar_20_7(3)_e33667.txt
14G>C,...have never been described before. A heterozygous −14G>C transversion in the 5′UTR was found in a sin...,125,241,PLoS_One_2012_Mar_20_7(3)_e33667.txt
14G>C,...have never been described before. A heterozygous −14G>C transversion in the 5′UTR was found in a sin...,125,241,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...ontrol chromosomes. Two heterozygous transitions, 52A>G and 73G>A, were found in the 3′UTR, each in ...",125,480,PLoS_One_2012_Mar_20_7(3)_e33667.txt
73G>A,"...omosomes. Two heterozygous transitions, 52A>G and 73G>A, were found in the 3′UTR, each in one of two...",125,490,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,...0-5p and 2). Verification of the possibility that 52A>G transition affected the level of RSPH9 expre...,127,778,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,...0-5p and 2). Verification of the possibility that 52A>G transition affected the level of RSPH9 expre...,127,778,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...as not pursued further, given that a heterozygous 52A>G was found in only one patient with no other ...",127,943,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...as not pursued further, given that a heterozygous 52A>G was found in only one patient with no other ...",127,943,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,Number of chromosomes with 325C>T (Q109X)		1	0	2	0	3,173,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,Number of chromosomes with 1468C>T (R490X)		1	0	2	0	3,175,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
460C>T,"The 460C>T (Q154X) mutation (rs118204041), found only ...",178,6,PLoS_One_2012_Mar_20_7(3)_e33667.txt
460C>T,"The 460C>T (Q154X) mutation (rs118204041), found only ...",178,6,PLoS_One_2012_Mar_20_7(3)_e33667.txt
66G>A,"...ighted several associations including infant MTRR 66G>A genotype with DNA methylation (χ2 = 8.82, p ...",5,1800,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,...ne report suggests that maternal and infant MTHFR 677C>T does not affect cord blood methylation of t...,12,931,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"...298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs...",37,174,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"...298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs...",37,174,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"...), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) we...",37,215,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Multipleł	Global	Infant MTRR 66 G>A*	117	−0.033	0.015	0.026	0.083	0.014	0.018	−...,82,30,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	IGF2 Site 3	Infant MTRR 66 G>A*	382	−0.706	0.498	0.157	0.005	0.497	0.156	−...,88,36,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677 C>T,Univariate	IGF2 Site 1	Maternal MTHFR 677 C>T‡	154	2.081	0.694	0.003	0.056	0.651	0.002	0...,90,39,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,Infant RFC1 80G>A*		0.273	0.268	0.311		0.274	0.321	0.099,102,15,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	Global*	179	0.37*	0.32, 0.44	117	0.35*	0.30,...",128,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Site 2	51	50.46	48.37, 53.91	80	51.74	...",135,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Mean	52	47.67	45.23, 51.00	86	49.28	46...",136,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,"MTHFR 1298A>C	ZNT5 Site3	60	92.25	75.00, 97.50	55	97.00	...",137,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"GCPII/FOLHI 1561C>T	IGFBP3 Site 2	83	5.71	5.24, 6.51	35	6.00	5...",138,13,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"GCPII/FOLHI 1561C>T	IGFBP3 Site 2	83	5.71	5.24, 6.51	35	6.00	5...",138,13,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,...t the ZNT5 site 5 locus. The maternal GCPII/FOLHI 1561C>T SNP had a low MAF so data were tested unde...,150,679,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66A>G,"...y assess effect the relationship between the MTRR 66A>G variant and DNA methylation patterns, given ...",157,2352,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66A>G,"...y assess effect the relationship between the MTRR 66A>G variant and DNA methylation patterns, given ...",157,2352,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...as inversely associated with carriage of the MTRR 66G>A variant [60]. In the present study, both vit...",157,2774,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,...argest individual effect sizes (∼6–7%). The MTHFR 677C>T and 1298A>C variant were selected for inves...,161,191,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...enetic factors, specifically vitamin B12 the MTRR 66G>A SNP and MTHFR variants can influence infant ...",168,1330,PLoS_One_2012_Mar_30_7(3)_e33290.txt
-12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	1.56(0...",63,18,PLoS_One_2012_May_18_7(5)_e36962.txt
-12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	1.56(0...",63,18,PLoS_One_2012_May_18_7(5)_e36962.txt
-765G>A,"...s17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three in M...",204,916,PLoS_One_2012_May_18_7(5)_e36962.txt
-2A>G,"...17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_8...",76,111,PLoS_One_2012_May_31_7(5)_e33673.txt
-2A>G,"...ous variants (Table 4). Heterozygous CYP4V2 c.1091-2A>G was one of the 26 variants, and was known to...",83,906,PLoS_One_2012_May_31_7(5)_e33673.txt
-2A>G,"...10del17insGC was carried by the mother II2. c.1091-2A>G mutation was carried by II3, the brother of ...",96,185,PLoS_One_2012_May_31_7(5)_e33673.txt
-7C>T,...in the fourth generation. Intronic variation c.802-7C>T is non-pathogenic,96,384,PLoS_One_2012_May_31_7(5)_e33673.txt
-2A>G,"... the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the splic...",111,56,PLoS_One_2012_May_31_7(5)_e33673.txt
-2A>G,"... the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the splic...",111,56,PLoS_One_2012_May_31_7(5)_e33673.txt
2578C>A,"...olymorphisms that may influence VEGF expression: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C ...",16,1033,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"... region polymorphisms, the T allele of the common 936C>T polymorphism in the 3′-untranslated region ...",37,304,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,There was strong LD between −1154G>A (rs 1570460) and −634G>C (rs2010963) (D′ =...,40,30,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"... (rs2010963) (D′ = 0.92), −2578C>A (rs 699947)and 1154G>A (rs1570360) (D′ = 0.89). There was strong ...",40,112,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control s...",42,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,56,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,62,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...o evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs20...",70,232,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...o evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs20...",70,232,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...o evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs20...",70,232,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"... −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T...",70,270,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"...KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T>A (rs1870377) polymorphisms in Korean patien...",70,315,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...e.0047158.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between...",72,70,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...e.0047158.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between...",72,70,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,74,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,86,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,132,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,138,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,180,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF −1154G>A,186,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,198,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,204,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,210,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,216,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"We used following primers: VEGF −2578C>A polymorphism, forward 5′-GGA TGG GGC TGA C...",227,34,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...bp (C allele) or 326 bp (A allele) product; VEGF −1154G>A polymorphism, forward 5′-CGC GTG TCT CTG G...",227,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...TTC AG-3′, that amplifies a 173 bp product; VEGF −634G>C polymorphism, forward 5′-CAG GTC ACT CAC TT...",227,367,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...TTC AG-3′, that amplifies a 173 bp product; VEGF −634G>C polymorphism, forward 5′-CAG GTC ACT CAC TT...",227,367,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...TCG-3′, that amplifies a 204 bp product; and VEGF 936C>T polymorphism, forward 5′-AAG GAA GAG GAG AC...",227,527,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,The VEGF −2578C>A and −634G>C polymorphisms were identified ...,229,11,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,The VEGF −2578C>A and −634G>C polymorphisms were identified ...,229,11,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"...yamoya patients and control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphis...",244,194,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the KDR −604T...",244,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the KDR −604T...",244,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...A, −634G>C, and 936C>T polymorphisms and the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms is show...",244,260,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634 G>C,"...ion, as suggested by the data in our study, VEGF −634 G>C may be a possible prognostic biomarker aft...",265,59,PLoS_One_2012_Oct_12_7(10)_e47158.txt
677C>T,"... Nagel D , Lohse P  (2006 ) Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofol...",235,91,PLoS_One_2012_Sep_26_7(9)_e46276.txt
677C>T,"... Nagel D , Lohse P  (2006 ) Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofol...",235,91,PLoS_One_2012_Sep_26_7(9)_e46276.txt
14C>T,...ng candidate gene for IO type V. The mutation (c.-14C>T) was predicted to generate an in-frame trans...,69,743,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...r sequencing, we identified the same mutation (c.-14C>T) in proband 4 (Figure 3). Furthermore, it wa...",69,961,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...f IFITM5 identified the identical heterozygous c.-14C>T mutation (black arrow) in all the affected p...,71,112,PLoS_One_2013_Aug_20_8(8)_e72337.txt
826C>T,"...ed risk of ESCC in females. Haplotypes of NFKBIA -826C>T and 3’UTRA>G polymorphisms, C-826G3’UTR and...",18,238,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...demiological studies exploring association of TNFA-308 G>A polymorphism with cancer risk are inconsi...,28,802,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,...NFKB1 (-94 ATTG ins/del; rs28720239) and NFKBIA (-826 C>T; rs2233406) and 3’UTR region of NFKBIA (3’...,30,1292,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,...NFKB1 (-94 ATTG ins/del; rs28720239) and NFKBIA (-826 C>T; rs2233406) and 3’UTR region of NFKBIA (3’...,30,1292,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...rd salting out method [31]. The genotyping of TNFA-308 G>A and NFKB1 -94ins/del ATTG polymorphisms w...,42,250,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...rd salting out method [31]. The genotyping of TNFA-308 G>A and NFKB1 -94ins/del ATTG polymorphisms w...,42,250,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"...equences as described previously [32,33]. NFKBIA -826 C>T and 3’UTR A>G polymorphisms were genotyped...",42,406,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"...rati Indian population in Hapmap database for TNFA-308 G>A polymorphism) and genetic effect of 2.0, ...",48,164,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Association of the TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",89,24,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Association of the TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",89,24,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Association of the TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",89,24,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,108,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,108,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"...sion analysis showed no significant effect of TNFA-308 G>A, NFKB1 -94ATTG ins/del, NFKBIA (-826 C>T ...",125,89,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA -308 G>A polymorphism,130,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA -308 G>A polymorphism,130,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,140,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,140,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,TNFA-308 G>A polymorphism,174,6,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,TNFA-308 G>A polymorphism,174,6,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,238,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,... disequilibrium (LD) analysis showed that NFKBIA -826 C>T and 3’UTR A>G polymorphisms were in modera...,254,58,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,... disequilibrium (LD) analysis showed that NFKBIA -826 C>T and 3’UTR A>G polymorphisms were in modera...,254,58,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Combined risk genotype analysis of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",264,40,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Combined risk genotype analysis of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",264,40,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Combined risk genotype analysis of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",264,40,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphism",264,85,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,The MAF of TNFA -308 G>A polymorphism in present study was 7.1% whi...,292,18,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"...ry, our results suggest independent role of TNFA -308 G>A polymorphism and combined effect of TNFA a...",311,59,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Table S1 Details of genotyping methods of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",314,47,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms",314,92,PLoS_One_2013_Dec_4_8(12)_e81999.txt
31G>C,...1 ) Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophagea...,381,116,PLoS_One_2013_Dec_4_8(12)_e81999.txt
2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end o...,61,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end o...,61,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-end of intron 1...,63,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_5074del]	mono-a...,64,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_5074del]	mono-a...,64,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del]	mono-alle...,68,17,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,IVS5−2A>Gd	c.476−2A>G	A	skipping of exons 6;up-regulation of Δexons...,69,18,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,IVS13−2A>Te*	c.7008−2A>T	A	skipping of exon 14;skipping of 10 bp at 5′...,70,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,IVS5−11T>Gd	c.213−11T>G	A	retention of 59 bp atthe 3′-end of intron ...,93,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,IVS5−11T>Gd	c.213−11T>G	A	retention of 59 bp atthe 3′-end of intron ...,93,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,IVS5−11T>Gd	c.213−11T>G	A	retention of 59 bp atthe 3′-end of intron ...,93,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,IVS9−4A>G	c.594−4A>G	A	none	r.[ = ]	bi-allelic	none	p. ...,95,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end...,98,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,IVS21+3G>Ch*	c.8754+3G>C	D	retention of 46 bp atthe 5′-end of intron 2...,102,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,IVS21+3G>Ch*	c.8754+3G>C	D	retention of 46 bp atthe 5′-end of intron 2...,102,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755...",125,104,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755...",125,104,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955de...",125,129,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,"... 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BR...",125,274,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c...",125,337,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss ...",125,380,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...ticular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss of the whole exons 8, 17 and ...",125,409,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,...s of exon 7 (62 bp at the 3′-end) for BRCA1 c.441+2T>G (Fig. 1E) and partial retention of intron 16 ...,125,678,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,...end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found to give rise to an abnormal transcr...,125,795,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,"...splice site in exon 23. Finally, the BRCA2 c.7008−2A>T variant was observed to give rise to 3 aberra...",125,1528,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,"...splice site in exon 23. Finally, the BRCA2 c.7008−2A>T variant was observed to give rise to 3 aberra...",125,1528,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,"...end of intron 16) (Fig. 2E), and for BRCA2 c.8754+3G>C (46 bp at the 5′-end of intron 21) (Fig. 2F)....",130,694,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,"...end of intron 16) (Fig. 2E), and for BRCA2 c.8754+3G>C (46 bp at the 5′-end of intron 21) (Fig. 2F)....",130,694,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"...are reported in Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revea...",135,406,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revealed maintenance ...",135,422,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... A total of 23 clones were analyzed for the c.476−2A>G mutation. Of these, 20 (87%) carried the rs14...",135,913,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"... A allele. Of the 52 clones analyzed for the 8755−1G>A mutation, 47 (90%) carried the G allele and 5...",135,1042,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,...e assessed for 2 intronic mutations (BRCA1 c.4986+1G>T and c.134+3_134+6delAAGT) due to the lack of ...,137,339,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,"...y analyzed [20]–[22] and BRCA1 c.548−3delT, c.594−4A>G, c.4097G>A, not previously characterized. To ...",139,179,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,c.594−4A>G	NO	0.0%; NS (C)	+1.5; NS (C)	−1.6%; NS (C)	+1...,163,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C)		−...,166,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C)		−...,166,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; S (C)	−...,170,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; S (C)	−...,170,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,...ed mutations (BRCA1 c.5278−2delA and BRCA2 c.7008−2A>T; c.8755−1G>A; c.8954−1_8955delGTTinsAA) of mo...,176,911,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...ted 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analyses indicated th...",181,1170,PLoS_One_2013_Feb_22_8(2)_e57173.txt
-1G>C,M4166	II:1	F	20	17	c.1708-1G>C/Pro840Leu	Hepatic	Absent	Present	Present	Pre...,41,26,PLoS_One_2013_Jul_2_8(7)_e66526.txt
-1G>C,"...mutation (c.2659delG), one splice mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.T...",73,500,PLoS_One_2013_Jul_2_8(7)_e66526.txt
-1G>C,"...mutation (c.2659delG), one splice mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.T...",73,500,PLoS_One_2013_Jul_2_8(7)_e66526.txt
11377 C>G,The common SNP -11377 C>G (rs266729) is located in the promoter re...,27,17,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11377 C>G,The common SNP -11377 C>G (rs266729) is located in the promoter re...,27,17,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type ...",201,137,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11391G>A,"...otide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes ...",201,148,PLoS_One_2013_Jun_24_8(6)_e66808.txt
238G>A,"..., Liu L , Gao T  (2007 ) TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of pso...",180,76,PLoS_One_2013_May_23_8(5)_e64376.txt
592	F>S,Right Lingual Gyrus	−5	83	−7.60	13.30	592	F>S,97,39,PLoS_One_2013_May_3_8(5)_e63220.txt
592	F>S,Right Lingual Gyrus	−5	83	−7.60	13.30	592	F>S,97,39,PLoS_One_2013_May_3_8(5)_e63220.txt
1554	N>R,...rontal Gyrus/Temporal Pole	35.8	−23.5	−16.1	13.35	1554	N>R,100,66,PLoS_One_2013_May_3_8(5)_e63220.txt
982	N>R,Right Lingual Gyrus	−18.4	77.6	−15.9	13.86	982	N>R,101,44,PLoS_One_2013_May_3_8(5)_e63220.txt
349	N>R,Left Amygdala	18.9	1.7	−11.8	16.10	349	N>R,108,36,PLoS_One_2013_May_3_8(5)_e63220.txt
349	N>R,Left Amygdala	18.9	1.7	−11.8	16.10	349	N>R,108,36,PLoS_One_2013_May_3_8(5)_e63220.txt
8590T>C,"..., Aherrahrou Z , et al (2005 ) Association of the 8590T>C polymorphism of CYP4A11 with hypertension ...",217,91,PLoS_One_2013_Nov_21_8(11)_e80072.txt
33T>C,"...sulting in the absence of DARC antigens on RBCs (-33T>C; FyES, erythrocyte-silent) [30]. Although mo...",17,480,PLoS_One_2014_Apr_7_9(4)_e93782.txt
125G>A,"...DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the forward pri...",36,1426,PLoS_One_2014_Apr_7_9(4)_e93782.txt
1G>A,"51	MLH1/Intron 9, c.790+1G>A	Pathogenic	Lost	Normal	Normal	Lost	Yes	Yes",109,25,PLoS_One_2014_Apr_7_9(4)_e94170.txt
418 G>C,...d studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsist...,8,255,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until Octo...,11,108,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until Octo...,11,108,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until Octo...,11,108,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,"...a) must evaluated the association between TIMP2 (-418 G>C) polymorphism and risk of cancer, b) used ...",33,138,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,"...aluate the strength of association between TIMP2 -418 G>C polymorphism and cancer risk, pooled ORs a...",39,65,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,Association of TIMP2 -418 G>C polymorphism and overall cancer susceptibi...,87,23,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...eta-analysis evaluated the relationship of TIMP2 -418 G>C polymorphism with the risk of cancer and s...,109,300,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,Figure S3 Sensitivity analysis of TIMP2 -418 G>C polymorphism,124,43,PLoS_One_2014_Aug_19_9(8)_e88184.txt
333T>C,c.-333T>C	n/a	76	P	0.6	—	—	rs147276162,65,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
-3C>T,ISL1	intron 2-3	c.219-3C>T	n/a	514	M	—	—	—	—,82,22,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,c.*271C>T	n/a	330	P	0.1	—	—	—,86,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
2435C>T,c.*2435C>T	n/a	28	P	—	—	—	rs142969860,88,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
333T>C,"... c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that were found in two patients each, and t...",98,266,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,"...ernal in origin); the second carried BOP/SMYD1 c.*271C>T and TBX1 c.129_185del, p.P43_G61del PPPPRYD...",98,771,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,"...ernal in origin); the second carried BOP/SMYD1 c.*271C>T and TBX1 c.129_185del, p.P43_G61del PPPPRYD...",98,771,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1G>A,...ily with progressive childhood cataracts and IVS3+1G>A CRYBA3/A1 mutations . Mol Vis 16 :2347 –53 .2...,129,123,PLoS_One_2014_Dec_17_9(12)_e115406.txt
5G>A,...and to explore the aberrant transcript from c.615+5G>A in the same CD infant,8,493,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...and to explore the aberrant transcript from c.615+5G>A in the same CD infant,8,493,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...e patient proved a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation....,11,130,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...ons, i.e. c.851_854delGTAT, c.1638_1660dup, c.615+5G>A and IVS16ins3kb, were screened by PCR/LA-PCR ...",30,169,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...rozygote of a maternally-inherited mutation c.615+5G>A and a novel missense mutation c.1064G>A (p.Ar...,103,143,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ipts from the SLC25A13 Allele Harboring the c.615+5G>A Mutatio,114,58,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...uct retained the entire intron 6 due to the c.615+5G>A mutation,118,412,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...uct retained the entire intron 6 due to the c.615+5G>A mutation,118,412,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,Our study in this paper documented c.615+5G>A a real splice-site mutation that led to reten...,134,42,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ation for intron 6 retention in cDNA due to c.615+5G>A in SLC25A13 gene. The retention may lead to p...,134,730,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...es supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, ...",139,304,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1236C>T,"...modulators. Several studies have associated ABCB1 1236C>T, 3435C>T, and 1199G>A with irinotecan conc...",16,867,PLoS_One_2014_Feb_25_9(2)_e89622.txt
3435C>T,"...unctional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant haplotypes 1236T-2677A-3...",157,528,PLoS_One_2014_Feb_25_9(2)_e89622.txt
3435C>T,"...unctional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant haplotypes 1236T-2677A-3...",157,528,PLoS_One_2014_Feb_25_9(2)_e89622.txt
77T>C,"... L , Wu C , Zhang X , et al (2011 ) A functional -77T>C polymorphism in XRCC1 is associated with ris...",212,74,PLoS_One_2014_Jan_28_9(1)_e86086.txt
129C>T,...4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,66,PLoS_One_2014_Jul_14_9(7)_e102065.txt
-138C>T,...7105083	G	G/A	0.263	0.238	0.47	0.266	0.93	C	c.2485-138C>T		intron,101,66,PLoS_One_2014_Jul_14_9(7)_e102065.txt
-110 G>A,"...de distribution of a selected mutation (e.g. IVS I-110 G>A) as well as information (frequencies, org...",130,1074,PLoS_One_2014_Jul_24_9(7)_e103020.txt
94C>A,"...A , Yusoff R , et al (2012 ) Polymorphism of ITPA 94C>A and risk of adverse effects among patients w...",255,99,PLoS_One_2014_Mar_10_9(3)_e91261.txt
94C>A,"...A , Yusoff R , et al (2012 ) Polymorphism of ITPA 94C>A and risk of adverse effects among patients w...",255,99,PLoS_One_2014_Mar_10_9(3)_e91261.txt
17677A>C,"...ns of three other ERCC1 polymorphisms (rs3212961 (17677A>C), rs3212948 G>C, and rs2298881 C>A) with ...",25,2760,PLoS_One_2014_May_19_9(5)_e97616.txt
1123G>C,"..., et al (2007 ) The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from t...",189,105,PLoS_One_2014_May_9_9(5)_e96943.txt
8939A>G,...able analyses. HIF2B rs12593988 (NM_014862.3:c.31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-849...,262,217,PLoS_One_2014_Nov_18_9(11)_e113513.txt
8939A>G,...able analyses. HIF2B rs12593988 (NM_014862.3:c.31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-849...,262,217,PLoS_One_2014_Nov_18_9(11)_e113513.txt
8939A>G,...able analyses. HIF2B rs12593988 (NM_014862.3:c.31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-849...,262,217,PLoS_One_2014_Nov_18_9(11)_e113513.txt
124 G>A,...be accounted for by a gain-of-function mutation (-124 G>A) in the hTERT promoter region (Table S1 an...,45,814,PLoS_One_2014_Nov_6_9(11)_e112438.txt
489C>A,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al....,106,36,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
3860G>A,"...ngle nucleotide polymorphisms (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T),...",57,184,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...morphisms (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516...",57,204,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...s (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and...",57,212,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), an...",57,225,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), an...",57,225,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,"...G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and th...",57,305,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,"...85 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequen...",57,314,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"... four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequencies were 11...",57,326,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation analysis. Sign...",94,185,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation analysis. Sign...",94,185,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation analysis. Sign...",94,185,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,5347C>T,107,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G >A,2159G >A,114,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,516 G>T,119,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785A>G,785A>G			-	-,123,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,-1293G>C,128,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,-1293G>C,128,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,-1293G>C,128,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,7632T>A,132,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,-333T>A			-	-,136,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,-333T>A			-	-,136,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785A>G,"...ax and CLint of CYP2B6 516GG (516 G>T) and 785AA (785A>G) genotypes. However, the Km values of CYP2B...",146,144,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"...ferent from that of CYP1A2. For SNPs -1293G>C and 7632T>A of CYP2E1, the Vmax and CLint of both the ...",146,333,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,...contents and Vmax and/or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also o...,146,549,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,".../or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also observed. However, for...",146,570,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,".../or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also observed. However, for...",146,570,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...n the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used ...",161,1156,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...esent study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used to asses...",161,1164,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...esent study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used to asses...",161,1164,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,...n HLM were rather interesting. SNPs -3860G>A and -3113G>A are located in the distal enhancer region ...,161,2120,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"... distal enhancer region of the CYP1A2 gene. Both -163C>A and 2159G>A are intronic mutations, whereas...",161,2196,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...ymous variant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to h...",161,2315,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...ymous variant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to h...",161,2315,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,"...ant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to have a pote...",161,2325,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to have a potential impact o...",161,2339,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"...lint, negatively correlated with the Km of CYP2B6 516 G>T and 785 A>G wild-type genes. However, no a...",163,737,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...e. However, amino acid changes in the 516 G>T and 785 A>G variants may prevent the interaction of Cy...",165,820,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,"...[13]. None of the 4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an eff...",167,207,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,"...[13]. None of the 4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an eff...",167,207,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,"... SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 activ...",167,226,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,...t heterozygote. This tendency may be because the -1293G>C and 7632T>A mutations can link together to...,167,472,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,...coffee consumption is associated with the CYP1A2 -163C>A polymorphism . Eur J Clin Pharmacol . 2010 ...,208,134,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-11426A>G,"...nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSC...",7,1091,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...esults showed that among these four SNPs, only SNP-12140G>A was associated with NSCLC risk(P<0.05). ...",7,1331,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12410G>A,...ciation of two adiponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a H...,19,82,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...iponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a Han Chinese popula...,19,99,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...dded two other adiponectin gene promoter SNPs (SNP-11426A>G and SNP-11391G>A) to evaluate the associ...,19,427,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...se four adiponectin gene promoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), S...",19,539,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...promoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) ...",19,564,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...promoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) ...",19,564,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...method. Four adiponectin promoter SNPs, namely SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), S...",29,148,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11391G>A,"...ectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,76,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11391G>A,"...ectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,76,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11391G>A,"...ectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,76,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"The allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-1137...",52,44,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ps. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HWE for the NSC...",52,289,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...011 and 0.046, respectively). The G allele for SNP-12140G>A occurred at a significantly higher frequ...",52,550,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,... and genotype frequencies for SNP-11426A>G and SNP-11377C>G were not significantly different in the ...,52,751,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...rison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCL...",54,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control ...",54,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control ...",54,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control groups",54,125,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,62,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,75,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...nectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,92,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...eritance model with the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive mo...,66,481,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...eritance model with the lowest AIC and BIC for SNP-11377C>G was the dominant and log-additive model....,66,602,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...enetic models revealed that the GG genotype of SNP-12140G>A conferred more NSCLC risk in the log-add...,66,730,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...o significant differences for SNP-11426A>G and SNP-11377C>G were found between the NSCLC and control...,66,844,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...3 Different inheritance models analysis of the SNP-12140G>A in adiponectin gene promoter between NSC...,68,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...3 Different inheritance models analysis of the SNP-12140G>A in adiponectin gene promoter between NSC...,68,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...4 Different inheritance models analysis of the SNP-11426A>G in adiponectin gene promoter between NSC...,81,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"Significant LD (D') values between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were...",108,42,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...NP-11377C>G and 0.864 between SNP-11426A>G and SNP-11377C>G. Based on the LD result, we calculated t...",108,263,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...NP-11377C>G and 0.864 between SNP-11426A>G and SNP-11377C>G. Based on the LD result, we calculated t...",108,263,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...NP-11377C>G and 0.864 between SNP-11426A>G and SNP-11377C>G. Based on the LD result, we calculated t...",108,263,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...1.t006Table 6 Different haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponect...",110,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...1.t006Table 6 Different haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponect...",110,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...Different haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponectin gene promot...",110,92,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...lele and genotype frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stag...",121,86,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...lele and genotype frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stag...",121,86,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages I+II and III+I...",123,125,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,128,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,131,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,131,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (A...",134,67,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (A...",134,67,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC) and squamous ce...",134,85,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...ces in the allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between A...",135,83,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Tabl...",135,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,114,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,114,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ysis of the adiponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC...",137,108,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...iponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC) and squamous...",137,122,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140 G>A,SNP-12140 G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	...,139,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140 G>A,SNP-12140 G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	...,139,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426 A>G,SNP-11426 A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	...,142,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377 C>G,SNP-11377 C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	...,145,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,... that the G allele of the adiponectin promoter SNP-12140G>A is a risk factor for NSCLC[23] and that ...,153,420,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"... with those of Cui et al. [30], indicated that SNP-11377C>G is not associated with NSCLC risk and su...",153,1524,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...SCLC risk. Unfortunately, to date, the role of SNP-12140G>A in adiponectin promoter activity and gen...",153,2092,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...just was partly in linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed ...",153,2480,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed this could be pos...",153,2497,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed this could be pos...",153,2497,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...ible one of causes of the divergence that only SNP-12140G>A associated with NSCLC in this Han Chines...,153,2598,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...llele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stag...",155,268,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...e frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stages I+II and III+I...",155,285,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...study. The statistical power for the effect of SNP-12140G>A was calculated using PS software [28],an...",157,180,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"... an association study for adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC...",160,78,PLoS_One_2015_May_27_10(5)_e0127751.txt
3140A>G,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,14,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3052G>A,D1018N	3052G>A	1	0.1,76,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3197C>T,A1066V	3197C>T hom	1	0.1,77,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3120G>A,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,18,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3120G>A,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,18,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3120G>A,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,18,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3197C>T,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,27,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
511 C>T,"...tion statuses were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C for s...",9,2844,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...eported lack of association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) residi...",15,1904,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...eported lack of association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) residi...",15,1904,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...f association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) residing in IL-1 gen...",15,1918,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"...3 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1R...",17,262,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"...3 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1R...",17,262,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"...3 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1R...",17,262,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1RN+8006 T>C (rs419598), IL...",17,314,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...sociation (p>0.0045), a couple of them i.e. IL1B -511 C>T and IL1RN 86bp VNTR certainly showed trend...",51,461,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...he T (minor) allele and the TT genotype for IL1B -511 C>T polymorphism showed a promising trend towa...,51,608,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...he T (minor) allele and the TT genotype for IL1B -511 C>T polymorphism showed a promising trend towa...,51,608,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,Interleukin-1 SNPs included- IL1A-889 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1...,86,34,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...9 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1...,86,87,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...9 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1...,86,87,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...1, 25] to be used for quantitative synthesis for -889 C>T with a data of 1,306 subjects (605 cases a...",91,194,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,... heterogeneity. Lack of association with CAD for -889 C>T was however indicated by our pooled result...,91,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...7–0.57). No significant association with CAD for -889 C>T was detected either, for EA and NIA in our...",91,590,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...range = 0.34–0.90). Apart from the MEA, in which +4845 G>T polymorphism (in the dominant genetic mod...",91,1187,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,-889 C>T (rs1800587),97,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,+4845 G>T (rs17561),105,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,-1903 C>T (rs1143627),126,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,-3954 C>T (rs1143634),134,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,+8006 T>C (rs419598),162,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,+8006 T>C (rs419598),162,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+...,177,131,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,...T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/...,177,160,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,...T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/...,177,160,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,...T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/2+X/X for RN 86bp VNTR; CC vs...,177,189,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...lele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; All...,179,91,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...lele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; All...,179,91,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...lele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; All...,179,91,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... X for RN 86bp VNTR; Allele C vs. Allele T for RN+8006 T>C,179,321,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...t plots depicting meta-analysis results for IL1A +4845 G>T (rs17561) polymorphism,181,95,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...tal of 4 SNPs from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected f...",184,55,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...tal of 4 SNPs from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected f...",184,55,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...present study, two studies[38] were included for -1903 C>T (total sample: 1,041 with 524 cases and 5...",189,65,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...7 controls), 9 studies[25–27, 31, 32, 34–36] for -3954 C>T (total sample: 3,975 with 2,018 cases and...",189,166,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...orementioned SNPs (p value range = 0.62–0.71 for -1903 C>T, p value range = 0.44–0.92 for -3954 C>T ...",189,592,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"... for -3954 C>T and p value range = 0.65–0.72 for -5887 C>T). Additionally, none of the ancestral sub...",189,677,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"... for -3954 C>T and p value range = 0.65–0.72 for -5887 C>T). Additionally, none of the ancestral sub...",189,677,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... as subgroup analysis. No hint of association of +8006 T>C polymorphism with CAD was deduced in the ...,196,281,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... plots depicting meta-analysis results for IL1RN +8006 T>C (rs419598) polymorphism,198,96,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...of ≥ 5 studies). Only three SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR qualified for the same. The...",205,209,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...ciation of both the studied IL1A gene SNPs (i.e. -889 C>T and +4845 G>T) with CAD. Neither of the po...,211,96,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...ry angioplasty (PTCA) has also been reported for -889 C>T which probably testifies its lack of assoc...,211,546,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as see...",220,27,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as see...",220,27,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our ca...",220,38,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...ack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our case-control stu...",220,52,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...5–27, 31, 32, 34–36, 38] Lack of association for -3954 C>T polymorphism with CAD has even been attes...",220,378,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...out of 5 selected IL1RN gene polymorphisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in...",225,171,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8061 C>T,"...N gene polymorphisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in our present case-cont...",225,193,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...r (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN 86bp VNTR) which duly qualifies...",229,358,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887C>T,...t plots depicting meta-analysis results for IL1B -5887C>T (rs1143633) polymorphism,261,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...r’s estimates for allelic genetic model of IL1RN +8006 T>C polymorphism. Abbreviations- EA: European...,290,838,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
938C>A,"...unctional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region...",7,721,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...unctional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region...",7,721,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...unctional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region...",7,721,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...p = 0.004). These results indicate that the BCL2 -938C>A polymorphism influences the occurrence and ...,7,1343,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...th regard to time to aseptic loosening. However, -938C>A genotype distribution of aseptic loosening ...",19,293,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...or might be an indicator of a risk modulation by -938C>A genotypes. To answer this question we perfo...,19,598,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...or might be an indicator of a risk modulation by -938C>A genotypes. To answer this question we perfo...,19,598,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... manufacturer’s protocols. Genotypes of the BCL2 -938C>A polymorphism were determined by Slowdown PC...,26,179,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... manufacturer’s protocols. Genotypes of the BCL2 -938C>A polymorphism were determined by Slowdown PC...,26,179,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... manufacturer’s protocols. Genotypes of the BCL2 -938C>A polymorphism were determined by Slowdown PC...,26,179,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...valuate the time to loosening, dependent on BCL2 -938C>A genotype. The impact of age, BMI, and BCL2 ...",29,555,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Clinical characteristics and BCL2 -938C>A genotype,32,36,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...he 231 patients with primary THA revealed a BCL2 -938C>A genotype distribution with 81 patients carr...,33,226,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...variables was significantly associated with BCL2 -938C>A genotypes. To control for differences in cl...,33,862,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...otypes to further analyze the impact of the BCL2 -938C>A polymorphism on aseptic loosening. Median t...,84,161,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A genotype,87,9,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... Despite correcting for these variables the BCL2 -938C>A polymorphism remained a significant factor ...,94,516,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A,108,7,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...oosening analysis, individual comparison of BCL2 -938C>A genotypes showed similar curve progression ...",117,103,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,We observed that BCL2 -938C>A genotype distributions of aseptic loosening...,122,24,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938 C > A,"...A , Eggert A , Schulte JH , Bachmann HS . The BCL2-938 C > A promoter polymorphism is associated wit...",184,95,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938 C > A,"...A , Eggert A , Schulte JH , Bachmann HS . The BCL2-938 C > A promoter polymorphism is associated wit...",184,95,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938 C > A,"...A , Eggert A , Schulte JH , Bachmann HS . The BCL2-938 C > A promoter polymorphism is associated wit...",184,95,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-2A>G,"...vity: CYP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E...",57,357,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
-2A>G,"...vity: CYP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E...",57,357,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
-2A>G,"...vity: CYP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E...",57,357,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
-2A>G,12. LMNAc	chr1:156100406	c.357-2A>G	Splicing	rs113610699	nd	nd	-,93,31,PLoS_One_2016_May_16_11(5)_e0155421.txt
-2A>G,12. LMNAc	chr1:156100406	c.357-2A>G	Splicing	rs113610699	nd	nd	-,93,31,PLoS_One_2016_May_16_11(5)_e0155421.txt
-2A>G,...fected individuals and heterozygous mutation c.357-2A>G / c.357-2A for the proband and affected fami...,128,322,PLoS_One_2016_May_16_11(5)_e0155421.txt
-2A>G,"We report LMNA c.357-2A>G, a novel transition at the splice acceptor s...",157,21,PLoS_One_2016_May_16_11(5)_e0155421.txt
-2A>G,"We report LMNA c.357-2A>G, a novel transition at the splice acceptor s...",157,21,PLoS_One_2016_May_16_11(5)_e0155421.txt
-1G>T,"...1,32]. In a cohort of 324 DCM patients, LMNA c.357-1G>T was detected in one family that consisted of...",157,344,PLoS_One_2016_May_16_11(5)_e0155421.txt
-2A>G,...tigate the molecular mechanism by which LMNA c.357-2A>G leads to adult-onset SSS and DCM in our fami...,159,59,PLoS_One_2016_May_16_11(5)_e0155421.txt
-1G>T,... with the RNA studies conducted for the LMNA c.357-1G>T family [31]. Since both mutations are at the...,161,144,PLoS_One_2016_May_16_11(5)_e0155421.txt
1805G>T,"... all subjects combined, 2 SNPs in TLR1 (−2192T>C, 1805G>T) were significantly associated with Td (Ta...",114,53,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"...ssociated with Td (Table 2), and one SNP in TLR2 (597T>C) was significantly associated with BOP (Tab...",114,132,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,...ed with BOP (Table 3). One of the 2 SNPs in TLR1 (1805G>T) was significantly associated with Td in C...,114,216,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.56	<0.001a,126,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.56	<0.001a,126,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,African American	Td	TLR1	rs5743618	1805G>T	Ser602Ile	G	Add	-1.72	0.009,127,36,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,African American	Td	TLR1	rs5743618	1805G>T	Ser602Ile	G	Add	-1.72	0.009,127,36,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
28A>G, 	 	 	rs5744077	28A>G	Met10Val	G	Add	-1.22	0.008,134,17,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1607T>C,Caucasian	PPD	TLR4	rs10759932	−1607T>C	-	C	Dom	18.12	0.005,145,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
15607A>G,REC	TLR2	rs1898830	−15607A>G	-	G	Add	12.92	0.006,146,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
15607A>G,REC	TLR2	rs1898830	−15607A>G	-	G	Add	12.92	0.006,146,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1174G>A,BOP	TLR9	rs352139	+1174G>A	-	A	Dom	20.57	0.004,148,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1635G>A,rs352140	1635G>A	Pro545Pro	A	Add	-12.98	0.006,149,13,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...on with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in sepsis, tube...",170,787,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"Most previous studies did not include 597T>C [12,19,22,23]. One study, conducted in 2 No...",174,39,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"... previously associated with PD [18]. In addition, 597T>C is in LD with a 22-bp insertion-deletion po...",174,727,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"... previously associated with PD [18]. In addition, 597T>C is in LD with a 22-bp insertion-deletion po...",174,727,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,"...th TLR1/6 lipopeptide ligands [74]. In addition, −502T>C is in strong LD with 4224C>T (S3 Table), lo...",176,839,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...significant SNPs in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated with HIV st...",178,1362,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
-13T>G,1	F	50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-1G>C,...	50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,54,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-1G>C,...	50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,54,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,... axial + respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,87,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,24,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-1G>A,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,37,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,7	F	51	Proximal weakness LL	IVS1-13T>G	c.236_246del	240	Yes	47	N	N,113,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,8	M	66	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,46,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,...eakness UL and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,69,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,...ximal weakness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,62,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,...eakness UL and LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	458	Yes	46	N	Y,122,69,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,25,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,25,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,22	F	40	Proximal weakness LL	IVS1-13T>G	c.1889-1G>A	831	No	-	N	Y,128,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,27	M	46	Proximal weakness LL	IVS1-13T>G	c.1532 C>A	882	Yes	43	N	Y,133,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,27	M	46	Proximal weakness LL	IVS1-13T>G	c.1532 C>A	882	Yes	43	N	Y,133,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,28	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	952	Yes	51	N	Y,134,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
-13T>G,29	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	432	No	-	N	Y,135,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
646C>G,BclI	c.1184+646C>G (p.?)	rs41423247	32.8%	37.97% (ss1317539254...,132,13,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
3833A>G,"...hat BclI, N363S, ER22/23EK and A3669G (rs6198, c.*3833A>G) did not influence the development of Cush...",192,794,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
409	C>M,"MMSE	27.29±2.31	25.68±2.68	19.33±3.82	201.32*	2, 409	C>M>A",152,50,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...-animal	17.40±4.14	12.86±3.75	8.84±4.31	80.74*	2, 409	C>M>A",157,54,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
404	C>M,"...t items	18.97±5.32	14.46±5.84	8.33±4.57	61.57*	2, 404	C>M>A",158,65,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
404	C>M,"...t items	18.97±5.32	14.46±5.84	8.33±4.57	61.57*	2, 404	C>M>A",158,65,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
354	C>M,"...ng)	88.30±17.91	70.41±23.45	40.73±24.30	63.86*	2, 354	C>M>A",161,85,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"K-BNT	48.15±8.09	40.48±9.97	28.70±11.22	63.33*	2, 409	C>M>A",162,51,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"K-BNT	48.15±8.09	40.48±9.97	28.70±11.22	63.33*	2, 409	C>M>A",162,51,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...-backward	4.10±1.15	3.56±0.97	2.92±0.95	25.23*	2, 409	C>M>A",164,61,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",208,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...Score	49.84±9.59	43.48±7.81	29.06±7.17	168.37*	2, 409	C>M>A",232,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
58 G>A,...A transcript [11]. We hypothesized that the prfA -58 G>A mutation also inactivated the P2 promoter a...,66,1364,PLoS_Pathog_2016_Jul_14_12(7)_e1005741.txt
58 G>A,...he ΔP2 gshF::Tn double mutant and the ΔgshF prfA -58 G>A suppressor mutants all formed plaques appro...,66,1512,PLoS_Pathog_2016_Jul_14_12(7)_e1005741.txt
521T > C,"...al-time polymerase chain reaction (PCR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>...",3,1519,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1639G>A,"... chain reaction (PCR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T,...",3,1537,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G>A,"...CR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T, +1075A>C). Genoty...",3,1555,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
636G > A,... frequency distribution of genotypes of CYP2C19 + 636G > A polymorphism found similar frequencies in...,32,70,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1075A > C,...he Yakuts and the Russians. The study of CYP2C9 + 1075A > C polymorphisms in the groups established ...,32,771,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1075A > C,...he Yakuts and the Russians. The study of CYP2C9 + 1075A > C polymorphisms in the groups established ...,32,771,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G > A,...f minor alleles of polymorphisms in the CYP2C19 + 681G > A and CYP2C9 + 430C > T in the sample we st...,35,656,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
403 G-->A,...RC Makki R Tavernier G Smilie FI Custovic A  The -403 G-->A promoter polymorphism in the RANTES gene...,340,106,Respir_Res_2003_Dec_4_4(1)_14.txt
1G > A,"Intron 1C, c.-5 + 1G > A. Splicing site variant, causing no expressi...",78,20,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...nerated by the wild type, c.-5 + 2dupT and c.-5 + 1G > A minigenes. Screenshots of Peak Scanner elec...",179,174,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Interestingly, mutations c.-5 + 1G > A and c.-5 + 2dupT triggered the elimination ...",183,33,Respir_Res_2014_Oct_7_15(1)_125.txt
33T>C,"...FY*B/FY*B in 158 (39.50%) samples. The mutation (-33T>C), which occurs in the GATA-box erythroid pro...",114,148,Rev_Bras_Hematol_Hemoter_2011_33(1)_21-25.txt
181A>G,Carriers for the MMP-7 (-181A>G) GG were associated with an increased risk ...,10,26,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...sent study was to investigate the role of MMP-7 (–181A>G) (rs11568818) in conferring genetic suscept...,21,659,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...erence. Observed genotype frequencies for MMP-7 (-181A>G) polymorphism (rs17878362) in controls were...,34,666,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...erence. Observed genotype frequencies for MMP-7 (-181A>G) polymorphism (rs17878362) in controls were...,34,666,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...ical models to predict the association of MMP-7 (-181A>G) genotypes with susceptibility to EC. Assoc...,34,1031,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Association of genetic variant of MMP-7 (-181A>G) polymorphism with susceptibility to E,42,43,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Association of genetic variant of MMP-7 (-181A>G) polymorphism with susceptibility to E,42,43,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...reference, we found that individuals with MMP-7 (-181A>G) GG genotype were significantly associated ...",43,344,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 3 Association of MMP-7 (–181A>G) genotypes with tumor histopathology and ri...,50,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...esent study, we looked for the effect of MMP- 7 (-181A>G) promoter polymorphism on the genetic susce...",62,60,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...rted studies suggesting an association of MMP-7 (-181A>G) GG genotypes with an increased risk of var...,62,484,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...graphical differences in the influence of MMP-7 (-181A>G) on the susceptibility of various cancers,62,888,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,... susceptibility to ESCC. Determination of MMP-7 (–181A>G) genotype may provide a useful genetic mark...,72,490,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
1G>T,... and each additional LoF allele in SLCO1B1 (c.481+1G>T) demonstrated an increasing effect on hexadec...,50,485,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,... effect on hexadecanedioate levels. LRRC69 (c.933+2T>A) homozygous LoF status appeared to have a mar...,50,567,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,... effect on hexadecanedioate levels. LRRC69 (c.933+2T>A) homozygous LoF status appeared to have a mar...,50,567,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,...rs. (D) Deoxycarnitine levels among LRRC69 (c.933+2T>A) LoF mutation carriers,53,376,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,"....975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous gen...",86,74,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2R > T,"...low the following inequalities: T > R > P ≥ S and 2R > T + S. Here, 2R > T + S makes mutual cooperat...",18,1340,Sci_Rep_2014_Aug_29_4_6224.txt
-1639G>A,. Association of VKORC1-1639G>A polymorphism with susceptibility to ossif...,216,24,Sci_Rep_2016_Feb_12_6_21580.txt
8422G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/...,90,12,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
4606C>G,RP:S-10	c.[4606C>G];[5038A>G]	55/M	40	NA	NA	NA	NA,93,12,Sci_Rep_2016_Jan_20_6_19432.txt
5038A>G,RP:S-10	c.[4606C>G];[5038A>G]	55/M	40	NA	NA	NA	NA,93,22,Sci_Rep_2016_Jan_20_6_19432.txt
9059T>C,RP:S-14	c.[9059T>C]	14/M	0	R-a/b	R-a/b	PD/ODW	PD/ODW,94,12,Sci_Rep_2016_Jan_20_6_19432.txt
1418G>T,RP:S-18	c.[1418G>T];[2971C>T]	55/M	52	NA	NA	NA	NA,95,12,Sci_Rep_2016_Jan_20_6_19432.txt
7187G>A,RP:S-34	c.[7187G>A]	44/F	14	NA	NA	NA	NA,97,12,Sci_Rep_2016_Jan_20_6_19432.txt
1G>A,RHD*DEL8 (IVS3+1G>A)	Splice site mutation	6,167,16,Sci_Rep_2016_Sep_1_6_32317.txt
1911A > G,"...ion, and transient receptor potential vanilloid 1 1911A > G (rs8065080, I585V) was associated with c...",58,2906,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
2677G > T,"...ementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A protect against the respiratory depres...",68,913,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
2677G > T,"...ementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A protect against the respiratory depres...",68,913,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
572G > C,...  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predict...,142,83,Stem_Cells_Int_2015_May_28_2015_498328.txt
572G > C,...  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predict...,142,83,Stem_Cells_Int_2015_May_28_2015_498328.txt
-857C>T,"...r ischemic stroke, we analyzed the role of the TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymo...",30,146,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...ndard salt extraction procedure. Polymorphisms TNF-857C>T  (rs1799724),  TNFRSF1A36A>G  (rs767455), ...",43,131,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...ndard salt extraction procedure. Polymorphisms TNF-857C>T  (rs1799724),  TNFRSF1A36A>G  (rs767455), ...",43,131,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...inberg equilibrium in patients.  Regarding the TNF-857C>T polymorphism distribution, a high prevalen...",51,241,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...ent study, we investigated the association of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymo...",58,62,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...rphism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic s...,60,368,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...rphism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic s...,60,368,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,... to exclude this polymorphism and focus on the TNF-857C>T polymorphism. Our study exerted that this ...,62,299,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,... to exclude this polymorphism and focus on the TNF-857C>T polymorphism. Our study exerted that this ...,62,299,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,Polymorphisms	TNF-857C>T	TNFRSF1A36A>G	TNFRSF1B676T>G,92,18,Stroke_Res_Treat_2011_May_29_2011_920584.txt
1173 C>T,"...*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T substitution of VKORC1 had minor allele f...",15,85,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"...*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T substitution of VKORC1 had minor allele f...",15,85,Thromb_J_2008_Jun_17_6_7.txt
1173C>T,...an CYP2C9 due to markedly higher frequency of the 1173C>T polymorphism than of the CYP2C9*2 and CYP2...,105,1306,Thromb_J_2008_Jun_17_6_7.txt
2255 C>T,...d a significant association between the rs2359612/2255 C>T VKORC1 polymorphism (a polymorphism found...,109,498,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,...e in strong linkage disequilibrium with rs9934438/1173 C>T) and the risk of coronary heart disease (...,109,603,Thromb_J_2008_Jun_17_6_7.txt
678 C>A,"...orted a new heterozygous MTHFR gene polymorphism (678 C>A), with an unusual melting point profile. A...",20,78,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
183	N>D,183	N>D	F>S,79,1,Virol_J_2009_Nov_16_6_198.txt
383	I>M,383	I>M	no change,109,1,Virol_J_2009_Nov_16_6_198.txt
616	L>I,616	L>I	V>F,137,1,Virol_J_2009_Nov_16_6_198.txt
668	S>L,668	S>L	no change	S>L,143,1,Virol_J_2009_Nov_16_6_198.txt
668	S>L,668	S>L	no change	S>L,143,1,Virol_J_2009_Nov_16_6_198.txt
379	R>K,379	R>K	no change,165,1,Virol_J_2009_Nov_16_6_198.txt
465T>C,"... determinants at 4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gen...",7,88,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,"...ic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functional effect...",7,116,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,"...ic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functional effect...",7,116,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
-2A>G,"... a heterozygous splice site mutation in TP53, IVS6-2A>G, and no other mutations in cancer-related ge...",22,978,Yale_J_Biol_Med_2015_Jun_1_88(2)_181-185.txt
46 A>G,"... the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a sing...",8,487,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a sing...",8,487,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a sing...",8,487,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79 C>G,"...adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base ...",8,495,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...rameters. The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly as...",11,178,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...rameters. The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly as...",11,178,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...pe of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated with work-re...",11,199,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
47 T>C,... extension 5'-CXCGCAGAGCXCCGCCGTGGGTCCGCC-3' for -47 T>C; forward 5'-CAGGAAACAGCTATGACCGCACATAACGGGC...,34,595,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"...s. Melting processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A S...",36,316,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252G>A,"...-47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for 1 minute. Extensions were done at 7...",36,358,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... USA), and three haplotype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Signif...",41,152,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...nd three haplotype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Significant de...",41,160,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...otype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Significant departures of t...",41,173,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...sons. The results of power analysis were 0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (...",52,393,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... WRS. When the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate ...",54,106,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...en the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-...",54,114,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...en the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-...",54,114,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...ype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-related sympt...",54,127,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,...est that workers with the AG/GG genotype of ADRB2 46 A>G are at a higher risk of generating wheat-sp...,68,1053,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...*The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic receptor genetic polym...",81,217,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"*The haplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic rece...",99,32,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
769C>T,c.[769C>T];[769C>T],102,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],102,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],106,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
47C>T,c.[769C>T];[47C>T],110,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
47C>T,c.[769C>T];[47C>T],110,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],116,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
